<SEC-DOCUMENT>0001047469-18-002886.txt : 20180417
<SEC-HEADER>0001047469-18-002886.hdr.sgml : 20180417
<ACCEPTANCE-DATETIME>20180417161736
ACCESSION NUMBER:		0001047469-18-002886
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20180521
FILED AS OF DATE:		20180417
DATE AS OF CHANGE:		20180417
EFFECTIVENESS DATE:		20180417

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRUKER CORP
		CENTRAL INDEX KEY:			0001109354
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				043110160
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30833
		FILM NUMBER:		18759186

	BUSINESS ADDRESS:	
		STREET 1:		40 MANNING RD
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821
		BUSINESS PHONE:		978663-3660

	MAIL ADDRESS:	
		STREET 1:		40 MANNING RD
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRUKER BIOSCIENCES CORP
		DATE OF NAME CHANGE:	20030721

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRUKER DALTONICS INC
		DATE OF NAME CHANGE:	20000315
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>a2235152zdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#18ZAG15601_1">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B> SCHEDULE 14A  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Proxy Statement Pursuant to Section 14(a) of<BR>
the Securities Exchange Act of 1934 (Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;) </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2> Filed by the Registrant <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Filed by a Party other than the Registrant <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2><BR>
Check the appropriate box:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Preliminary Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Definitive Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Definitive Additional Materials</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Soliciting Material under &sect;240.14a-12<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> Bruker Corporation</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> (Name of Registrant as Specified In Its Charter)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> (Name of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2><BR>
Payment of Filing Fee (Check the appropriate box):</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>No fee required.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and&nbsp;0-11.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Title of each class of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Aggregate number of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Proposed maximum aggregate value of transaction:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(5)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Total fee paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Fee paid previously with preliminary materials.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Check box if any part of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><BR><FONT SIZE=2>Amount Previously Paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Form, Schedule or Registration Statement No.:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Filing Party:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Date Filed:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=389667,FOLIO='blank',FILE='DISK133:[18ZAG1.18ZAG15601]BA15601A.;3',USER='CHE109863',CD='10-APR-2018;02:04' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="bc15601_bruker_corporation_40_manning___bru01584"> </A>
<A NAME="toc_bc15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  BRUKER CORPORATION<BR>  40 Manning Road<BR>  Billerica, MA 01821<BR>  (978)&nbsp;663-3660    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>Dear
Stockholder: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
behalf of the board of directors and management of Bruker Corporation, I would like to invite you to attend our Annual Meeting of Stockholders to be held on Monday, May&nbsp;21,
2018 at 9:30&nbsp;a.m., Local Time, at the offices of Nixon Peabody&nbsp;LLP, 100 Summer Street, Boston, Massachusetts. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Notice of Annual Meeting of Stockholders and Proxy Statement, which describe the formal business to be conducted at the meeting, and Proxy Card accompany this letter. The Company's
Annual Report to Stockholders is also enclosed for your information. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
Stockholders are invited to attend the Meeting. To ensure your representation at the Meeting, however, you are urged to vote by proxy by completing, dating and returning the enclosed
Proxy Card. A postage-paid envelope is enclosed for that purpose. Regardless of the number of shares you own, your careful consideration of, and vote on, the matters before the Stockholders is
important. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
look forward to your participation and thank you for your continued support. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="50%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Sincerely,</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B>
<IMG SRC="g83886.jpg" ALT="GRAPHIC" WIDTH="337" HEIGHT="40">
 </B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Frank H. Laukien, Ph.D.</B></FONT><FONT SIZE=2><BR>
Chairman, President and Chief Executive Officer</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=2,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=976410,FOLIO='blank',FILE='DISK133:[18ZAG1.18ZAG15601]BC15601A.;3',USER='CHE109863',CD='10-APR-2018;02:04' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="be15601_bruker_corporation_not__be102461"> </A>
<A NAME="toc_be15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  BRUKER CORPORATION<BR>  NOTICE OF ANNUAL MEETING OF STOCKHOLDERS    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>To
Our Stockholders: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notice
is hereby given that the Annual Meeting of the Stockholders of Bruker Corporation will be held on Monday, May&nbsp;21, 2018, at 9:30&nbsp;a.m., Local Time, at the offices of
Nixon Peabody&nbsp;LLP, 100&nbsp;Summer Street, Boston, Massachusetts, for the following purposes: </FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>1.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>To
elect the Class&nbsp;III nominees for director named in the accompanying proxy statement to hold office until the 2021 Annual Meeting of Stockholders.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>2.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>To
hold an advisory vote to approve compensation paid to our named executive officers.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>3.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>To
ratify the selection of PricewaterhouseCoopers&nbsp;LLP as our independent registered public accounting firm for fiscal year 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>4.</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>To
transact such other business as may properly come before the meeting or any adjournment or postponement thereof. </FONT></DD></DL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
board of directors has fixed the close of business on March&nbsp;26, 2018 as the record date for the determination of stockholders entitled to notice of and to vote at this Annual
Meeting and at any adjournment or postponement thereof. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="50%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>By order of the board of directors</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B>
<IMG SRC="g83886.jpg" ALT="GRAPHIC" WIDTH="337" HEIGHT="40">
 </B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Frank H. Laukien, Ph.D.</B></FONT><FONT SIZE=2><BR>
Chairman, President and Chief Executive Officer</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>Billerica,
Massachusetts<BR>
April&nbsp;17, 2018 </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
stockholders are invited to attend the meeting. Whether or not you plan to attend, you can ensure that your shares are represented at the meeting by promptly voting and submitting
your proxy by telephone or by the internet, or by completing, dating and returning the enclosed Proxy Card in the enclosed postage-paid envelope. Your shares cannot be voted unless you vote by
telephone or internet, date, sign and return the enclosed Proxy Card, or attend the meeting in person. Regardless of the number of shares you own, your careful consideration of, and vote on, the
matters before the stockholders is important. Even if you have given your proxy, you may still vote in person if you attend the meeting. Please note, however, that if your shares are held of record by
a broker, bank or other nominee and you wish to vote at the meeting, you will not be permitted to vote in person at the meeting unless you first obtain a proxy issued in your name from the record
holder. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>**************</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON MAY 21, 2018:</B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B>This Proxy Statement and the accompanying Annual Report are available via the Internet at: </B></FONT><FONT SIZE=2><B><I>https://ir.bruker.com</I></B></FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=3,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=414627,FOLIO='blank',FILE='DISK133:[18ZAG1.18ZAG15601]BE15601A.;6',USER='HYUNG',CD='10-APR-2018;15:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="da15601_bruker_corporation_proxy_statement"> </A>
<A NAME="toc_da15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  BRUKER CORPORATION<BR>  PROXY STATEMENT    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This proxy statement and the enclosed proxy card are furnished in connection with the solicitation of proxies by the board of directors of
Bruker Corporation (the "Company") for use at the 2018 Annual Meeting of Stockholders (the "2018 Annual Meeting") to be held on May&nbsp;21, 2018, at the time and place set forth in the notice of
the meeting and at any adjournments thereof. The approximate date on which this proxy statement and form of proxy are first being sent to stockholders is April&nbsp;17, 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
holders of a majority in interest of all of the Company's common stock, par value $.01 per share ("Common Stock") issued, outstanding and entitled to vote are required to be present
in person or be represented by proxy at the 2018 Annual Meeting in order to constitute a quorum for the transaction of business. Each share of Common Stock outstanding on the record date will be
entitled to one vote on all matters. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
Proposal No.&nbsp;1, the candidates for election as Class&nbsp;III directors at the 2018 Annual Meeting who receive the highest number of affirmative votes will be elected to
serve for terms expiring at the 2021 Annual Meeting of Stockholders. For Proposal No.&nbsp;2, the non-binding, advisory vote regarding the compensation of the Company's named executive officers, and
Proposal No.&nbsp;3, the ratification of the appointment of PricewaterhouseCoopers&nbsp;LLP as our independent registered public accounting firm for fiscal 2018, the affirmative vote of holders of
a majority of the shares of Common Stock represented in person or by proxy and entitled to vote on the proposal will be required for approval. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Because
abstentions with respect to any matter are treated as shares present or represented and entitled to vote for the purposes of determining whether that matter has been approved by
the stockholders, abstentions have the same effect as negative votes for each proposal other than the election of directors. "Withhold" votes for any of the nominees for election as a director will
have no effect on the outcome of Proposal No.&nbsp;1, the election of the nominees for director. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the enclosed proxy card is properly executed and returned, it will be voted in the manner instructed by the stockholder. If a proxy card is properly submitted but contains no
instructions, the shares represented thereby will be voted FOR all nominees for director in Proposal No.&nbsp;1, FOR approval of the non-binding, advisory vote regarding the compensation of the
Company's named executive officers in Proposal No.&nbsp;2 and FOR ratification of the appointment of PricewaterhouseCoopers&nbsp;LLP as our independent registered public accounting firm for fiscal
2018 in Proposal No.&nbsp;3. In addition, if other matters come before the meeting, the persons named in the accompanying proxy and acting thereunder will have discretion to vote on those matters in
accordance with their best judgment. Any person signing the enclosed form of proxy has the power to revoke it by voting in person at the meeting or by giving written notice of revocation to the
Secretary of the Company at any time before the proxy is exercised. Please note, however, that if your shares are held of record by a broker, bank or nominee and you wish to vote at the meeting, you
will not be permitted to vote in person unless you first obtain a proxy issued in your name from the record holder. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
shares are held in the "street name" of a broker or other nominee, the broker or nominee may not be permitted to exercise voting discretion with respect to certain of the proposals to
be acted upon. If the broker or nominee is not given instructions as to how to vote such shares, the broker has authority under New York Stock Exchange rules to vote those shares for or against
"routine" matters, such as Proposal No.&nbsp;3, the ratification of PricewaterhouseCoopers&nbsp;LLP as our independent registered public accounting firm. Brokers cannot vote on their customers'
behalf on "non-routine" matters such as Proposal No.&nbsp;1, the election of directors or Proposal No.&nbsp;2, the approval of the advisory vote on the compensation of the Company's named
executive officers. These rules apply notwithstanding the fact that shares of the Company's Common Stock are traded on the NASDAQ Global Select Market. If you provide voting instructions to the broker
or nominee holder of your shares for Proposal No.&nbsp;1 or Proposal No.&nbsp;2, but do not provide voting instructions for each of these proposals, your shares will be voted in accordance with
your instructions on the particular matters for which you provided instructions, and will result in a "broker non-vote" with respect to the matters for which you did not </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=4,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=569168,FOLIO='blank',FILE='DISK133:[18ZAG1.18ZAG15601]DA15601A.;7',USER='CHE109863',CD='10-APR-2018;02:46' -->
<A NAME="page_da15601_1_2"> </A>

<P style="font-family:times;"><FONT SIZE=2>provide
voting instructions. If the brokerage firm lacks discretionary voting power with respect to an item that is not a routine matter and you do not provide voting instructions, such shares will be
counted for purposes of establishing a quorum to conduct business at the 2018 Annual Meeting, but
will not be counted for purposes of determining whether stockholder approval of any particular matter has been obtained. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will bear the cost of the solicitation. Although it is expected that the solicitation will be primarily by mail, regular employees or representatives of the Company (none of
whom will receive any extra compensation for their activities) may also solicit proxies by telephone, facsimile and in person and arrange for brokerage houses and other custodians, nominees and
fiduciaries to send proxies and proxy materials to their principals at the expense of the Company. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
2018 Annual Meeting will be held at the offices of Nixon Peabody&nbsp;LLP, 100&nbsp;Summer Street, Boston, Massachusetts. Directions to the meeting may be obtained by contacting
Investor Relations at&nbsp;(978)&nbsp;663-3660, extension&nbsp;1479. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company's 2017 Annual Report, including the Company's audited financial statements for the fiscal year ended December&nbsp;31, 2017, is being mailed to stockholders concurrently
with this proxy statement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company's principal executive offices are located at 40 Manning Road, Billerica, Massachusetts 01821, and its telephone number is (978)&nbsp;663-3660. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="da15601_record_date_and_voting_securities"> </A>
<A NAME="toc_da15601_2"> </A>
<BR></FONT><FONT SIZE=2><B>  RECORD DATE AND VOTING SECURITIES    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Only stockholders of record at the close of business on March&nbsp;26, 2018 are entitled to notice of and to vote at the 2018 Annual Meeting.
On March&nbsp;26, 2018, the Company had outstanding and entitled to vote 156,077,866 shares of Common Stock. Each outstanding share of Common Stock entitles the record holder to one vote. Broadridge
Financial Solutions,&nbsp;Inc. will tabulate all votes that are received prior to the date of the 2018 Annual Meeting. The inspector of elections, who will be one of our employees or one of our
attorneys, will receive Broadridge's tabulation, tabulate all other votes, and certify the voting results. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="da15601_corporate_information"> </A>
<A NAME="toc_da15601_3"> </A>
<BR></FONT><FONT SIZE=2><B>  CORPORATE INFORMATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bruker Corporation was incorporated in Massachusetts as Bruker Federal Systems Corporation. In February 2000, we reincorporated in Delaware as
Bruker Daltonics&nbsp;Inc. In July 2003,
we merged with Bruker AXS&nbsp;Inc., and we were the surviving corporation in that merger. In connection with that merger, we changed our name to Bruker BioSciences Corporation and formed two
operating subsidiaries, Bruker Daltonics and Bruker AXS, into which we transferred substantially all of their respective assets and liabilities, except cash. We acquired Bruker Optics&nbsp;Inc. in
July 2006 and the Bruker BioSpin group of companies in February 2008. In connection with the Bruker BioSpin acquisition, we changed our name to Bruker Corporation. Our four principal operating
segments are the Bruker BioSpin Group, the Bruker CALID Group, the Bruker Nano Group and Bruker Energy&nbsp;&amp; Supercon Technologies, or BEST. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=5,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=154069,FOLIO='2',FILE='DISK133:[18ZAG1.18ZAG15601]DA15601A.;7',USER='CHE109863',CD='10-APR-2018;02:46' -->
<A NAME="page_da15601_1_3"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="da15601_proposal_no._1_election_of_directors"> </A>
<A NAME="toc_da15601_4"> </A>
<BR></FONT><FONT SIZE=2><B>  PROPOSAL NO. 1<BR>  ELECTION OF DIRECTORS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The first proposal on the agenda for the 2018 Annual Meeting is the election of Joerg C. Laukien, William A. Linton, Ph.D. and Adelene Q.
Perkins to serve as Class&nbsp;III directors for three-year terms beginning at the 2018 Annual Meeting and ending at our 2021 Annual Meeting of Stockholders or until a successor has been duly
elected and qualified. The Company's Certificate of Incorporation, as amended, provides that the board of directors shall consist of three classes of directors with overlapping three-year terms. One
class of directors is to be elected each year for a three-year term. Directors are assigned to each class in accordance with a resolution or resolutions adopted by the board of directors, each class
consisting, as nearly as possible, of one-third the total number of directors. There are currently twelve members of our board of directors, consisting of four Class&nbsp;I directors serving terms
expiring at the Annual Meeting of Stockholders in 2019, four Class&nbsp;II directors serving terms expiring at the Company's 2020 Annual Meeting and four Class&nbsp;III directors serving terms
expiring at the Company's Annual Meeting of Stockholders in 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effective
as of the 2018 Annual Meeting, in conjunction with the expiration of the terms of the four current Class&nbsp;III directors, the number of directors will be reduced to eleven
and the classes will be adjusted to consist of four Class&nbsp;I directors, four Class&nbsp;II directors and three Class&nbsp;III directors. At the 2018 Annual Meeting, three nominees will be
elected as Class&nbsp;III directors to serve for terms expiring at the 2021 Annual Meeting of Stockholders. Each of the nominees for Class&nbsp;III director, Joerg C. Laukien, William A. Linton,
Ph.D. and Adelene Q. Perkins, was previously elected by our stockholders and is currently serving as a Class&nbsp;III director. All nominees were unanimously approved by our board of directors,
including unanimous approval by our independent directors, upon the recommendation of the Nominating Committee. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Richard
D. Kniss, who has served as a Class&nbsp;III director since 2003, has not been nominated for re-election and, accordingly, his service on the board of directors will terminate
at the 2018 Annual Meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
marked otherwise, proxies received will be voted </FONT><FONT SIZE=2><B>FOR</B></FONT><FONT SIZE=2> the election of each of the nominees for the office of director. If any such
nominee is unwilling or unable to serve as a nominee for the office of director at the time of the 2018 Annual Meeting, the proxies may be voted for a substitute nominee who shall be designated by the
present board of directors to fill such vacancy. Alternatively, if no such nominee is designated, a vacancy will be created in Class&nbsp;III. The board of directors has no reason to believe that
any of the nominees will be unwilling or unable to serve if elected as a director. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B><I>The Board of Directors recommends a vote FOR the election of Joerg C. Laukien, William A. Linton,&nbsp;Ph.D. and Adelene Q. Perkins to serve as Class&nbsp;III
directors.</I></B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Certain Information Regarding Directors and Nominees  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The biographies of the nominees and each of our continuing directors below contain information regarding each person's service as a director,
business experience, director positions held currently or at any time during the last five years, information regarding involvement in certain legal or administrative proceedings, if applicable, and
the experiences, qualifications, attributes or skills that caused the board of directors to determine that the person should serve as a director of the Company. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=6,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=438654,FOLIO='3',FILE='DISK133:[18ZAG1.18ZAG15601]DA15601A.;7',USER='CHE109863',CD='10-APR-2018;02:46' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dc15601_1_4"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Nominees for Election to a Three-Year Term Expiring at the 2021 Annual Meeting  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <P style="font-family:times;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="126pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="238pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><B>Joerg C. Laukien</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2> Age 64</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>Director Since 2003</B></FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Mr.&nbsp;Joerg Laukien served as Executive Chairman of Bruker BioSpin Corporation from 2010 until his retirement from employment effective December&nbsp;31, 2017. Until December
2013, Joerg Laukien was a Managing Director of Bruker BioSpin MRI&nbsp;GmbH since 1997 and a Managing Director of Bruker Elektronik&nbsp;GmbH from 1991 until its merger with Bruker BioSpin&nbsp;GmbH in 2010, a director and President of Bruker BioSpin
MRI,&nbsp;Inc. from 1997 to 2010 and a director of Bruker Energy&nbsp;&amp; Supercon Technologies,&nbsp;Inc. from 2008 through March 2013. Joerg Laukien is the Company's third largest shareholder, and he is the brother of Dr.&nbsp;Frank H. Laukien,
the Chairman, President and Chief Executive Officer of the Company. Joerg Laukien serves as a member of the regional advisory council of Deutsche Bank AG in Germany. He holds a Bachelor of Arts degree from the Verwaltungs- und Wirtschafts-Akademie in
Karlsruhe, Germany. Joerg Laukien brings extensive executive experience within the Company to the Board, as well as experience in financial and strategic planning.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2><B> William A. Linton, Ph.D.</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2> Age 70</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2> Director Since 2000</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Dr.&nbsp;Linton serves as the lead director of our board of directors. He was appointed lead director in March 2004 by the independent members of the board of directors. As lead
director, Dr.&nbsp;Linton performs the usual responsibilities of a lead director including acting as a liaison between management and the board of directors. Since 1978, Dr.&nbsp;Linton has served as the Chairman, President and Chief Executive
Officer of Promega Corporation, Madison, Wisconsin, a privately-held life science supply company founded by Dr.&nbsp;Linton. Dr.&nbsp;Linton received a Bachelor of Science degree from University of California, Berkeley in 1970 and honorary doctorate
degrees from Hannam University (Korea) in 2004 and the University of Wisconsin Madison in 2015. Dr.&nbsp;Linton is a director of ALDA (Analytical, Life Science&nbsp;&amp; Diagnostics Association), a director of Heffter Research Institute (a
non-profit research institute), a member of the Supervisory Board of Eppendorf AG, Hamburg (a private life sciences company), founder and Executive Director of Usona Institute (a non-profit medical research organization) and President of the
BioPharmaceutical Technology Center Institute (a non-profit organization). Dr.&nbsp;Linton brings to the board extensive executive, international operations management and technical expertise in the life sciences industry, as well as significant
experience in strategic planning, corporate governance, and executive compensation matters.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Dr.&nbsp;Linton serves on the Company's Nominating Committee.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=7,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=1006739,FOLIO='4',FILE='DISK133:[18ZAG1.18ZAG15601]DC15601A.;10',USER='CHE109863',CD='10-APR-2018;02:04' -->
<A NAME="page_dc15601_1_5"> </A>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <P style="font-family:times;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="126pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="238pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Adelene Q. Perkins</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2> Age 58</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2> Director Since 2017</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Ms.&nbsp;Perkins currently serves as Chief Executive Officer of Infinity Pharmaceuticals,&nbsp;Inc., a publicly traded clinical-stage biopharmaceutical company, a position she
has held since January 2010. Ms.&nbsp;Perkins also has served as Chair of Infinity Pharmaceuticals,&nbsp;Inc.'s board of directors since November 2012. Within Infinity Pharmaceuticals,&nbsp;Inc., Ms.&nbsp;Perkins served as President and Chief
Business Officer from October 2008 through December 2009, and as Executive Vice President and Chief Business Officer from June 2002 to October 2008. Ms.&nbsp;Perkins served from 2000 to 2002 as Vice President of Business and Corporate Development of
TransForm Pharmaceuticals,&nbsp;Inc., a privately-held specialty pharmaceutical company. From 1992 to 1999, Ms.&nbsp;Perkins held various positions at Genetics Institute, now a unit of Pfizer. From 1985 to 1992, Ms.&nbsp;Perkins held a variety of
positions at Bain&nbsp;&amp; Company, a management consulting firm. Ms.&nbsp;Perkins currently serves on the board of directors of Massachusetts General Hospital, BIO (Biotechnology Industry Organization), the Massachusetts Biotechnology Council and
two biotechnology industry trade organizations, and is the Vice Chairman of the board of Project Hope, a not-for-profit social service agency. She previously served on the board of Padlock Therapeutics,&nbsp;Inc., a privately-held biotechnology
company, prior to its acquisition by Bristol-Myers Squibb Company in 2016. Ms.&nbsp;Perkins holds a Master of Business Administration from the Harvard Business School, as well as a Bachelor of Science degree in chemical engineering from Villanova
University. Ms.&nbsp;Perkins has more than 30&nbsp;years of international business and corporate strategy experience and brings to the board a valuable understanding of the pharmaceutical and life sciences industries, as well as significant
experience in various aspects of public company management and governance.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Ms.&nbsp;Perkins serves on the Company's Audit Committee.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2><B><BR>
Directors Continuing in Office until the 2019 Annual Meeting</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Frank H. Laukien, Ph.D.</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2> Age 58</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2><B>Director Since 1991</B></FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Dr.&nbsp;Frank H. Laukien has been the Chairman, President and Chief Executive Officer of the Company since February 1991 and is the Company's largest shareholder.
Dr.&nbsp;Laukien also serves as a director of various subsidiaries of the Company. Dr.&nbsp;Laukien is the brother of Joerg C. Laukien, a director of the Company. Dr.&nbsp;Laukien served as a director of ALDA (Analytical, Life Science&nbsp;&amp;
Diagnostics Association), an industry association formerly known as Analytical&nbsp;&amp; Life Sciences Systems Association, or ALSSA, for several terms in the past, and was ALSSA Chairman from 2002 to 2003. Dr.&nbsp;Laukien holds a Bachelor of
Science degree in physics from the Massachusetts Institute of Technology, as well as a Ph.D. in chemical physics from Harvard University. Dr.&nbsp;Laukien was a member of the Dean's Advisory Committee of the MIT School of Science until 2014, and a
Trustee of the Rivers School in Weston, Massachusetts until mid-2013. In May 2017, Dr.&nbsp;Laukien was elected a senator of acatech, the German National Academy of Science and Engineering. As the Company's largest shareholder and based on his long
history of leading the profitable growth of the Company, Dr.&nbsp;Laukien brings to the board the perspective of a significant stakeholder with an in-depth knowledge of all aspects of the Company's operations. He also provides extensive executive
experience in organizational management, strategic planning, finance, global business development and life-science tools markets, as well as the scientific and technical background required for a deep understanding of the Company's key technologies,
markets and industry dynamics.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=8,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=165855,FOLIO='5',FILE='DISK133:[18ZAG1.18ZAG15601]DC15601A.;10',USER='CHE109863',CD='10-APR-2018;02:04' -->
<A NAME="page_dc15601_1_6"> </A>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <P style="font-family:times;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="126pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="238pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2><B> John Ornell</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2> Age 60</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2> Director Since 2015</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Mr.&nbsp;Ornell is retired from Waters Corporation, where he served as Vice President, Finance and Administration and Chief Financial Officer from 2001 to 2013. During his time
at Waters, he was also responsible for information technology, investor relations and the TA Instruments Division. Mr.&nbsp;Ornell joined Waters in 1994 and served there in a variety of operational and financial leadership roles before assuming the
position of Waters' Chief Financial Officer. During 2014, Mr.&nbsp;Ornell continued to serve Waters on a part-time, transitional basis. Prior to joining Waters, Mr.&nbsp;Ornell progressed through a series of roles of increasing responsibility at a
number of multinational corporations, primarily in operational finance functions. Mr.&nbsp;Ornell holds a Master of Business Administration degree from Southern New Hampshire University. Mr.&nbsp;Ornell brings to the board a depth of knowledge in the
life sciences and analytical instruments industry, as well as a global perspective with significant experience managing the operational, strategic and financial matters of life sciences companies.</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Mr.&nbsp;Ornell serves as Chair of the Company's Audit Committee.</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2><B> Richard A. Packer</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><BR><FONT SIZE=2> Age 60</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B>Director Since 2007</B></FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Mr.&nbsp;Packer is a Primary Executive Officer of Asahi Kasei Corporation and co-leader of Asahi Kasei's healthcare business unit. Mr.&nbsp;Packer also serves as the
non-executive Chairman of ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions that was publicly traded until it was acquired by Asahi Kasei Corporation in April 2012. From November 1999 to April 2016,
Mr.&nbsp;Packer was the Chief Executive Officer and a director of ZOLL. He served as Chairman of ZOLL from 1999 until November 2010. From 1996 until his appointment as Chairman and Chief Executive Officer in 1999, Mr.&nbsp;Packer served as ZOLL's
President, Chief Operating Officer and director. From 1992 to 1996, he served as Vice President of Operations of ZOLL and also served as Chief Financial Officer and Head of North American Sales of ZOLL from 1995 to 1996. Prior to joining ZOLL,
Mr.&nbsp;Packer served for five years as Vice President of various functions for Whistler Corporation, a consumer electronics company. Before joining Whistler in 1987, Mr.&nbsp;Packer was a manager with the consulting firm of PRTM/KPMG, specializing
in operations of high technology companies. Mr.&nbsp;Packer has served as a director of Teleflex Incorporated, a publicly traded provider of medical devices, since May 2017 and is a member of the Teleflex Incorporated governance committee.
Mr.&nbsp;Packer is the past Chairperson of MassMEDIC, the industry council for Medical Devices in Massachusetts. He also currently serves as a board member of the Medical Device Manufacturers Association and the ZOLL Foundation. Mr.&nbsp;Packer holds
a Master of Business Administration from the Harvard Business School, as well as Bachelor of Science and Master of Engineering degrees from Rensselaer Polytechnic Institute. Mr.&nbsp;Packer has extensive financial, operations and management
experience in the medical devices industry. He also brings to the board significant experience in corporate governance, strategic planning and public company compensation matters.</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Mr.&nbsp;Packer serves on the Company's Audit and Compensation Committees and is the Chair of the Company's Nominating Committee.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=9,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=414882,FOLIO='6',FILE='DISK133:[18ZAG1.18ZAG15601]DC15601A.;10',USER='CHE109863',CD='10-APR-2018;02:04' -->
<A NAME="page_dc15601_1_7"> </A>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <P style="font-family:times;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="126pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="238pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Robert Rosenthal, Ph.D.</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2> Age 61</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2><B>Director Since 2015</B></FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Dr.&nbsp;Rosenthal currently serves as Chief Executive Officer of Taconic Biosciences,&nbsp;Inc., a privately-held provider of research models for the pharmaceutical and biotech
industry, a position he has held since joining Taconic Biosciences in June 2014. Dr.&nbsp;Rosenthal also serves as a director of Taconic Biosciences and The ECHO Group, a privately-held information management company. Dr.&nbsp;Rosenthal previously
served since 1995 in a variety of senior management positions with companies involved in the development of diagnostics, therapeutics, medical devices, and life sciences tools, most recently including from 2010 through 2012 as President and Chief
Executive Officer of IMI Intelligent Medical Implants, AG, a medical technology company, and from 2005 through 2009 as President and Chief Executive Officer of Magellan Biosciences,&nbsp;Inc., a provider of clinical diagnostics and life sciences
research tools. Dr.&nbsp;Rosenthal has served since 2007 as a director of Safeguard Scientifics,&nbsp;Inc., a publicly-traded provider of capital for early- and growth-stage companies, and as Chairman of its board of directors since May 2016. He also
currently serves as a director of Galvanic Applied Sciences,&nbsp;Inc., a privately-held Canadian company. Earlier in his career, Dr.&nbsp;Rosenthal served in senior management positions at Perkin Elmer&nbsp;Inc. and Thermo Fisher Scientific,
&nbsp;Inc. Dr.&nbsp;Rosenthal holds a Ph.D. from Emory University and a Master of Science degree from the State University of New York. Dr.&nbsp;Rosenthal brings to the board an extensive understanding of corporate governance due to his public
company board experience as well as an entrepreneurial perspective due to his success as an entrepreneur.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Dr.&nbsp;Rosenthal serves on the Company's Audit Committee.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2><B><BR>
Directors Continuing in Office until the 2020 Annual Meeting</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Cynthia M. Friend, Ph.D.</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2> Age 63</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2><B>Director Since 2016</B></FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Dr.&nbsp;Friend currently serves as Director of the Rowland Institute at Harvard University, a non-profit organization whose goal is to support the high risk/high reward research
of early career scientists. In 2014, she became Director of the Energy Frontier Research Center for Sustainable Catalysis at Harvard University, a Department of Energy-funded multi-institution effort focused on the design of efficient catalytic
processes, where her responsibilities include management of the fiscal health of the Center and strategic scientific planning. Dr.&nbsp;Friend became the Theodore Williams Richards Professor of Chemistry in 1998 and a Professor of Materials Science
in 2002 at Harvard University. Since joining the Harvard University Department of Chemistry in 1982, Dr.&nbsp;Friend has served in a variety of senior faculty and leadership roles at Harvard, including member of the Advisory Board to the Dean of
Faculty of Arts and Sciences from 1999 to 2012, Associate Director of the Harvard Materials Research Science and Engineering Center from 2001 to 2011 and Chair of the Harvard University Department of Chemistry and Chemical Biology from 2004 to 2007.
Dr.&nbsp;Friend has received numerous awards for her scientific research and scholarship and has served on a number of research and scientific advisory boards and panels. Dr.&nbsp;Friend holds a Ph.D. in Chemistry from the University of California,
Berkeley. Dr.&nbsp;Friend brings to the board extensive technical expertise and significant experience in the investment strategy and infrastructure of academic as well as government research markets. Further, Dr.&nbsp;Friend has substantial
management experience in non-profit scientific institutions and brings to the board valuable insight into science policy and scientific research funding priorities.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=10,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=284782,FOLIO='7',FILE='DISK133:[18ZAG1.18ZAG15601]DC15601A.;10',USER='CHE109863',CD='10-APR-2018;02:04' -->
<A NAME="page_dc15601_1_8"> </A>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <P style="font-family:times;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="126pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="238pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Marc A. Kastner, Ph.D.</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2> Age 72</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2><B>Director Since 2015</B></FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Dr.&nbsp;Kastner currently serves as President of the Science Philanthropy Alliance, a non-profit organization whose goal is to increase private funding for fundamental research,
a position he has held since March 2015. In January 2016 he became Donner Professor of Science Emeritus at Massachusetts Institute of Technology ("MIT"), having held the Donner Chair since 1989. After joining the MIT Department of Physics in 1973,
Dr.&nbsp;Kastner served in a variety of senior faculty and leadership roles at MIT, including as Dean of the MIT School of Science from July 2007 to December 2013, Head of the MIT Department of Physics from 1998 to 2007, Director of MIT's Center for
Materials Science and Engineering from 1993 to 1998 and as Associate Director of MIT's Consortium for Superconducting Electronics from 1989 to 1992. Dr.&nbsp;Kastner previously served a term on the Company's board of directors from February 2013 to
May 2014. Dr.&nbsp;Kastner has received numerous awards for his scientific research and scholarship and currently serves on a number of research and scientific advisory boards. Dr.&nbsp;Kastner holds a Ph.D. in Physics from the University of Chicago.
Dr.&nbsp;Kastner brings to the board significant expertise in recent and emerging scientific, technological and research funding trends, as well as in academic and government research markets, from which the Company derives approximately half of its
revenues. Moreover, Dr.&nbsp;Kastner has extensive organizational and management experience in non-profit institutions and insights into U.S. government research management and priorities.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Dr.&nbsp;Kastner serves on the Company's Nominating Committee.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Gilles G. Martin, Ph.D.</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2> Age 54</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2><B>Director Since 2014</B></FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Dr.&nbsp;Martin is Chairman and Chief Executive Officer of the Eurofins Scientific Group, a Luxembourg-based international life sciences company with approximately 30,000
employees in laboratories located in 42 countries. The Eurofins Scientific Group provides a range of analytical testing services to clients across multiple industries. Dr.&nbsp;Martin is also a director of Eurofins Scientific SE, Analytical
Bioventures SCA and certain of their affiliates. Dr.&nbsp;Martin founded the original Eurofins Scientific Nantes food authenticity laboratory in 1988 and is a past President of the French Association of private analytical laboratories, or APROLAB,
and the North American Technical Committee for Juice and Juice Products. Dr.&nbsp;Martin holds a Ph.D. in Statistics and Applied Mathematics from Ecole Centrale, Paris, and a Master of Science from Syracuse University. As Chairman and Chief Executive
Officer of Eurofins Scientific, the largest group of independent food testing laboratories in the world, Dr.&nbsp;Martin is and has been involved throughout his career with many generations of analytical instruments and their suppliers.
Dr.&nbsp;Martin brings extensive international business and management experience in the life-science and analytical testing industries to the board, including specialized expertise in the environmental testing, food safety analysis, pharmaceutical
research and clinical markets. Dr.&nbsp;Martin also brings an entrepreneurial perspective to the board.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=11,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=413714,FOLIO='8',FILE='DISK133:[18ZAG1.18ZAG15601]DC15601A.;10',USER='CHE109863',CD='10-APR-2018;02:04' -->
<A NAME="page_dc15601_1_9"> </A>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <P style="font-family:times;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_TABLEWIDTH,"100%" -->


  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="126pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="238pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Hermann Requardt, Ph.D.</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2> Age 63</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2><B>Director Since 2015</B></FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Dr.&nbsp;Requardt currently serves as an independent strategic advisor to a number of European public and private life science and healthcare technology companies. From 2009 to
February 2015 he served as Chief Executive Officer of the healthcare division of Munich, Germany-based Siemens AG. He also served as Chief Technology Officer of Siemens AG from 2008 through 2011. Additionally, from 2006 through January 2015 he was a
member of the Siemens AG Managing Board, during which time he also held a variety of regional and operational responsibilities at Siemens and its affiliates. Dr.&nbsp;Requardt joined Siemens Medical Solutions in 1984 and served there in roles of
increasing responsibility before assuming global responsibility for the magnetic resonance business unit in 1994. Dr.&nbsp;Requardt is an honorary Professor of Physics at the University of Frankfurt and serves on several academic and industrial
boards in Germany, including, among other positions, Vice President of acatech, the National Academy of Science and Engineering. He also is a member of the Advisory Board of Dekra SE, headquartered in Stuttgart, Germany, and the Supervisory Board of
Sivantos Group, which was Siemens Audiology Solutions prior to its spin-off from Siemens AG in early 2015. Dr.&nbsp;Requardt holds a Ph.D. in Biophysics, with a focus on radiation biophysics and microbiology, from the University of Frankfurt. In
addition to his global and technical industry expertise, Dr.&nbsp;Requardt brings to the board significant experience in the management and strategic planning of life sciences companies.</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD COLSPAN=5 VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>Dr.&nbsp;Requardt serves on the Company's Compensation Committee.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc15601_board_leadership_structure"> </A>
<A NAME="toc_dc15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  BOARD LEADERSHIP STRUCTURE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under our bylaws, the chairman of the Company's board of directors has the power to preside at all meetings of the board. Dr.&nbsp;Frank
Laukien, our Chief Executive Officer and President, serves as the Chairman of our board of directors and has done so throughout the time we have been a public company. Although the board believes that
the combination of the Chairman and Chief Executive Officer roles is appropriate in the current circumstances, the board does not have a fixed policy regarding the combination or separation of the
offices of Chairman and Chief Executive Officer. Our board of directors believes that it should have the flexibility to make these determinations
at any given point in time in the way that it considers best to provide appropriate leadership for the Company at that time. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Chief Executive Officer is appointed by our board to manage the Company's daily affairs and operations. Dr.&nbsp;Laukien's extensive industry knowledge and long history of direct
involvement in the Company's operations make him best suited to serve as Chairman in order to (i)&nbsp;lead the board in productive discussions on important matters affecting the Company;
(ii)&nbsp;create a firm link between management and the board and promote the development and implementation of corporate strategy; (iii)&nbsp;determine necessary and appropriate agenda items for
meetings of the board with input from the independent lead director and board committee chairpersons; and (iv)&nbsp;determine and manage the amount of time and information devoted to discussion and
analysis of agenda items and other matters that may come before the board. Additionally, his significant equity ownership, at approximately 26% of the outstanding shares of the Company's common stock,
means that he has a close and direct alignment of interests with the interests of our other stockholders. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=12,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=954882,FOLIO='9',FILE='DISK133:[18ZAG1.18ZAG15601]DC15601A.;10',USER='CHE109863',CD='10-APR-2018;02:04' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_de15601_1_10"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While
we believe that having a unified Chairman and Chief Executive Officer is appropriate and in the best interests of the Company and its stockholders at this time, our board structure
also fosters strong oversight by independent directors. Since 2004, an independent lead director has been appointed by the independent directors to ensure an independent leadership contact. The lead
director's responsibilities include: (i)&nbsp;consulting with the Chairman regarding agenda items for board meetings; (ii)&nbsp;chairing executive sessions of the independent directors;
(iii)&nbsp;calling executive sessions of the independent directors of the board and advising the Chairman and Chief Executive Officer of actions or deliberations at such sessions; (iv)&nbsp;acting
as a liaison between the independent directors and the full board, as necessary; and (iv)&nbsp;establishing, in consultation with the Chairman and Chief Executive Officer and any appropriate board
committees, procedures to govern the board's work, ensuring that the board of directors is appropriately approving strategy and supervising management's progress. Dr.&nbsp;William Linton has served
in the role of lead director since the position was established in 2004. Our Chairman and Chief Executive Officer consults periodically with the lead director on governance matters and on issues
facing the Company. In addition, the lead director serves as the principal liaison between the Chairman and the independent directors and presides at executive sessions of independent directors at
regularly scheduled in-person board meetings. The board of directors believes that this approach appropriately and effectively complements the Company's combined Chairman and Chief Executive Officer. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de15601_board_meetings,_committees_and_compensation"> </A>
<A NAME="toc_de15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  BOARD MEETINGS, COMMITTEES AND COMPENSATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There are currently twelve members of our board of directors. Ten of our current directors, Cynthia M. Friend, Marc A. Kastner, Richard D.
Kniss, William A. Linton, Gilles G. Martin, John Ornell, Richard A. Packer, Adelene Q. Perkins, Hermann Requardt and Robert Rosenthal, meet the independence requirements of the NASDAQ Stock
Market&nbsp;LLC, or NASDAQ, listing standards. All
of our director nominees, other than Joerg C. Laukien, are independent under such standards. Our former director, Chris van Ingen, was also determined to be independent when serving as a member of our
board. In making its independence determinations, the board of directors considered, among other things, relevant transactions between the Company and entities associated with the independent
directors, as further described in this proxy statement under the heading "</FONT><FONT SIZE=2><I>Transactions with Related Persons</I></FONT><FONT SIZE=2>," and determined that none have any
relationship with the Company or other relationships that would impair the directors' independence. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Following
the 2018 Annual Meeting, the board of directors will consist of eleven members, nine of whom are expected to be independent. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
2017, the board of directors of the Company held four meetings and acted by unanimous written consent twice. Our incumbent directors, on average, attended 91&nbsp;percent of
board and committee meetings during 2017. No director, other than Ms.&nbsp;Perkins, attended less than 75&nbsp;percent of the total number of 2017 meetings of the board of directors and board
committees of which he or she was a member. Ms.&nbsp;Perkins was elected to the board of directors at the 2017 Annual Meeting held in May. During her term, there were two meetings of the board of
directors in 2017. Due to a prior commitment, Ms.&nbsp;Perkins was unable to attend one such meeting. It is the policy of our board of directors that at least two directors, including at least one
independent director, attend our Annual Meeting, either in person or by telephonic conference. Two directors attended our 2017 Annual Meeting. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
described below, the board of directors has three standing committees: an Audit Committee, a Compensation Committee and a Nominating Committee. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Audit Committee.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee of the board of directors currently consists of John Ornell, Robert Rosenthal, Richard A.
Packer and Adelene Q.
Perkins, each of whom satisfies the applicable independence requirements of the rules and regulations of the SEC and NASDAQ. Under </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=13,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=192359,FOLIO='10',FILE='DISK133:[18ZAG1.18ZAG15601]DE15601A.;7',USER='HYUNG',CD='10-APR-2018;15:21' -->
<A NAME="page_de15601_1_11"> </A>

<P style="font-family:times;"><FONT SIZE=2>these
rules, we are required to have an Audit Committee consisting of at least three independent members. The Audit Committee met seven times during 2017. Mr.&nbsp;Ornell, Chair of the Audit
Committee, qualifies as an audit committee financial expert pursuant to applicable SEC rules and regulations. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee provides assistance to the board of directors in fulfilling its legal and fiduciary obligations with respect to matters involving the accounting, auditing, treasury,
financial reporting and internal control functions of the Company and its subsidiaries. The Audit Committee works extensively with the independent auditors, pre-approves all audit and non-audit
services provided to the Company by its independent auditors, reviews the performance of the independent auditors and replaces or terminates the independent auditors when circumstances warrant. The
Audit Committee is also charged with establishing and monitoring procedures for (i)&nbsp;the receipt, retention or treatment of complaints received by the Company regarding accounting, internal
accounting controls or auditing matters, and (ii)&nbsp;the confidential submission by the Company's employees of concerns regarding questionable accounting or auditing matters. None of the members
of the Audit Committee has participated in the preparation of any financial statements of the Company at any time during the last three fiscal years. The Audit Committee's charter is available on the
Company's website at https://ir.bruker.com under the "Corporate Governance" section. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compensation Committee.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee currently consists of Richard D. Kniss, Hermann Requardt and Richard Packer,
all of whom meet the
independence requirements of the NASDAQ listing rules. The Compensation Committee met eight times and acted by unanimous written consent four times during 2017. Mr.&nbsp;Kniss is the Chair of the
Compensation Committee. The Compensation Committee (i)&nbsp;administers the Company's stock incentive plan; (ii)&nbsp;determines the chief executive officer's salary, bonus, and equity based
compensation; (iii)&nbsp;oversees the executive compensation program for the Company's other executive officers; and (iv)&nbsp;determines such compensation, reviews general policy matters relating
to compensation and employee benefits and makes recommendations concerning these matters to the board of directors. From time to time, the Company expects that various of its senior executive officers
will provide analysis and recommendations to the Compensation Committee on compensation issues, as requested by the Compensation Committee. In particular, the Chief Executive Officer annually
evaluates the performance of the executive officers who report directly to him, including, among others, the Chief Financial Officer, and makes recommendations to the Compensation Committee regarding
such executive officers' compensation. Additionally, the Chief Financial Officer provides the Chief Executive Officer input on the annual evaluations of the performance of the Company's other named
executive officers and makes recommendations to the Compensation Committee regarding compensation of these officers. The Compensation Committee reviews these performance evaluations and
recommendations and discusses the recommendations with our Chief Executive Officer and, as appropriate, our Chief Financial Officer. In some cases, these discussions may lead to adjustments to an
executive officer's performance evaluation and compensation recommendation. In other cases in which the Compensation Committee deems it appropriate, the evaluations and management recommendations may
be approved by the Compensation Committee with little or no change. Our Chief Executive Officer, Chief Financial Officer and our Corporate Senior Director of Human Resources may routinely attend
meetings of the Compensation Committee to provide information relating to matters the Compensation Committee is considering. The Compensation Committee may, from time to time, meet in executive
session without any executive officers or other members of management present. The Compensation Committee's charter is available on the Company's website at https://ir.bruker.com under the "Corporate
Governance" section. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company anticipates appointing an incumbent independent director to succeed Mr.&nbsp;Kniss in his Compensation Committee assignments prior to the 2018 Annual Meeting. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=14,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=908512,FOLIO='11',FILE='DISK133:[18ZAG1.18ZAG15601]DE15601A.;7',USER='HYUNG',CD='10-APR-2018;15:21' -->
<A NAME="page_de15601_1_12"> </A>

<P style="font-family:times;"><FONT SIZE=2><B><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nominating Committee.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Nominating Committee currently consists of Marc A. Kastner, Richard A. Packer and William A. Linton,
all of whom meet the
independence requirements of the NASDAQ listing rules. Mr.&nbsp;Packer is the Chair of the Nominating Committee. The purpose of the Nominating Committee is to assist the board in identifying and
recruiting individuals qualified to become board members, consistent with criteria approved by the board, and to recommend to the board nominees for election to the office of director at the next
annual meeting of stockholders, or for election to fill any vacancies between annual meetings. While the board of directors retains responsibility for selecting nominees and recommending them for
election by the Company's stockholders, the Nominating Committee is responsible for developing and implementing a process to identify qualified and willing candidates for recommendation to the board.
The Nominating Committee's charter is available on the Company's website at https://ir.bruker.com under the "Corporate Governance" section. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Nominating Committee met one time and acted by unanimous written consent once during 2017. In addition, members of the Nominating Committee communicated periodically throughout the
year regarding candidates for director and director nomination matters. At a meeting held in February 2018, the Nominating Committee unanimously recommended each of the current nominees for director
to the full board of directors. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de15601_director_nominations"> </A>
<A NAME="toc_de15601_2"> </A>
<BR></FONT><FONT SIZE=2><B>  DIRECTOR NOMINATIONS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On March&nbsp;3, 2004, the Company adopted a policy by board resolution governing the nomination of directors, according to which the full
board of directors approves all nominees for board membership. All nominees must also be approved by a majority of the Company's independent directors. Upon recommendation of the Nominating Committee,
the qualifications of candidates will be reviewed by at least a majority of the independent directors of the Company, as well as the full board of directors. Stockholders may recommend director
candidates for inclusion by the board of directors in the slate of nominees which the board recommends to stockholders for election as described below. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
process followed to identify and evaluate potential candidates includes requests to board members and others for recommendations, meetings from time to time to evaluate biographical
information and background material relating to potential candidates and interviews of selected candidates by the members of the Nominating Committee, the independent directors and the board. The
Nominating Committee, the independent directors and the board are each authorized to retain advisers and
consultants and to compensate them for their services. No such advisers or consultants were retained for this purpose during 2017. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company does not have a formal policy with regard to the consideration of diversity in identifying director nominees, but strives to identify and recruit director candidates with a
variety of complementary skills, expertise and backgrounds so that, as a group, the board will possess the appropriate talent, skills and expertise to oversee the Company's business. The Committee
seeks to promote through the nominations process an appropriate diversity in board composition, recognizing that the Corporation's businesses and operations are diverse and global in nature. In
considering individual director candidates, the Committee takes into account such factors as diversity in professional experience, skills and background, as well as diversity in gender, race and
ethnicity. Search firms retained to assist the Committee are advised to actively seek to identify qualified, diverse candidates, including women and minorities. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
considering whether to recommend any candidate for inclusion in the board's slate of recommended director nominees, the board and the independent directors apply the criteria which
are set forth in a resolution of the board approved and adopted on March&nbsp;3, 2004. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>12</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=15,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=46590,FOLIO='12',FILE='DISK133:[18ZAG1.18ZAG15601]DE15601A.;7',USER='HYUNG',CD='10-APR-2018;15:21' -->
<A NAME="page_de15601_1_13"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
criteria include, but are not limited to, the following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> experience in aspects of business or technology relevant to the Company's business; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> sufficient time available to devote to the affairs of the Company; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> character and integrity; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> ability to represent the best interests of stockholders as a whole rather than special interest groups; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> willingness to participate actively as a board member; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> communication, decision-making and interpersonal skills. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
board and the independent directors may also consider the following for some of the director nominees:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> experience serving as a director of a public company; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> familiarity with corporate governance issues; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> independence, as determined in accordance with SEC rules and regulations and NASDAQ listing standards; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> experience in running a comparable company or division of a comparable company; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> insight into the Company, its strategy, business model, operations, and financials; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> knowledge of industry trends and markets; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> qualification as an "audit committee financial expert" to serve on the Audit Committee in accordance with SEC and NASDAQ definitions. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
evaluating candidates recommended by the Nominating Committee, the board and the independent directors do not assign specific weights to particular criteria and no particular
criterion is necessarily applicable to all prospective nominees. We believe that the backgrounds and qualifications of the directors, considered as a group, should provide a significant composite mix
of experience, knowledge, backgrounds and abilities that will allow the board to fulfill its responsibilities. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although
the Company does not have a specific policy with respect to the nomination of directors by stockholders, the Nominating Committee will consider nominations made by stockholders.
The Company believes that it is not necessary to have a policy for director nominations by stockholders because the board of directors, including the Nominating Committee and the independent
directors, is able to effectively locate and evaluate potential candidates for nomination to the board of directors due to the directors' intimate knowledge of the Company and the life science
industry. However, stockholders may communicate directly with the Nominating Committee of the board of directors by written communication submitted to Richard M. Stein at the address set forth below
under "Stockholder Communications." Mr.&nbsp;Stein shall be primarily responsible for monitoring the communications and providing summaries or copies of such communications to the Nominating
Committee or the board of directors as he deems appropriate, and, as described below, will submit communications to the Nominating Committee or the board of directors, as appropriate, relating to
corporate governance matters and long-term corporate strategy. Stockholders may use this process to suggest potential nominations to the board of directors. Such suggested nominations shall be
forwarded to the Nominating Committee and the proposed candidates shall be evaluated using substantially the same process and applying the same criteria as used and applied in evaluating candidates
submitted by board members. Nominations must be received by the Company within the timeframe set forth herein under "Time for Submission of Stockholder Proposals." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>13</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=16,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=833193,FOLIO='13',FILE='DISK133:[18ZAG1.18ZAG15601]DE15601A.;7',USER='HYUNG',CD='10-APR-2018;15:21' -->
<A NAME="page_de15601_1_14"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the 2018 Annual Meeting, stockholders will be asked to consider the re-election of Joerg C. Laukien, William A. Linton, Ph.D. and Adelene Q. Perkins to serve as Class&nbsp;III
directors. Each of the nominees is standing for election following the unanimous recommendation for nomination first by the Nominating Committee, and then by the full board of directors, including the
unanimous approval of all of the Company's independent directors. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de15601_role_of_the_board_in_risk_oversight"> </A>
<A NAME="toc_de15601_3"> </A>
<BR></FONT><FONT SIZE=2><B>  ROLE OF THE BOARD IN RISK OVERSIGHT    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors considers general oversight of the Company's risk management efforts to be a responsibility of the entire board. The
Audit and Compensation Committees assist the board in carrying out this responsibility by focusing on specific key areas of risk that our business faces. The board's role in risk oversight includes
receiving regular reports from members of senior management on areas of material risk to the Company, or to the success of a particular project or endeavor under consideration, including operational,
financial, legal and regulatory, strategic and reputational risks. The full board of directors, the Audit Committee in the case of financial and compliance risks that are within the oversight of the
Audit Committee or the Compensation Committee in the case of matters relating to our compensation policies and practices, receives these reports from members of management to enable the board or the
Audit or Compensation Committee, as applicable, to understand the Company's risk identification, risk management, and risk mitigation strategies. To facilitate this process and assist the Audit
Committee in fulfilling its responsibility for monitoring legal and compliance risks, our senior director of internal audit, who reports directly to our Chief Financial Officer, also has a dotted line
reporting relationship to the chairperson of the Audit Committee. The Audit Committee chairperson is authorized to give instructions and assignments directly to the senior director of internal audit,
as to which assignments the director of internal audit reports directly and only to the Audit Committee chairperson. When a report is evaluated at the Audit Committee level, the chairperson of the
Audit Committee subsequently reports on the matter to the full board to ensure coordination of the board's risk oversight activities. Our board of directors also believes that risk management is an
integral part of our strategic planning process, which addresses, among other things, the risks and opportunities facing the Company. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de15601_compensation_of_directors"> </A>
<A NAME="toc_de15601_4"> </A>
<BR></FONT><FONT SIZE=2><B>  COMPENSATION OF DIRECTORS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We pay the non-employee members of our board of directors a mix of cash and share-based compensation based on the determination of the
Compensation Committee. Employee
directors, including Dr.&nbsp;Frank Laukien and, until December&nbsp;31, 2017, Mr.&nbsp;Joerg Laukien, receive compensation only as employees of the Company and receive no additional
compensation for service as a director. Directors are reimbursed for reasonable out-of-pocket expenses incurred in attending meetings of the board or board committees. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>14</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=17,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=768054,FOLIO='14',FILE='DISK133:[18ZAG1.18ZAG15601]DE15601A.;7',USER='HYUNG',CD='10-APR-2018;15:21' -->
<A NAME="page_de15601_1_15"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Components of Director Compensation  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During 2017, directors other than employee directors were paid cash compensation according to the following schedule: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="91pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 Director Cash<BR>
Compensation </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Board Service</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit Committee Service</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit Committee Chair</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Compensation Committee Service</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Compensation Committee Chair</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Nominating Committee Service</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Nominating Committee Chair</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Lead Director Service</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to the cash component of director compensation, it is currently our policy to grant non-employee directors as a component of their compensation an annual equity award. These
awards from 2013 through 2016 consisted of an option to purchase 10,000 shares of common stock, with an exercise price equal to the fair market value of our common stock on the date of grant and
vesting over a three-year period in approximately equal annual increments. Effective as of January&nbsp;1, 2017, the board of directors, upon the recommendation of the Compensation Committee,
approved a change in the form and amount of annual non-employee director equity compensation from option awards to awards of restricted stock units valued at $100,000 as of the grant date. As of
January&nbsp;1, 2018, the value of the awards of restricted stock units increased to $125,000. Restricted stock unit awards to non-employee directors vest in full on the first anniversary of the
grant date. Additionally, it has been our policy to grant an equity award to each newly-elected non-employee director, effective upon commencement of service on the board, upon terms consistent with
those of the annual awards to incumbent non-employee directors. The number of shares underlying such new director awards are determined as follows: 100% of the annual director equity award amount if
elected to service commencing in the first quarter of the calendar year; 75% of the annual director equity award amount if elected to service commencing in the second quarter of the calendar year; 50%
of the annual director equity award amount if elected to service commencing in the third quarter of the calendar year; and 25% of the annual director equity award amount if elected to service
commencing in the fourth quarter of the calendar year. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
January&nbsp;5, 2017, the Company granted each non-employee director an annual equity award consisting of 4,577 restricted stock units. The 2017 restricted stock unit awards vested
in full on January&nbsp;5, 2018. Upon initial election to our board of directors in May 2017, Ms.&nbsp;Perkins received an award of 2,756 restricted stock units which will vest in full on
May&nbsp;31, 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table provides information concerning the compensation paid by us to each of our non-employee directors for the fiscal year ended December&nbsp;31, 2017. The compensation
paid to Dr.&nbsp;Frank Laukien, our President and Chief Executive Officer, is shown in the Summary Compensation Table on page 46 of this proxy statement. The compensation paid in 2017 to
Mr.&nbsp;Joerg Laukien as an employee of the Company is described in this proxy statement under the heading "</FONT><FONT SIZE=2><I>Transactions with Related Persons</I></FONT><FONT SIZE=2>." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=18,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=11335,FOLIO='15',FILE='DISK133:[18ZAG1.18ZAG15601]DE15601A.;7',USER='HYUNG',CD='10-APR-2018;15:21' -->
<A NAME="page_de15601_1_16"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de15601_2017_director_compensation_table"> </A>
<A NAME="toc_de15601_5"> </A>
<BR></FONT><FONT SIZE=2><B>  2017 Director Compensation Table    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fees Earned<BR>
or Paid in Cash<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Equity<BR>
Awards(1)<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stephen W. Fesik(2)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>26,714</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>26,714</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cynthia M. Friend</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>160,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chris van Ingen(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>40,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>140,507</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Marc A. Kastner</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>63,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>163,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Richard D. Kniss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>78,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>178,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>William A. Linton</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>71,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>171,507</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gilles G. Martin</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>160,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>John Ornell</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>93,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>193,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Richard A. Packer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>91,879</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>191,886</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Adelene Q. Perkins(4)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>36,593</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>74,991</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>111,584</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Hermann Requardt</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>68,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>168,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Robert Rosenthal</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>78,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>178,007</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reported
amounts reflect the grant date fair value of restricted stock units granted to each director in 2017, computed in accordance with Financial Accounting
Standards Board Accounting Standards Codification Topic 718. Assumptions used in the calculations of these amounts may be found in Note&nbsp;2 to our 2017 audited financial statements included in
the Company's Annual Report on Form&nbsp;10-K filed with the SEC on March&nbsp;16, 2018. The actual amount realized by the director will likely vary based on a number of factors, including our
performance, stock price fluctuations and applicable vesting.  </FONT>
<BR>

<P style="font-family:times;"><FONT SIZE=2>As
of December&nbsp;31, 2017, our non-employee directors held the following aggregate vested and unvested options to purchase common stock of the Company and unvested restricted stock units
("RSUs"): </FONT></P>

</DD></DL>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 </DIV>
<DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="70pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="83pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="73pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name


<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Vested Options </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Unvested Options </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Unvested RSUs </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Stephen W. Fesik(2)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cynthia M. Friend</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,475</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,025</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,577</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chris van Ingen(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Marc A. Kastner</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,577</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Richard D. Kniss</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,577</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>William A. Linton</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,577</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gilles G. Martin</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>19,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,577</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>John Ornell</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,650</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,350</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,577</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Richard A. Packer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,577</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Adelene Q. Perkins(4)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,756</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Hermann Requardt</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,650</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,350</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,577</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Robert Rosenthal</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,950</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,550</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,577</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Dr.&nbsp;Fesik's
term of service on the board of directors expired May&nbsp;22, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;van
Ingen's term of service on the board of directors ended June&nbsp;27, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Ms.&nbsp;Perkins
was elected to the board of directors effective May&nbsp;22, 2017.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>16</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=19,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=111339,FOLIO='16',FILE='DISK133:[18ZAG1.18ZAG15601]DE15601A.;7',USER='HYUNG',CD='10-APR-2018;15:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dg15601_1_17"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dg15601_security_ownership_of_certain___sec02525"> </A>
<A NAME="toc_dg15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information regarding beneficial ownership of the Company's common stock as of April&nbsp;2, 2018 by
(i)&nbsp;each person who is known by the Company to own beneficially more than 5% of the Company's common stock, (ii)&nbsp;each of our directors and nominees for director, (iii)&nbsp;each named
executive officer of the Company, as defined under the heading "</FONT><FONT SIZE=2><I>Summary of Executive Compensation</I></FONT><FONT SIZE=2>," and (iv)&nbsp;all directors and executive officers
who served as directors or executive officers as of April&nbsp;2, 2018 as a group. Unless otherwise noted, the address of each beneficial owner is c/o Bruker Corporation, 40 Manning Road, Billerica,
Massachusetts 01821. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="111pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Beneficial Owners

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount and Nature of<BR>
Beneficial Ownership(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Percent<BR>
of Class(1) </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Executive Officers, Directors and Director Nominees</I></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Frank H. Laukien(2)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>40,660,761</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>26.1%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gerald N. Herman(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,419</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Michael G. Knell</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mark R. Munch(4)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>70,394</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Burkhard Prause(5)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,734</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Juergen Srega(6)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>196,426</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony L. Mattacchione(7)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>97,734</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Cynthia M. Friend(8)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,527</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Marc A. Kastner(9)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21,177</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Richard D. Kniss(10)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>83,353</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Joerg C. Laukien</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15,212,295</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9.8%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>William A. Linton(11)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>117,927</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gilles G. Martin(12)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>31,177</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>John Ornell(13)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,527</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Richard A. Packer(14)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100,284</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Adelene Q. Perkins(15)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,756</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Hermann Requardt(16)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,527</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Robert Rosenthal(17)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12,827</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>All executive officers and directors as a group (17 persons)(18)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>56,651,845</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>36.3%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="111pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Beneficial Owners

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Amount and Nature of<BR>
Beneficial Ownership(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Percent<BR>
of Class(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2><I>5% Beneficial Owners</I></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>T. Rowe Price Associates,&nbsp;Inc.(19)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>28,418,579</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>100 E. Pratt Street</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Baltimore, MD 21202</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 The Vanguard Group(20)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
9,673,104</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
6.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 100 Vanguard Blvd.</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Malvern, PA 19355</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Less
than one percent
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Beneficial
ownership is determined in accordance with the rules of the Securities and Exchange Commission. In computing the number of shares beneficially owned by a
person and the percentage ownership of that person, shares of common stock subject to options held by that person that are currently exercisable, or become exercisable within 60&nbsp;days from the
date hereof, are deemed outstanding. However, such shares are not deemed outstanding for purposes of computing the percentage ownership of any other person. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>17</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=20,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=59449,FOLIO='17',FILE='DISK133:[18ZAG1.18ZAG15601]DG15601A.;7',USER='CHE109572',CD='10-APR-2018;11:43' -->
<A NAME="page_dg15601_1_18"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 161,474 shares of common stock that are currently exercisable, or become exercisable within 60&nbsp;days of the date hereof and 43,187
shares of restricted common stock. Also includes: 1,846,499 shares owned by Robyn Laukien, his former spouse, as to which Dr.&nbsp;Laukien has sole voting power; 336,607 shares held by each of his
adult children, as to which Dr.&nbsp;Laukien has sole voting power and shared investment power; and 224,522 aggregate shares held as custodian for the benefit of his minor children, as to which
Dr.&nbsp;Laukien has sole voting and investment power. 5,000,000 shares have been pledged by Dr.&nbsp;Laukien to secure a personal loan. Dr.&nbsp;Laukien retains voting power of all such pledged
shares. Does not include 6,920 shares held in trust for Dr.&nbsp;Laukien's adult daughter, 7,400 shares held by Dr.&nbsp;Laukien's adult son or 1,042 shares held by his spouse, in each case as to
which Dr.&nbsp;Laukien disclaims beneficial ownership.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 2,001 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 50,244 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof and 17,942
shares of restricted common stock.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 2,842 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 136,615 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof and
14,569 shares of restricted common stock.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 93,474 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(8)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 4,950 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(9)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 16,600 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(10)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 42,600 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(11)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 60,600 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(12)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 26,600 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(13)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 9,950 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(14)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 60,600 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(15)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
2,756 restricted stock units that vest within 60&nbsp;days of the date hereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(16)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 9,950 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(17)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 8,250 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>18</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=21,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=954744,FOLIO='18',FILE='DISK133:[18ZAG1.18ZAG15601]DG15601A.;7',USER='CHE109572',CD='10-APR-2018;11:43' -->
<A NAME="page_dg15601_1_19"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(18)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
options to purchase 686,750 shares of common stock that are currently exercisable, or become exercisable, within 60&nbsp;days of the date hereof and
2,756 restricted stock units that vest within 60&nbsp;days of the date hereof.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(19)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>According
to a Schedule&nbsp;13G filed February&nbsp;14, 2018, T. Rowe Price Associates,&nbsp;Inc. ("Price Associates") beneficially owns, or may be deemed to
beneficially own, 28,418,579 shares as a result of acting as investment advisor to various investment companies, including the T. Rowe Price Mid-Cap Growth Fund,&nbsp;Inc. (the "Fund"), and
institutional clients. Price Associates reported sole power to dispose of 28,418,579 shares and sole power to vote or direct the voting of 7,493,659 shares. The Fund reported sole power to vote or
direct the voting of 9,400,000 shares.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(20)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>According
to a Schedule&nbsp;13G filed February&nbsp;8, 2018, The Vanguard Group ("Vanguard") and certain of its affiliates, subsidiaries and other companies
beneficially own, or may be deemed to beneficially own, 9,673,104 shares. Vanguard reported sole power to dispose of 9,612,576 shares, sole power to vote or direct the voting of 54,597 shares and
shared power to vote or direct the voting of 14,151 shares.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>19</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=22,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=20333,FOLIO='19',FILE='DISK133:[18ZAG1.18ZAG15601]DG15601A.;7',USER='CHE109572',CD='10-APR-2018;11:43' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_di15601_1_20"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="di15601_executive_officers"> </A>
<A NAME="toc_di15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  EXECUTIVE OFFICERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our executive officers are designated annually by the board of directors. The persons listed below are serving as the Company's executive
officers for the fiscal year ending December&nbsp;31, 2018. Each of these executive officers, other than Dr.&nbsp;Prause, who was appointed an executive officer of the Company in February 2018,
and Mr.&nbsp;Herman, who was appointed an executive officer in March 2018, also served as executive officers of the Company throughout the fiscal year ended December&nbsp;31, 2017. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="187pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="14pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Age </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Position </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Frank H. Laukien, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>58</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chairman, President and Chief Executive Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gerald N. Herman</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Interim Chief Financial Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mark R. Munch, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>56</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Burkhard Prause, Ph.D.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>51</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>President and Chief Executive Officer, BEST</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Juergen Srega</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>63</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>President, Bruker CALID Group and Bruker Daltonics Division</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
biographical information relating to Dr.&nbsp;Laukien, who serves as both an executive officer and a director of the Company, please see "</FONT><FONT SIZE=2><I>Certain
Information Regarding Directors and Nominees</I></FONT><FONT SIZE=2>" above. Biographical information relating to our current non-director executive officers is presented below. As previously reported
in our Current Report on Form&nbsp;8-K filed with the SEC on February&nbsp;21, 2018, Mr.&nbsp;Anthony Mattacchione, who served as the Company's Chief Financial Officer throughout the fiscal year
ended December&nbsp;31, 2017 and is a "named executive officer" as discussed in this proxy statement under the heading "Compensation Discussion and Analysis," resigned from the Company, effective
March&nbsp;16, 2018. Mr.&nbsp;Mattacchione continued to serve as Chief Financial Officer of the Company and as an executive officer of the Company until the effective date of his resignation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gerald N. Herman.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;Herman has served as the Company's Interim Chief Financial Officer since March 2018. Mr.&nbsp;Herman joined
the
Company in 2016 as Vice President and Corporate Controller. Prior to joining Bruker, Mr.&nbsp;Herman had served in senior executive positions with various publicly traded companies, including as
Corporate Vice President&#151;Clinical Operations of PAREXEL International from 2014 to February 2016, and as Corporate Vice President&nbsp;&amp; Controller-Finance of PAREXEL from 2008 to 2013.
Prior to 2008, Mr.&nbsp;Herman was Vice President&#151;Corporate Controller of Presstek,&nbsp;Inc. He also served in financial, consulting and accounting roles at various organizations,
including as Senior Manager at Arthur Andersen&nbsp;LLP
from 1979 to 1987. Mr.&nbsp;Herman is a Certified Public Accountant (CPA) and holds a Master of Business Administration degree from the University of Chicago, and a Master of Science in Taxation
from Bentley University. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mark R. Munch, Ph.D.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Dr.&nbsp;Munch has served since September 2012 as President, Bruker Nano Group, with responsibility for management
of the
global operations of our Bruker Nano Group, which manufactures and distributes the Company's advanced analytical X-ray technologies and spark-optical emission spectroscopy, atomic force microscopy,
fluorescence microscopy, and stylus and optical metrology instrumentation used in non-destructive molecular, materials and elemental analysis. He has also served, since July 2015, as an Executive Vice
President of the Company, and in that capacity is responsible for providing oversight to the Company's global information technology function and enterprise resource planning, as well as other
strategic management development and business process initiatives. Dr.&nbsp;Munch has also served as President of Bruker Nano,&nbsp;Inc., a wholly-owned subsidiary of the Company, since October
2010. Prior to joining Bruker Nano,&nbsp;Inc., from February 2008 to October 2010, Dr.&nbsp;Munch was Executive Vice President of Veeco Instruments&nbsp;Inc. Dr.&nbsp;Munch also served as a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>20</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=23,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=37663,FOLIO='20',FILE='DISK133:[18ZAG1.18ZAG15601]DI15601A.;41',USER='HYUNG',CD='10-APR-2018;15:03' -->
<A NAME="page_di15601_1_21"> </A>

<P style="font-family:times;"><FONT SIZE=2>Senior
Vice President of Coherent,&nbsp;Inc. from February 2006 to January 2008 and as President and Chief Executive Officer of Cooligy,&nbsp;Inc., a subsidiary of Emerson Electric, from 2004 to
2006. Dr.&nbsp;Munch's background includes over 26&nbsp;years of experience in marketing, product development, operations and sales, as well as experience in managing significant business units of
multi-national corporations. Dr.&nbsp;Munch holds a Bachelor of Science degree in Chemical Engineering from the University of Colorado and a Master of Science degree and Ph.D. in Chemical
Engineering from Stanford University. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Burkhard Prause, Ph.D.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Dr.&nbsp;Prause has served as President and Chief Executive Officer of BEST since April 2008, with
responsibility for
management of the global operations of BEST, which designs, manufactures and distributes superconducting materials for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy
research and other applications, as well as ceramic, second generation high temperature superconductors for energy technology and magnet research applications. Dr.&nbsp;Prause also was a director of
BEST from April 2012 to February 2013. Additionally, he has served as a director of Hydrostatic Extrusions&nbsp;Ltd. since April 2013, and as a Managing Director of Bruker EAS&nbsp;GmbH and Bruker
HTS&nbsp;GmbH since January 2005, RI Research Instruments&nbsp;GmbH since December 2008, and Bruker ASC&nbsp;GmbH since March 2009. Prior to that time, Dr.&nbsp;Prause served as Product
Manager for Bruker BioSpin MRI&nbsp;GmbH. Before joining Bruker BioSpin MRI&nbsp;GmbH in 2002, Dr.&nbsp;Prause was a senior staff scientist at the Max-Planck Institute in Tubingen, Germany.
Dr.&nbsp;Prause currently is a director of CCAS (the Coalition for the Commercial Application of Superconductors), and from 2006 to 2010, Dr.&nbsp;Prause was Chairman of ivSupra, a German
superconductor industry coalition. Dr.&nbsp;Prause holds a Ph.D. in Physics from the University of Notre Dame. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Juergen Srega.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;Srega has served as President of the Bruker CALID Group since January 2013, with responsibility for management
of the
global operations of our Bruker CALID Group, which manufactures and distributes the Company's mass spectrometry and chromatography instruments for life science and applied markets, as well as
analytical instruments for chemical, biological, radiological, nuclear and explosives detection and research and process instruments based on infrared and Raman molecular spectroscopy technologies.
Mr.&nbsp;Srega also serves as a Managing Director of Bruker Daltonik&nbsp;GmbH, an indirect wholly-owned subsidiary of the Company located in Germany. Prior to joining the Company,
Mr.&nbsp;Srega served since 1996 in a variety of senior management roles at Thermo Fisher Scientific&nbsp;Inc., a global provider of analytical instruments, equipment, reagents and consumables,
software and services for research, analysis, discovery and diagnostics headquartered in Waltham, Massachusetts. At Thermo Fisher Scientific, Mr.&nbsp;Srega led a number of significant operating
divisions, including as Vice President and General Manager Biomarkers, BRAHMS&nbsp;GmbH, from 2011 to 2012, Vice President and General Manager Scientific Instruments Division Global Products from
2005 to 2011 and Vice President and General Manager Advanced MS from 1996 to 2004. Prior to 1996, Mr.&nbsp;Srega was with Badenwerk AG, a German power utility company located in Karlsruhe, Germany,
from 1988 to 1995 and an employee of Bruker&nbsp;GmbH from 1980 to 1988. Mr.&nbsp;Srega holds a Bachelor of Arts degree in Finance from Nord Akademie in Hamburg, Germany and a Bachelor of Arts
degree in Engineering from Karlsruhe University of Applied Science in Karlsruhe, Germany. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>21</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=24,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=237071,FOLIO='21',FILE='DISK133:[18ZAG1.18ZAG15601]DI15601A.;41',USER='HYUNG',CD='10-APR-2018;15:03' -->
<A NAME="page_di15601_1_22"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="di15601_compensation_discussion_and_analysis"> </A>
<A NAME="toc_di15601_2"> </A>
<BR></FONT><FONT SIZE=2><B>  COMPENSATION DISCUSSION AND ANALYSIS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Compensation Discussion and Analysis ("CD&amp;A") describes the principles, objectives, and features of our executive compensation program,
which is generally applicable to each of our senior officers. However, this CD&amp;A focuses primarily on the program as applied to our Chief Executive Officer and the other executive officers listed
below and included in the Summary Compensation Table, whom we refer to collectively in this proxy statement as the "named executive officers."</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Dr.&nbsp;Frank H. Laukien, Chairman, President and Chief Executive Officer</FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Mr.&nbsp;Anthony L. Mattacchione, Former Senior Vice President and Chief Financial Officer </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Dr.&nbsp;Mark R. Munch, Executive Vice President and President, Bruker Nano Group and Bruker Nano Surfaces Division </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Mr.&nbsp;Juergen Srega, President, Bruker CALID Group and Bruker Daltonics Division </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Mr.&nbsp;Michael G. Knell, Former Vice President of Finance and Chief Accounting Officer </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;Mattacchione,
who served as our Chief Financial Officer throughout 2017, resigned from the Company effective March&nbsp;16, 2018. Additionally, Mr.&nbsp;Knell resigned
from the Company effective March&nbsp;31, 2017. These former executive officers are included as named executive officers in this proxy statement pursuant to applicable rules of the SEC. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Overview  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our executive compensation program is designed to attract, motivate, retain and reward the individuals who lead the Company and who are
responsible for developing and executing the overall business strategy. Our approach to compensation for our executive officers targets a mix of competitive salaries, performance-based cash incentive
awards linked to corporate and individual objectives and long-term equity incentive awards. The majority of our executive officers' pay opportunities are in the form of incentives, rather than base
salary, with a significant amount of those opportunities tied to long-term equity incentive awards, thereby strongly linking the interests of our overall pay program with those of our shareholders. We
provide limited perquisites and no excise tax gross ups. We also have a recoupment ("clawback") provision under our 2017 incentive plans that allows us to seek reimbursement of short-term incentive
payments and repayment of stock award gains
in the following circumstances: (a)&nbsp;to the extent of the excess of what would have been paid to the participant in the event of a restatement, due to material noncompliance with any financial
reporting requirements, that is required to be prepared at any time during the three-year period following such payment or (b)&nbsp;in the event the recipient engages in activities that are
detrimental to the business of the Company. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe that our compensation policies and practices are effectively designed to motivate and reward performance, and that the mix of compensation elements creates incentives that are
closely aligned with increasing shareholder value without encouraging excessive or unnecessary risk-taking. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Financial Performance  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our business strategy is to create value for our stockholders based on our ability to innovate and generate revenue growth, both organically and
through acquisitions. Achieving improvements in our gross profit margins, operating margins, earnings and cash flow are also important to our success. In 2017, our revenues increased by
$154.6&nbsp;million, or 9.6%, to $1,765.9&nbsp;million from $1,611.3&nbsp;million in 2016. Included in our 2017 revenues was an increase of approximately $77.2&nbsp;million attributable to our
recent acquisitions and an increase of approximately $19.6&nbsp;million from the impact of foreign currency translation caused by the weakening of the U.S. Dollar versus the euro and other
currencies. Excluding the effects of foreign currency translation and our recent acquisitions, our organic revenue, a non-GAAP financial measure, increased by $57.8&nbsp;million, or 3.6%. Our gross
profit margin remained </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>22</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=25,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=197640,FOLIO='22',FILE='DISK133:[18ZAG1.18ZAG15601]DI15601A.;41',USER='HYUNG',CD='10-APR-2018;15:03' -->
<A NAME="page_di15601_1_23"> </A>

<P style="font-family:times;"><FONT SIZE=2>approximately
consistent at 46.0% during the year ended December&nbsp;31, 2017, compared to 46.1% during the year ended December&nbsp;31, 2016. Excluding various charges for amortization of
acquisition-related intangible assets and other acquisition-related costs and restructuring costs, our non-GAAP gross profit margin also was consistent at 48.1% in each of the years ended
December&nbsp;31, 2017 and 2016. Operating income for the year ended December&nbsp;31, 2017 was $214.7&nbsp;million, resulting in an operating margin of 12.2%, compared to income from operations
of $177.2&nbsp;million and an operating margin of 11.0%, for the year ended December&nbsp;31, 2016. The operating margin increase reflected improved operating leverage on higher sales following
our multi-year operational transformation, cost discipline and savings from restructuring initiatives. These factors more than offset dilution from recent acquisitions and foreign currency translation
effects. Excluding various charges for amortization of acquisition-related intangible assets and other acquisition-related costs and restructuring costs, our non-GAAP operating margin also improved to
15.6% for the year ended December&nbsp;31, 2017, compared to 14.8% in the year ended December&nbsp;31, 2016. For the year ended December&nbsp;31, 2017, we reported GAAP diluted earnings per
share&nbsp;(EPS) of $0.49, compared to $0.95 for the year ended December&nbsp;31, 2016. The decrease in our
GAAP EPS was primarily attributed to charges related to the estimated impact of U.S.&nbsp;tax reform legislation which resulted in a significantly higher effective tax rate for the year ended
December&nbsp;31, 2017. On a non-GAAP basis, our diluted non-GAAP EPS for the year ended December&nbsp;31, 2017 of $1.21 compared to $1.19 for the year ended December&nbsp;31, 2016, which in
turn had benefited from an unusually favorable effective tax rate in fiscal year 2016. Our working capital ratio weakened slightly in 2017, with working capital per dollar of revenue of $0.405,
compared to $0.371 in 2016. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Organic
revenue, non-GAAP gross profit margin, non-GAAP operating margin and non-GAAP EPS are non-GAAP financial measures we use to supplement our financial results prepared and
presented in accordance with U.S. generally accepted accounting principles (GAAP).<SUP>(1)</SUP> The Compensation Committee considers these non-GAAP measures, as well as other non-GAAP measures,
when setting incentive compensation targets. We use these non-GAAP financial measures to evaluate </FONT></P>


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >


<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B><I>Non-GAAP Financial Measures&#151;</I></B></FONT><FONT SIZE=2>For additional information regarding our organic revenue,
non-GAAP gross profit margin and non-GAAP operating margin non-GAAP financial measures, including reconciliations to the most directly comparable GAAP financial measures, please see pages&nbsp;41 to
42 and pages&nbsp;45 to 47 under Part&nbsp;II, Item&nbsp;7&#151;</FONT><FONT SIZE=2><I>Management's Discussion and Analysis of Financial Condition and Results of
Operations</I></FONT><FONT SIZE=2> of our Annual Report on Form&nbsp;10-K filed with the SEC on March&nbsp;16, 2018. Non-GAAP EPS includes the following adjustments to our reported GAAP EPS: </FONT></DD></DL>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="34pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><B> 2017</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><B> 2016 </B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2><B></b></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 GAAP Earnings Per Share (Diluted)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.49</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.95</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:27pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Non-GAAP Adjustments</I></FONT><FONT SIZE=2>:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Restructuring Costs</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.10</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.13</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Acquisition-Related Costs</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.06</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.07</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Purchased Intangible Amortization</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.19</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.14</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Other Costs</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.03</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.04</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Bargain Purchase Gain</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(0.06</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>)</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Income Tax Rate Differential</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.33</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>(0.08</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>) </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:27pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2><I>Total Non-GAAP Adjustments</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.72</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0.24 </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Non-GAAP Earnings Per Share (Diluted)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.21</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1.19</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>23</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=26,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=815776,FOLIO='23',FILE='DISK133:[18ZAG1.18ZAG15601]DI15601A.;41',USER='HYUNG',CD='10-APR-2018;15:03' -->
<A NAME="page_di15601_1_24"> </A>

<P style="font-family:times;"><FONT SIZE=2>our
period-over-period operating performance because our management believes they provide more comparable measures of our continuing business because they adjust for certain items that are not
reflective of the underlying performance of our business. These measures may also be useful to investors in evaluating the underlying operating performance of our business. We regularly use these
non-GAAP financial measures internally to understand, manage, and evaluate our business results and make operating decisions. We also measure our employees and compensate them, in part, based on such
non-GAAP measures and use this information for our planning and forecasting activities. The presentation of these non-GAAP financial measures is not intended to be a substitute for, or superior to,
the financial information prepared and presented in accordance with GAAP and may be different from non-GAAP financial measures used by other companies, and therefore, may not be comparable among
companies. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2017, we significantly exceeded the performance goals for each of the financial performance goals established by the Compensation Committee at the Corporate level, other than our goal
linked to reducing our working capital ratio. Specifically, our Corporate level goals linked to currency-adjusted revenue growth, increasing our non-GAAP operating profit and meeting our earnings per
share target were exceeded. Our goal of reducing our working capital ratio was not achieved. Our underlying business results also were generally favorable, with the Bruker CALID and Bruker Nano Groups
overachieving with respect to their Group level currency-adjusted revenue growth, non-GAAP gross profit improvement and non-GAAP operating profit improvement metrics, though not achieving their Group
level goals related to reducing the working capital ratio. The Bruker BioSpin Group did not achieve its Group level financial objectives in 2017. Our management team also continued to make
significant progress returning the business to positive revenue growth, as well as on a number of strategic initiatives aimed at reducing our operating costs and improving our operating efficiency,
which we believe will contribute to positive shareholder value creation over the long-term. Consequently, consistent with our pay for performance philosophy, the 2017 cash incentive awards approved
for our executive officers reflect these generally strong results at the Corporate and Group levels and were substantially above target award levels. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Executive Compensation Actions  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Highlighted below are some of the key actions and decisions with respect to our executive compensation programs for fiscal year 2017, as
approved by the Compensation Committee: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><I> Salaries.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;For fiscal 2017, the Compensation Committee evaluated our
executive officers' base salaries in light of competitive market levels and approved a 5.2% salary increase for Dr.&nbsp;Frank Laukien, our Chief Executive Officer. The Compensation Committee
considered this adjustment appropriate based on peer group survey data, as Dr.&nbsp;Laukien's base salary and total target cash compensation continue to be significantly below the market median for
chief executive officers of the Company's compensation peer group. The 2017 base salaries for each of our other executive officers, other than Mr.&nbsp;Knell, were set at levels which the
Compensation Committee considered appropriate given their respective responsibilities, overall performance and competitive market conditions with salary increases ranging from 5% to 7%. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><I> Performance-Based Cash Incentive Awards and Payouts.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;Consistent with our
pay-for-performance philosophy, a significant portion of our executive officers' total compensation potential for fiscal 2017 was linked to achievement of corporate and individual performance goals.
Additionally, as executive officers assume greater responsibility, a larger portion of their total cash compensation is designed to and does become dependent on and varies based on Company and
individual performance. For example, the Chief Executive Officer's variable cash compensation represented nearly 60% of his total cash compensation opportunity based on target levels. For the
remaining named executive officers, cash-based variable pay represented nearly 40% of total cash </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>24</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=27,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=813542,FOLIO='24',FILE='DISK133:[18ZAG1.18ZAG15601]DI15601A.;41',USER='HYUNG',CD='10-APR-2018;15:03' -->
<A NAME="page_di15601_1_25"> </A>
<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>compensation
based on target levels, tying over one-third of their total earnings opportunity to strategic performance objectives which are aligned with shareholder value creation.  </FONT></P>

<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> As in past years, the Compensation Committee established specific fiscal year 2017 financial and individual performance goals for
our executive officers. Financial goals represented 70% of each of our executive officers' total cash incentive compensation potential, with the remaining 30% allocated to individual performance goals
established by the Compensation Committee.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The Compensation Committee approved 2017 financial performance targets related to revenue growth, operating profit improvement,
earnings per share growth and working capital management for our corporate level executives, including Dr.&nbsp;Laukien and Mr.&nbsp;Mattacchione, based on our business plan goals for these key
metrics. The Compensation Committee selected as 2017 metrics the same metrics used to measure 2015 and 2016 performance, as they continued to be considered the critical operating imperatives for our
business. The financial performance targets approved by the Compensation Committee for our executive officers with primary operating Group management responsibilities, including Mr.&nbsp;Srega and
Dr.&nbsp;Munch, varied based on key performance drivers for their respective operating Group, with approximately 85% of such targets allocated to Group financial performance (60% of the total 70%)
and approximately 15% (10% of the total 70%) allocated to Corporate financial objectives.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Payment for cash incentive bonuses linked to the achievement of pre-established financial performance goals is calculated based on
percentage achievement of the respective goals relative to a threshold level of performance established by the Compensation Committee based on our 2016 financial results and the goals included in our
2017 business plan. While there is no maximum payout for any of the financial goals, total 2017 incentive award payouts, after combining both financial and individual portions, are subject to a
maximum payout amount equal to 200% of the executive officer's incentive award target.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Annual cash incentive awards for fiscal 2017 rewarded our executive officers for generally strong operational performance relative
to their individual goals, and also reflected the fact that our financial performance was mixed across the Groups. Examples of operational successes include returning to revenue growth, closing
several strategic acquisitions, launching and successfully selling new product innovations, continuing to build operational efficiencies and lean strategies throughout the Company, and implementing
tax planning strategies to optimize effective tax rates around the world. Based on 2017 financial goals and performance results, cash incentive payments calculated for performance against financial
goals ranged from 162% to 184% of our named executive officers' target bonuses linked to their 2017 financial performance goals. In addition, cash incentive payments calculated for performance against
2017 individual performance goals were in amounts ranging from 90% to 104% of our named executive officers' target bonuses linked to their individual performance goals. Reflecting this performance,
total cash incentive payouts to our named executive officers for 2017 ranged from 141% to 159% of incentive award targets.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD></DL>
</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><I> Long-Term Incentive Awards.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;In 2017, the Compensation Committee approved
long-term incentive awards to our named executive officers and senior management team, including awards of stock options and restricted stock units, in each case subject to time-based vesting. The
value of such awards to our Chief Executive Officer approximated 3.6 times his base salary and almost 62% of his total direct compensation, which includes base salary, target bonus and long-term
equity incentives, thus linking a significant portion of his total compensation to shareholder value. Our Group presidents, Dr.&nbsp;Munch and Mr.&nbsp;Srega, and our Chief Financial Officer also </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>25</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=28,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=47838,FOLIO='25',FILE='DISK133:[18ZAG1.18ZAG15601]DI15601A.;41',USER='HYUNG',CD='10-APR-2018;15:03' -->
<A NAME="page_di15601_1_26"> </A>
<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>were
awarded significant equity stakes, approximating 1.6 times their base salaries, and had long-term incentives represent approximately 50% of their total direct compensation at target levels. We
believe the combination of a high proportion of total compensation tied to share price performance and a four-year vesting period for equity awards further aligns the interests of our executives with
the long-term interests of our stockholders. </FONT></P>

</UL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Say on Pay Vote  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At the Company's 2017 Annual Meeting of Stockholders, our stockholders voted on a proposal on the frequency of future stockholder advisory votes
regarding the compensation of the Company's named executive officers. A frequency of once every year received the highest number of votes cast, as well as a majority of the votes cast on the proposal.
Our Board of Directors considered these results and determined that we will hold an annual advisory say on pay vote. In May 2017, our stockholders also cast the most recent advisory vote on the
Company's executive compensation decisions and policies as disclosed in the proxy statement for the 2017 Annual Meeting of Stockholders. Over 97% percent of the shares voted on the matter at the 2017
Annual Meeting of Stockholders approved the compensation decisions and policies described in the 2017 proxy statement. The Compensation Committee considered this result in 2017 and determined that it
was not necessary to make any material changes to the Company's compensation policies and practices in response to the most recent advisory vote. However, the Compensation Committee regularly reviews
the compensation programs of our executive officers to ensure that they achieve our objectives. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the 2018 Annual Meeting, our stockholders are being asked to cast an advisory vote regarding executive officer compensation. Our stockholders will next be asked to cast a vote on the
frequency of future stockholder advisory votes regarding executive compensation at the Company's 2023 Annual Meeting of Stockholders. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Compensation Philosophy and Process  </B></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Key Considerations in Setting Compensation  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our key objectives in structuring and determining executive compensation are to:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> attract and retain qualified executive officers by offering competitive and comprehensive compensation packages; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> motivate existing officers to perform by providing meaningful incentive-based compensation; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> align compensation with Bruker Corporation's annual and long-term strategic performance goals; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> balance both the short-term goals of the Company with a focus on creating long-term value for our stockholders, without encouraging excessive
or unnecessary risk-taking. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
achieve these objectives, we have embraced a compensation philosophy that seeks to align compensation with our strategic objectives and reward our executive officers for meeting or
exceeding certain pre-determined performance goals. Executive compensation at Bruker is based in large part on a pay-for-performance philosophy, through annual incentive bonus awards which emphasize
both company and individual performance measures that correlate closely with the achievement of our short and long term strategic performance objectives. To motivate our executive officers, we focus
on cash compensation in the form of salary and annual performance incentives, a portion of which is tied to the individual's performance, and we augment this cash compensation with equity grants. In
structuring executive compensation, the Compensation Committee focuses on our goal of long-term enhancement of shareholder value through grants of equity incentive awards with extended multi-year
vesting schedules. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>26</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=29,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=796732,FOLIO='26',FILE='DISK133:[18ZAG1.18ZAG15601]DI15601A.;41',USER='HYUNG',CD='10-APR-2018;15:03' -->
<A NAME="page_di15601_1_27"> </A>
<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Role of the Compensation Committee  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our executive compensation program is administered by the Compensation Committee of the board of directors. The Compensation Committee oversees
the Company's equity incentive plan, including determining overall option and restricted stock award guidelines and aggregate share usage and dilution levels, determines the Chief Executive Officer's
salary, target and actual bonus, and equity-based compensation, oversees the executive compensation program for our other executive officers, including reviewing and approving the overall values and
forms of compensation for the named executive officers listed in the Summary Compensation Table included in this proxy statement as well as for other officers, reviews general policy matters relating
to compensation and employee benefits and makes recommendations concerning these matters to the board of directors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee conducts the annual performance evaluation of our Chief Executive Officer. Generally, the process begins with the Chief Executive Officer completing a
self-evaluation, which is submitted to the Compensation Committee for review and discussion. As part of this review, the Chair of the Compensation Committee may solicit views from other members of our
board of directors, after which the Chair of the Compensation Committee provides feedback to the Chief Executive Officer. The Compensation Committee uses this evaluation along with market data
comprised of peer group and salary survey information in setting the Chief Executive Officer's compensation. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
executive officers other than our Chief Executive Officer, the Compensation Committee relies primarily on input and recommendations from our Chief Executive Officer in the case of
our Chief Financial Officer and Group presidents. Our Chief Executive Officer, Chief Financial Officer and Corporate Senior Director of Human Resources also may contribute input to the Compensation
Committee in connection with its evaluation of executive officers' performance objectives and performance of the executive officers against those objectives to assist it in making appropriate
decisions regarding salary and incentive awards. The Corporate Senior Director of Human Resources may also provide market analyses and other relevant market intelligence to the Compensation Committee
as part of its evaluation and deliberations. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the end of the first quarter of each fiscal year, the Compensation Committee reviews and approves changes to our executive officers' total target cash compensation, including
base salary and target incentive compensation. Also during this time, the Compensation Committee reviews recommendations from management on the most recently completed fiscal year short-term incentive
compensation programs relative to anticipated corporate and individual performance. Additionally, during the third and fourth quarters of each fiscal year, the Compensation Committee reviews and makes
recommendations to the full board of directors regarding any changes to board compensation. The Compensation Committee generally reviews recommendations for long-term equity incentive awards during
the second and third quarters of the fiscal year. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee assesses competitive market compensation for our executive officers using a variety of external sources, including cash and long-term incentive compensation
data derived from independent sources, including market surveys and proxy information, for a reference group of publicly-traded companies in the same or similar industries. Although individual pay is
driven largely by individual and corporate performance considerations, the Compensation Committee has historically used reference group data as a "market check" to help ensure that individual cash
compensation levels remain reasonable and competitive. The Company has retained independent consulting firm Radford Consulting, or Radford, since September 2013 to provide support in evaluating the
Company's executive compensation levels and practices, particularly with respect to total direct compensation, internal pay equity, pay for performance alignment, and long-term incentive award levels,
and types of equity vehicles and processes, including the impact of overall stockholder dilution resulting from equity awards. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>27</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=30,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=843801,FOLIO='27',FILE='DISK133:[18ZAG1.18ZAG15601]DI15601A.;41',USER='HYUNG',CD='10-APR-2018;15:03' -->
<A NAME="page_di15601_1_28"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee retains the discretion to approve awards in excess of those calculated to have been earned under the pre-established cash incentive plans of our executive
officers in recognition of exceptional individual performance or contributions to Company performance. Additionally, the Compensation Committee may exercise its discretion not to approve cash
incentive plan awards calculated to have been earned under a pre-established cash incentive plan of an executive officer in the event the Compensation Committee determines that such executive officer
has violated Company policies or has failed to meet minimum performance expectations of an executive officer in that executive's position. The Compensation Committee may also recoup incentive
compensation payments if it determines that a recipient has engaged in activities detrimental to the Company's business, as well as excess payments made resulting from a financial restatement which
results from material non-compliance with accepted financial requirements or reporting standards. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Role of Management  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Chief Executive Officer, with the assistance of the Chief Financial Officer, is responsible for making recommendations to the Compensation
Committee for our Company-wide financial performance goals and their respective weightings. He is also responsible for making recommendations to the Compensation Committee for the individual incentive
goals and weightings for the Company's other executive officers. The Chief Executive Officer is also responsible for developing and providing a proposal to the Compensation Committee for his own cash
incentive plan, including the goals, weightings and target levels. The Compensation Committee reviews the recommendations of the Chief Executive Officer and Chief Financial Officer and determines the
final incentive plan structure and goals for each of the executive officers, including threshold and target performance levels. After the close of the fiscal year, the Chief Executive Officer,
assisted by the Chief Financial Officer and the Senior Director of Human Resources, provides the Compensation Committee with his
assessment of the performance of the other executive officers against their respective bonus goals and proposed cash incentive payout. When determining the cash incentive plan payout for our executive
officers, the Compensation Committee, while considering the recommendations of the Chief Executive Officer, makes the final determination based on its assessment of each executive officer's
performance relative to his or her performance-based goals. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Chief Executive Officer and the Senior Director of Human Resources participate in Compensation Committee meetings, at the request of the Compensation Committee, to provide background
information and explanations supporting compensation recommendations, including the results of annual performance evaluations for our Chief Executive Officer, Chief Financial Officer and our other
named executive officers. The Chief Financial Officer also participates in Compensation Committee meetings to provide perspective and supplemental information related to the Company's financial goals
and other financial plan topics. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Role of Compensation Consultants  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In light of the growth and evolution in recent years in the size and complexity of the Company and its global operations, changes in the
competitive landscape as a result of industry consolidation and changes in the Company's own organizational and management structure, the Compensation Committee and management have worked with Radford
to, among other things, review market surveys, observations and recommendations regarding our executive compensation program relative to other similarly situated public companies and receive external
perspectives on evolving trends related to executive compensation program design, best practices and changes in the regulatory landscape. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Since
September 2013, Company management has engaged Radford to provide support to management and the Compensation Committee, including the selection of a peer group of companies and
development of peer group survey data, as well as analysis and advice on the Company's executive compensation structure, program design and market practices. Services provided during fiscal 2017 by </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>28</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=31,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=601271,FOLIO='28',FILE='DISK133:[18ZAG1.18ZAG15601]DI15601A.;41',USER='HYUNG',CD='10-APR-2018;15:03' -->
<A NAME="page_di15601_1_29"> </A>

<P style="font-family:times;"><FONT SIZE=2>Radford
under its engagement with the Company included working with the Company to assess the current peer group for reasonableness and various compensation analyses and assessments. The analyses and
recommendations provided by Radford were among the inputs considered in the evaluation of the Company's compensation process, program design and executive compensation determinations for 2017. The
selected peer group is generally used for compensation assessments and
analyzing the Company's executive compensation pay levels and practices, including the Company's share allocation and utilization for employee equity awards as compared with peer companies. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Aon
and Aon Hewitt, affiliates of Radford, provided insurance consulting services to the Company in 2017 for which services they received aggregate fees of $52,500. For its services as
an executive compensation consultant to the Company, Radford received aggregate fees of approximately $84,000 in 2017, as well as approximately $43,000 for non-executive compensation consulting and
surveys. The Committee has evaluated Radford's independence by considering each of the independence factors adopted by NASDAQ and the SEC. Based on such evaluation, the Committee determined that no
conflicts of interest existed during fiscal 2017 or exist currently. The Compensation Committee has the authority to retain, compensate and terminate any consultants or advisers it deems necessary to
assist it in the fulfillment of its responsibilities. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Peer Group Review and Market Data  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In establishing and evaluating fiscal 2017 compensation for our executive officers, the Compensation Committee utilized survey market data and
peer group analysis provided by Radford. The Compensation Committee believes that it is important to consider compensation practices of companies that are comparable to us in terms of revenue, market
capitalization, employees, global reach, scale and complexity, along with industry. Radford generally targeted companies in the range of 1/2 to three times the size of the Company across various
categories, considering the global complexity and reach of the Company. The market data provided by Radford was based on published survey sources, including Radford's Global Technology Survey and Aon
Hewitt's Total Compensation Management Database, as well as recent proxy statements of the Company's peer group companies. The Compensation Committee references ranges of the market data provided,
including the 10th, 25th, 50th, and 75th&nbsp;percentiles, considering all of these sources in determining the appropriate level of compensation for our executive officers. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
fiscal 2017 compensation evaluations, the peer group identified by Radford and referenced by the Compensation Committee comprised 16 other companies in the scientific tools,
instruments, and services industries. The Compensation Committee believes that a peer group consisting of broad competitors of various sizes provides useful insight for its consideration of
compensation levels, including information about the range and median of competitive salaries, cash bonuses and long-term incentives. In addition to industry, complexity and size characteristics, the
Compensation Committee also considers the extent to which our selected peer group companies consider us a peer, how other third-party organizations categorize the Company, such as the Standard and
Poor's GICS methodology, and other companies which shareholder advisory firms, such as ISS, consider comparable to us. The Committee also strives for consistency in the peer group from year to year,
to maintain consistency of results. The same peer group has generally been used since 2013, with modifications primarily due to industry consolidation. In 2017, at the time Radford compiled data for
the peer group companies, the companies in our selected peer group ranged in size on a revenue basis from approximately $1.97 to $3.0&nbsp;billion, at the 25th&nbsp;and 75th&nbsp;percentiles,
respectively, with a median of $2.3&nbsp;billion, compared to our
trailing twelve month revenue of $1.6&nbsp;billion, and a range of 5,560 to 12,675 employees at the 25th&nbsp;and 75th&nbsp;percentiles, respectively, with median number of employees of 7,900
compared to our </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>29</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=32,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=402800,FOLIO='29',FILE='DISK133:[18ZAG1.18ZAG15601]DI15601A.;41',USER='HYUNG',CD='10-APR-2018;15:03' -->
<A NAME="page_di15601_1_30"> </A>

<P style="font-family:times;"><FONT SIZE=2>6,200.
The peer group considered by the Compensation Committee for its evaluation of 2017 executive compensation levels and practices included: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="279pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>



<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>Agilent
Technologies</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT
SIZE=2>Illumina&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>AMETEK,
&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>KLA-Tencor
Corporation</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>



<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>Bio-Rad Laboratories,
&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>Mettler-Toledo
International&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>C.R. Bard,
&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>OSI Systems,
&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>



<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>Charles River Laboratories
International,&nbsp;Inc.</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>PAREXEL</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>



<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>FLIR Systems,
&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>PerkinElmer,
&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>



<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>Haemonetics
Corporation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>Varian Medical Systems,
&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>Hologic,
&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>Waters
Corporation</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
general, in light of our relative market position, the Compensation Committee considered the range and median compensation levels of the companies in the peer group to be appropriate
and reasonable competitive comparisons for our executive officers when evaluating and approving 2017 compensation packages. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Compensation Components and 2017 Compensation Determinations  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consistent with our compensation objectives and philosophy, when setting compensation for our named executive officers the Compensation
Committee focuses on providing a competitive and complementary mix of pay components, including base salary, annual incentive compensation and long-term equity incentive awards, designed to work
together to reward performance and create incentives that encourage behavior consistent with the overall short- and long-term interests of the Company. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
determining compensation packages for our named executive officers, the Compensation Committee seeks to strike an appropriate balance between fixed and variable compensation and
between short-and long-term compensation. We believe that making a significant portion of our named executive officers' compensation variable and long-term supports our pay-for-performance executive
compensation philosophy, while also mitigating potential excessive risk-taking behavior. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Components of Executive Compensation  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total direct compensation consists of cash compensation in the form of annual base salary and annual incentive bonus awards, as well as
long-term incentive compensation in the form of stock option and restricted stock grants. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annual Base Salary.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Base salaries are determined based on a variety of factors, including each officer's level of responsibility, scope
of the role,
experience and potential, performance and a comparison of salaries paid to peers within the Company and to those with similar roles at other similarly situated companies, including those found in the
market surveys and peer group data reviewed by the Compensation Committee. Base salaries are set at levels that the Compensation Committee believes are reasonably competitive to allow us to attract
and retain qualified executives. Base salaries are reviewed annually and may be adjusted after considering the various factors described above. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annual Cash Incentive Awards.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Annual incentive awards in the form of performance-based cash incentive bonuses for the Chief Executive
Officer and our
other executive officers are based upon management's
success in meeting our financial and strategic goals. Specific criteria for these awards are based on a combination of financial and individual measures established each year by the Compensation
Committee after consultation with management. The specific goals vary for each executive officer based on responsibilities and role within our Company and may include financial or strategic measures,
including, among others, revenue growth, gross profit and operating profit margin improvement, working capital ratio improvements, achieving return on invested capital goals, meeting earnings per
share targets, identifying and developing new product and market opportunities and furthering or achieving other strategic initiatives. The individual goals are intended to reward performance which
results in our Company meeting or exceeding its financial or operational goals. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>30</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=11,SEQ=33,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=846864,FOLIO='30',FILE='DISK133:[18ZAG1.18ZAG15601]DI15601A.;41',USER='HYUNG',CD='10-APR-2018;15:03' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dk15601_1_31"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee also considers the mix of performance goals to balance the incentives created to mitigate risks that may be associated with a particular performance goal. In
2017, for example, and as in recent prior years, the cash incentive compensation plans, or ICPs, established for our corporate level officers, including our Chief Executive Officer and Chief Financial
Officer, consisted of a revenue target goal along with targets for non-GAAP operating profit improvement, improvement in working capital and non-GAAP earnings per share, such that the combination of
goals emphasized profitable revenue growth and cash flow improvements based on the business plan approved by our board of directors. For our Group presidents, the financial metrics included Group
level revenue growth, increases in Group level non-GAAP gross and operating profit and improvements in Group level working capital, as well as linkage to the overall Bruker non-GAAP earnings per share
result, to ensure alignment and teamwork across the leadership team. Through a mix of financial metrics and individual goals, cash incentive awards reflect both the individual's contributions compared
to his or her specific performance goals for the year and the overall performance of our Company or the particular operations under the executive officer's leadership. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-Term Incentive Awards.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Equity incentive compensation in the form of stock option, restricted stock awards and restricted stock
unit (RSU) awards
is designed to provide long-term incentives to executive officers and other employees, to encourage the executive officers and other employees to remain with us and to enable recipients to develop and
maintain a long-term stock ownership position in our common stock, which in turn motivates the recipient to focus on creating long-term enhancement to shareholder value. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effective
as of its approval by our stockholders in May 2016, the Company's 2016 Incentive Compensation Plan, or the 2016 Plan, is the vehicle used for grants of equity incentive awards
to our executive officers and other employees. Prior to the approval of the 2016 Plan, equity incentives in the
form of stock option and restricted stock awards were granted pursuant to the Company's 2010 Incentive Compensation Plan. The 2016 Plan provides for the grant of awards of options, including
nonqualified stock options or incentive stock options, restricted stock, unrestricted stock, restricted stock units, stock appreciation rights, performance shares and performance units, as well as
cash-based awards. Following adoption of the 2016 Plan, we shifted to the use of RSU awards from restricted stock awards to provide a more tax-effective equity vehicle for our international employees
and additional flexibility for the Company to deliver awards in the form of stock or cash. The Company management evaluates the efficacy of our long-term incentive compensation on an ongoing basis and
provides input and recommendations to the Compensation Committee with regard to the optimal form and extent of equity incentives to be granted to employees, including the executive officers. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity
incentive awards are discretionary and may be granted by the Compensation Committee at any time. Historically, we have not awarded equity incentive compensation with
performance-based vesting, meaning that individual vesting is not based upon the achievement of any specific pre-determined goals or objectives. However, increases in stock price provide the only
value available to executives from stock options, and increases in shareholder value deliver higher values in the restricted stock and RSU awards held by our executive officers and other key
personnel. The Compensation Committee also considers individual and Company performance in determining the value of total and individual equity awards. The Compensation Committee has determined that
equity compensation awards to executives and all other employees should be based upon the economic value of the grant award and should be considered part of the compensation package in determining
award levels. In making specific grants to executives, the Compensation Committee evaluates each executive officer's total equity compensation package. The Compensation Committee also generally
reviews the option and restricted stock holdings of each of the executive officers, including vesting and exercise price and the then current in-the-money value of such options or restricted stock, in
addition to the impact of those values under various stock price scenarios. We consider long-term equity compensation to be an integral part of a competitive executive compensation package as both a
way to reinforce the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>31</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=34,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=847844,FOLIO='31',FILE='DISK133:[18ZAG1.18ZAG15601]DK15601A.;16',USER='CHE108057',CD='10-APR-2018;12:07' -->
<A NAME="page_dk15601_1_32"> </A>

<P style="font-family:times;"><FONT SIZE=2>individual's
commitment to the Company, create an ownership mentality and provide an important mechanism to align the interests of management with those of our stockholders. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Mix of Compensation  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In accordance with our pay-for-performance philosophy, variable compensation in the form of short-term cash incentive compensation and long-term
equity incentive awards are intended to be a significant portion of overall compensation, with this at-risk component increasing as a percentage of overall compensation potential as the individual
officer's responsibility increases. For
example, approximately 84% of the Chief Executive Officer's total compensation is variable or "at risk," meaning these amounts must be re-earned each year. Similarly, almost 69% of the total
compensation of our other named executive officers is comprised of variable pay. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Specifically,
on a target basis in 2017, approximately 58% of our Chief Executive Officer's total potential cash compensation at the target level was at risk through his short-term cash
incentive program. Additionally, recognizing the importance of providing further incentives directly linked to the performance of our common stock and aligned with stockholder interests, in 2017 the
Compensation Committee approved market competitive long-term incentive awards to our named executive officers, including, among others, awards to Dr.&nbsp;Laukien, our Chief Executive Officer, and
Mr.&nbsp;Mattacchione, our Chief Financial Officer during fiscal year 2017, of stock options and RSU awards valued at the time of the respective awards at over 385% and 184% of base salary,
respectively, in each case subject to time-based vesting over four years and continued employment. Equity awards for our Group presidents on average approximated 155% of base salary, signifying strong
alignment for our executive team with stockholder interests. Equity compensation comprised approximately 62% of our Chief Executive Officer's total direct compensation and approximately half of our
Chief Financial Officer's total direct compensation, which includes base salary, annual bonus and long-term incentives. Long-term incentives as a percent of total direct compensation for our Group
presidents also approximated half of their total direct compensation. Long-term incentives as a percent of total direct compensation for the named executive officers as a group, including the CEO,
ranged from approximately 49% to 62%. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following charts and table illustrate the mix of base salary at approved 2017 levels, short-term cash incentive bonus at target levels and long-term incentive awards ("LTI") provided
in the compensation packages of our Chief Executive Officer ("CEO"), and, on average, our named executive officers other than our Chief Executive Officer ("Other NEOs"). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>32</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=35,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=1040963,FOLIO='32',FILE='DISK133:[18ZAG1.18ZAG15601]DK15601A.;16',USER='CHE108057',CD='10-APR-2018;12:07' -->
<A NAME="page_dk15601_1_33"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk15601_named_executive_officer_compensation_mix"> </A>
<A NAME="toc_dk15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Named Executive Officer Compensation Mix    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g257822.jpg" ALT="GRAPHIC" WIDTH="255" HEIGHT="216">
 </B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g866941.jpg" ALT="GRAPHIC" WIDTH="255" HEIGHT="216">
 </B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>CEO Pay Mix </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Other NEO Average Pay Mix </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Element

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Value<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>% of Total Direct<BR>
Compensation </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Value(1)<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>% of Total Direct<BR>
Compensation </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Base Salary(2)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>704,269</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>16</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>448,811</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>31</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Bonus(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,000,999</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>278,041</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>19</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Long Term Incentives(4)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,750,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>62</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>756,667</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>50</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Direct Compensation</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,455,268</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,483,519</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
values reported reflect conversions from euros, in the case of Mr.&nbsp;Srega, to U.S. dollars at a conversion rate of &euro;1.0 =$1.1300 reflecting
the 2017 average midpoint rates as published on www.oanda.com.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Base
salaries are as reported in the Summary Compensation Table following this CD&amp;A.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Bonus
represents the target level of the short-term cash incentive plan of the CEO and Other NEOs.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Long-term
incentive awards are based on the economic values of the awards as approved by the Compensation Committee.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Base Salaries  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annual base salaries approved by the Compensation Committee for each of our named executive officers for 2017 were as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 Base Salary<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2016 Base Salary<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>% Change </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dr.&nbsp;Frank Laukien</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>715,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>680,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mr.&nbsp;Mattacchione</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>447,260</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>418,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mr.&nbsp;Srega</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>369,238</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(1)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>351,121</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%(3)</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dr.&nbsp;Munch</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>529,935</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>504,700</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mr.&nbsp;Knell</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>233,147</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>233,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Amount
represents the U.S. dollar equivalent value of Mr.&nbsp;Srega's base salary (&euro;326,759), based on the 2017 average midpoint conversion rate
of &euro;1.0 =$1.1300.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Amount
represents the U.S. dollar equivalent value of Mr.&nbsp;Srega's base salary (&euro;317,240), based on the 2016 average midpoint conversion rate
of &euro;1.0 =$1.1068. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>33</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=36,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=334230,FOLIO='33',FILE='DISK133:[18ZAG1.18ZAG15601]DK15601A.;16',USER='CHE108057',CD='10-APR-2018;12:07' -->
<A NAME="page_dk15601_1_34"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>For
2017, the Compensation Committee approved a 3.0% increase in Mr.&nbsp;Srega's base salary denominated in euros, the currency of payment, from
&euro;317,440 to &euro;326,759. The dollar amount reported in the table above is converted from euros and reflects the impact of changes in foreign exchange rates in 2017. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
fiscal 2017, the Compensation Committee approved a 5.2% salary increase for Dr.&nbsp;Laukien, our Chief Executive Officer. The Compensation Committee considered this adjustment
appropriate based on the updated peer group data reviewed by the Compensation Committee, as Dr.&nbsp;Laukien's base salary and total compensation potential was, and after the increase continued to
be, significantly below the market median for chief executive officers of the Company's compensation peer group. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
fiscal 2017, the Compensation Committee approved a 7.0% salary increase for Mr.&nbsp;Mattacchione, our former Chief Financial Officer. The Compensation Committee considered this
adjustment appropriate based on the updated peer group data and Mr.&nbsp;Mattacchione's performance evaluation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee determined that, based on Dr.&nbsp;Munch's performance evaluation and the comparison to compensation paid to executives in comparable positions according to
peer group and other market data reviewed by the Compensation Committee, Dr.&nbsp;Munch's base salary for fiscal 2017
should be increased by 5.0% from $504,700 to $529,935. The change reported in the table above reflects the cumulative effect of these determinations. The base salary established for Mr.&nbsp;Srega
reflects the Compensation Committee's assessment of competitive market levels, individual performance, experience and overall responsibilities, as well as internal pay equity. Mr.&nbsp;Knell's base
salary remained essentially unchanged in 2017 as his pay was not adjusted by the Compensation Committee due to his resignation from the Company effective March 2017. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Base
salary increases became effective April&nbsp;1, 2017. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Cash Incentive Plans and Review of 2017 Performance  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annual cash incentive compensation supports the Compensation Committee's pay-for-performance philosophy and aligns individual goals with those
of the Company. Under the annual short-term incentive compensation plans, or ICPs, executive officers are eligible for cash awards based on a combination of the Company's attainment of pre-established
financial performance metrics and achievement of specific individual performance goals. While still measurable, individual performance goals may not always be as quantifiable as the financial
objectives. Thus, and consistent with its past practice, the Compensation Committee structured our executive officers' 2017 ICPs as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> At the beginning of the fiscal year, the Compensation Committee set individual target awards for each executive officer, expressed as a
percentage of base salary, based on the executive's level of responsibility and upon a review of management recommendations, compensation information from our peer group and survey market data for
comparable positions. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Also at the beginning of the fiscal year, the Compensation Committee established performance measures and goals for the ICPs, which included
the financial and strategic metrics being assessed, performance thresholds and targets and weightings for each metric. The Compensation Committee also approved the executive officers' individual
performance goals. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> After the close of the fiscal year, the Compensation Committee received a report from management regarding Company, operating Group and
individual performance against the pre-established performance goals of the ICPs. Actual awards for 2017 were approved based on each named executive officer's individual award target percentage and
the overall Company, Group and/or individual performance relative to the specific performance goal, as determined by the Compensation Committee. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>34</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=37,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=694241,FOLIO='34',FILE='DISK133:[18ZAG1.18ZAG15601]DK15601A.;16',USER='CHE108057',CD='10-APR-2018;12:07' -->
<A NAME="page_dk15601_1_35"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee sets the performance metrics as well as the performance thresholds and targets for each metric after consultation with management. The two primary
classifications of performance goals utilized in ICPs are financial goals and individual goals. Each performance metric represents part of the total incentive award calculation, with the financial
goals accounting for, in the aggregate, 70% of the target award potential and the individual goals accounting for, in the aggregate, 30% of the total incentive award potential. Payments for cash
incentive bonuses linked to the achievement of pre-established financial performance goals are calculated based on percentage achievement of the financial target goal. While there is no maximum payout
for any single financial goal, total incentive award payouts, after combining both financial and individual portions, are subject to a maximum amount of 200% of the individual's incentive award
target. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments
for individual performance goals are made in a range of 0% to 125%, based on evaluation of the named executive officer's performance and determined by the Compensation Committee
according to the following schedule: </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk15601_2017_individual_goal_performan__20102313"> </A>
<A NAME="toc_dk15601_2"> </A>
<BR></FONT><FONT SIZE=2><B>  2017 Individual Goal Performance Measurement and Payout Levels    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="87pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="84pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Performance Descriptor

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Performance Level </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Payout Percentage </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Significantly Exceeded</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>125</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>125</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Achieved</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mostly Achieved</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>75</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>75</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Partially Achieved</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>50</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>50</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Not Achieved</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Individual
performance goals are generally set as stretch but attainable goals, with over-achievement of goals anticipated to occur in limited circumstances. Additionally, the
Compensation Committee may, in its discretion, award cash incentive bonuses above the target level in the event it determines that an executive officer has delivered exceptional performance. Cash
incentive compensation plans of our named executive officers operate under a common set of performance metrics and calculation methodologies, with goals adjusted at the Corporate or Group level to
reflect individual areas of responsibility. Moreover, each Group president also has a portion of his financial goals tied to the overall profitability of the Company, creating additional alignment,
unity of purpose and teamwork across the Company. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Cash Incentive Plans  </I></B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Setting Incentive Target Levels.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee establishes annual ICPs for our executive officers, including each of our
named executive
officers, which are designed to provide meaningful performance incentives, relative to both fixed cash compensation in the form of salary and overall potential cash compensation, consistent with the
Company's strategic goals and objectives and each individual executive officer's responsibilities. The following table summarizes the 2017 ICP target levels approved for each of our named executive
officers, other than Mr.&nbsp;Knell, and the relationship of performance-based cash compensation at target levels to base salary and total potential cash compensation. Mr.&nbsp;Knell resigned
effective March&nbsp;31, 2017 and was not eligible to participate in the 2017 ICP program. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>35</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=38,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=49127,FOLIO='35',FILE='DISK133:[18ZAG1.18ZAG15601]DK15601A.;16',USER='CHE108057',CD='10-APR-2018;12:07' -->
<A NAME="page_dk15601_1_36"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk15601_2017_cash_incentive_t&#97;rgets"> </A>
<A NAME="toc_dk15601_3"> </A>
<BR></FONT><FONT SIZE=2><B>  2017 Cash Incentive Targets    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="103pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="103pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Target Level ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>% of Base Salary<BR>
at Target Achievement </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>% of Total Potential<BR>
Cash Compensation<BR>
at Target Achievement </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dr.&nbsp;Frank Laukien</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,000,999</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>140</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>58</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mr.&nbsp;Mattacchione</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>313,082</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>70</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>41</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mr.&nbsp;Srega(1)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>203,081</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>55</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dr.&nbsp;Munch</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>317,961</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>38</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Amounts
in the table represent the U.S. dollar equivalent value of Mr.&nbsp;Srega's cash incentive target (&euro;179,718), based on the 2017 average
midpoint conversion rate of &euro;1.0&nbsp;=$1.1300.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When
setting individual target incentive levels for fiscal 2017 ICPs, the Compensation Committee reviewed, for each named executive officer, individual target awards applicable in fiscal
2016, the total cash compensation established for fiscal 2016 and the projected cash compensation for fiscal 2017, considering how the total cash compensation of each named executive officer compared
to peer group
and related market data, and the responsibilities of each named executive officer. Additionally, the Committee considered long-term incentive target levels, to take into account a total direct
compensation view, so that no one element was determined in isolation, but rather the entire total compensation picture was considered. Based upon this review, the Compensation Committee determined
Dr.&nbsp;Laukien's cash incentive target should remain at 140% of base pay. The Compensation Committee also determined that a greater amount of Mr.&nbsp;Mattacchione's potential cash compensation
should be tied to performance incentives in light of his responsibilities and therefore increased his cash incentive target to 70% of base salary from 65% of base salary in 2016. Finally, based on its
review of peer group data and the overall compensation of each other named executive officer, the Compensation Committee determined to maintain the relative levels of Mr.&nbsp;Srega's and
Dr.&nbsp;Munch's cash incentive targets for 2017 at 55% and 60% of base salary, respectively. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Setting Performance Goals and Thresholds.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee establishes specific Corporate level financial performance goals
for our
executive officers with corporate responsibilities, including named executive officers Dr.&nbsp;Laukien and Mr.&nbsp;Mattacchione, and Group level financial performance goals for our executive
officers with Group level management responsibilities, including Mr.&nbsp;Srega and Dr.&nbsp;Munch, based on key Corporate, Group or divisional business plan goals for the fiscal year. In addition
to goals tied to Group level financial performance, each of our Group Presidents has a portion of his incentive award potential linked directly to our profitability at the Corporate level, creating
additional alignment with the overall strategic objectives of the Company. Financial performance goals generally reflect targeted growth over the results achieved in the prior year for the relevant
metric, with a threshold level of current year performance required for any cash incentive payout that is typically equal to the prior year performance. However, in the case of business plan goals for
which only modest or no growth is forecast, performance thresholds may be set at 95% of the business plan goal, which may result in a performance threshold that is less than the results achieved in
the prior year. For example, because our 2017 business plan included goals of less than 5% currency-adjusted revenue growth at the Corporate and Group levels, the performance thresholds for our named
executive officers' financial performance targets tied to revenue growth at the Corporate or Group level, as applicable, were set at approximately 95% of the relevant business plan goal. As a result,
the threshold level of 2017 revenue needed to earn any portion of their goals linked to revenue growth, on a currency-adjusted basis, was slightly below 2016 results. Similarly, the performance
threshold for our named executive officers' financial performance tied to the increase in non-GAAP EPS was set at 95% of the relevant business plan goal. As a result, the threshold level of 2017
non-GAAP EPS needed to earn any portion of their goals linked to non-GAAP EPS growth was below 2016 results. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>36</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=39,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=108084,FOLIO='36',FILE='DISK133:[18ZAG1.18ZAG15601]DK15601A.;16',USER='CHE108057',CD='10-APR-2018;12:07' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dm15601_1_37"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Cash Incentive Award Determinations  </I></B></FONT></P>

</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Corporate Level Performance Goals  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B><I>Dr.&nbsp;Frank Laukien<BR>
Mr.&nbsp;Mattacchione</I></B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm15601_financial_performance___dm102170"> </A>
<A NAME="toc_dm15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Financial Performance Goals<BR>  (70% of Target Bonus Potential)    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="27%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="27%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>2017 Corporate Level Performance Goals(1)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighting </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Performance<BR>
Threshold </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 Performance(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>% of<BR>
Incentive<BR>
Goal<BR>
Achieved </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>% of Total<BR>
Incentive<BR>
Target<BR>
Earned </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->





<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>$82.7&nbsp;million
Currency-</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$120.0&nbsp;million Currency-</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Adjusted Revenue Growth</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>95</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%(3)</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Adjusted Revenue Growth</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>145.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>21.75</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>$17.6&nbsp;million
Non-GAAP</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating Profit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$39.7&nbsp;million increase in</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Improvement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%(4)</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Non-GAAP Operating Profit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>225.4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>45.08</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->




<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>$0.05 Increase
in</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Non-GAAP Earnings Per</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$0.19 increase in Non- GAAP</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>95</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%(3)</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Earnings Per Share</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>380.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>57.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>$0.018 Reduction
in</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Working Capital Ratio</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>105</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%(3)</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$0.033 increase</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:37pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2><B>Total</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 70</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 176.9</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 123.8</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
performance goal reflected for each financial goal is equal to the difference between (x)&nbsp;the Company's 2017 business plan goal for the respective
financial measure and (y)&nbsp;the corresponding threshold performance level established by the Compensation Committee for the executive officer's 2017 ICP.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
2017 results, after adjustments for restructuring costs, acquisition-related costs, purchased intangible amortization, information technology transformation
costs, impairment and the exclusion of acquisitions not included in the Company's 2017 business plan goal, relative to the threshold performance level established by the Compensation Committee for the
executive officer's 2017 ICP for the corresponding financial goal.  </FONT>
<BR>

<P style="font-family:times;"><FONT SIZE=2>Currency-Adjusted
Revenue Growth is the difference between the Company's 2017 actual results and 95% of the 2017 business plan. The Currency-Adjusted Revenue Growth is determined by applying the 2017
business plan exchange rates to local currency results, which resulted in a $70.1&nbsp;million downward adjustment. Currency-Adjusted Revenue Growth also includes a $4.5&nbsp;million downward
adjustment associated with acquisitions not included in the Company's 2017 business plan goal.  </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>The
change in Non-GAAP Operating Profit is the difference between the Company's 2017 and 2016 non-GAAP results and has been adjusted upward $1.5&nbsp;million for the impact associated with
acquisitions not included in the Company's 2017 business plan goal.  </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>The
change in Non-GAAP Earnings Per Share is the difference between the 2017 non-GAAP results and 95% of the 2017 business plan. The change has been adjusted upward $0.01 for the impact associated
with acquisitions not included in the Company's 2017 business plan goal.  </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>The
change in the Working Capital Ratio is the difference between the 2017 actual results and 105% of the 2017 business plan, and includes a $0.001 adjustment associated with acquisitions not included
in the Company's 2017 business plan goal.  </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>For
additional information regarding our GAAP and non-GAAP results, please see Part&nbsp;II, Item&nbsp;7&#151;</FONT><FONT SIZE=2><I>Management's Discussion and Analysis of Financial
Condition and Results of Operations</I></FONT><FONT SIZE=2> of our Annual </FONT></P>

</DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>37</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=40,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=934079,FOLIO='37',FILE='DISK133:[18ZAG1.18ZAG15601]DM15601A.;16',USER='CHE109572',CD='10-APR-2018;11:45' -->
<A NAME="page_dm15601_1_38"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <UL>

<P style="font-family:times;"><FONT SIZE=2>Report
on Form&nbsp;10-K filed with the SEC on March&nbsp;16, 2018 and the Executive Overview&#151;2017 Financial Performance section of this CD&amp;A.  </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
the performance threshold expressed as a percentage of the Company's 2017 business plan goal. Since working capital ratio improvement is a reduction
measure, threshold performance is expressed as a percentage higher than the targeted performance goal.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
the performance threshold expressed as a percentage of the Company's 2016 results. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
2017, the Compensation Committee established financial performance targets that represented 70% of each named executive officer's total incentive award target. The Corporate level
goals for these executive officers emphasized key elements of our strategy for providing value to our stockholders, with a mix of goals that focus on generating revenue growth, improving efficiency
and profitability, and working capital reduction. As summarized in the table above, we did not achieve our Corporate level reduction in working capital goal, but significantly exceeded each of our
other Corporate level financial performance goals. Consistent with our pay-for-performance philosophy, the cash incentives earned by Dr.&nbsp;Laukien and Mr.&nbsp;Mattacchione for the financial
performance portion of their 2017 ICPs was equal to approximately 177% of their cash incentive targets linked to financial performance goals, or approximately 124% of their respective total cash
incentive targets. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm15601_individual_performance__dm102233"> </A>
<A NAME="toc_dm15601_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Individual Performance Goals<BR>  (30% of Target Bonus Potential)    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to the financial performance goals, the Compensation Committee established individual performance goals for each of our executive
officers to measure and reward performance with respect to organizational, strategic and other predominantly, although not exclusively, non-financial focuses of corporate or individual development. In
determining award payouts for these goals, the Compensation Committee considered each of the executive officers' achievements in meeting their individual performance goals and the substantial progress
made during 2017 with respect to a variety of strategic, organizational and infrastructure initiatives implemented under their leadership. The individual performance goals for Dr.&nbsp;Laukien's and
Mr.&nbsp;Mattacchione's 2017 ICPs are described below. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Dr.&nbsp;Laukien  </I></B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The individual performance goals established by the Compensation Committee for Dr.&nbsp;Laukien's 2017 ICP were designed to measure and reward
the achievement of objectives relating to strategic acquisition targets, continued strengthening and development of the senior management team, innovation in product development to drive organic
revenue growth, tax planning and implementation of operational efficiency initiatives and management of the Bruker BioSpin Group leadership transition. The Compensation Committee assessed
Dr.&nbsp;Laukien's performance relative to these individual performance goals and rewarded Dr.&nbsp;Laukien for fully achieving his goals relating to strategic
acquisition targets, management development, implementation of operational efficiency initiatives and management of the Bruker BioSpin Group leadership transition. The Compensation Committee also
rewarded Dr.&nbsp;Laukien for mostly achieving goals linked to product innovation and tax planning initiatives. Consistent with this assessment of performance, Dr.&nbsp;Laukien earned 90% of the
portion of his cash incentive target linked to individual performance goals, or 27% of his total cash incentive target. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Mr.&nbsp;Mattacchione  </I></B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;Mattacchione's individual performance goals were designed to measure and reward the achievement of goals relating to strengthening
and increasing the effectiveness of the global finance and internal audit organizations, implementing process improvement initiatives and advancing systems improvements. Based on the Compensation
Committee's assessment that Mr.&nbsp;Mattacchione fully or </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>38</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=41,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=275162,FOLIO='38',FILE='DISK133:[18ZAG1.18ZAG15601]DM15601A.;16',USER='CHE109572',CD='10-APR-2018;11:45' -->
<A NAME="page_dm15601_1_39"> </A>

<P style="font-family:times;"><FONT SIZE=2>mostly
achieved his individual performance goals relating to organizational development and process improvements and advancing the global finance organization, and significantly exceeded his goal
relating to capital allocation, tax planning and focused investor relations, Mr.&nbsp;Mattacchione earned 100% of the portion of his cash incentive target linked to individual performance goals, or
30% of his total cash incentive target. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Bruker CALID Group Performance Goals  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Mr.&nbsp;Srega  </I></B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm15601_financial_performance___dm102184"> </A>
<A NAME="toc_dm15601_3"> </A></FONT> <FONT SIZE=2><B>  Financial Performance Goals<BR>  (70% of Target Bonus Potential)    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="195pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>2017 Bruker CALID Group<BR>
(CALID) Performance Goals(1)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighting </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Performance<BR>
Threshold </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 Performance(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>% of<BR>
Incentive<BR>
Goal<BR>
Achieved </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>% of Total<BR>
Incentive<BR>
Target<BR>
Earned </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->




<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>$23.5&nbsp;million CALID
Currency-Adjusted</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$29.1&nbsp;million increase in Currency-</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Revenue Growth</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>95</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%(3)</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Adjusted Revenue Growth</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>123.7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18.6</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>$12.7&nbsp;Million
CALID</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Non-GAAP Gross</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$27.2&nbsp;million increase in</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Profit Improvement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>95</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%(3)</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Non-GAAP Gross Profit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>214.4</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>32.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->




<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>$7.3&nbsp;Million
CALID</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Non-GAAP Operating</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>$19.4&nbsp;million increase in</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Profit Improvement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%(4)</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Non-GAAP Operating Profit</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>265.3</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>39.8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>$0.02 Reduction
in</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CALID Working</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Capital Ratio</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%(4)</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$0.00 reduction</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>0.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->





<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:9pt;"><font size=2></FONT><FONT SIZE=2>$0.05 Increase
in</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Non-GAAP Earnings</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>$0.19 increase in Non-GAAP</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Per Share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>95</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%(3)</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Earnings Per Share</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>380.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>38.0</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:37pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Total</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 70</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 184.0</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><B> 128.5</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
performance goal reflected for each financial goal is equal to the difference between (x)&nbsp;the Company's 2017 business plan goal for the respective
financial measure and (y)&nbsp;the corresponding threshold performance level established by the Compensation Committee for the executive officer's 2016 ICP.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
2017 results, after adjustments for restructuring costs, acquisition-related costs, purchased intangible amortization and the exclusion of acquisitions not
included in the Company's 2017 business plan goal, relative to the threshold performance level established by the Compensation Committee for the executive officer's 2017 ICP for the corresponding
financial goal. Currency-Adjusted Revenue Growth is determined by applying 2017 business plan exchange rates to local currency results.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
the performance threshold expressed as a percentage of the Company's 2017 business plan goal.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
the performance threshold expressed as a percentage of the Company's 2016 results. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
President of the Bruker CALID Group, Mr.&nbsp;Srega's 2017 ICP included financial performance goals directly relating to his leadership of the Bruker CALID Group. As summarized in
the table above, the Bruker CALID did not achieve its goal related to working capital ratio reduction but exceeded its other 2017 financial performance goals. As a result, the cash incentive award
payout earned by Mr.&nbsp;Srega for the financial performance portion of his 2017 ICP opportunity was equal to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>39</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=42,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=636506,FOLIO='39',FILE='DISK133:[18ZAG1.18ZAG15601]DM15601A.;16',USER='CHE109572',CD='10-APR-2018;11:45' -->
<A NAME="page_dm15601_1_40"> </A>

<P style="font-family:times;"><FONT SIZE=2>approximately
184% of his cash incentive target linked to financial performance goals, or approximately 129% of his total cash incentive target. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm15601_individual_performance__dm102247"> </A>
<A NAME="toc_dm15601_4"> </A>
<BR></FONT><FONT SIZE=2><B>  Individual Performance Goals<BR>  (30% of Target Bonus Potential)    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Similar to the individual performance goals established by the Compensation Committee to measure and reward Dr.&nbsp;Laukien's and
Mr.&nbsp;Mattacchione's performance in 2017, Mr.&nbsp;Srega's individual performance goals were designed to measure and reward the achievement of Bruker CALID Group objectives relating to
strategic acquisition targets and investment opportunities, innovation in product development and service offerings to drive organic revenue growth, and implementation of operational efficiency
initiatives. The Compensation Committee assessed Mr.&nbsp;Srega's performance relative to these individual performance goals and rewarded Mr.&nbsp;Srega for significantly exceeding his goals
relating to integrating recent acquisitions and leveraging overhead, fully achieving his goals linked to improving selling processes, growing the Pharma business, innovation in product development to
drive organic revenue growth and implementation of operational efficiency initiatives, and partially achieving his goal relating to strategic acquisition targets. Consistent with this assessment of
performance, Mr.&nbsp;Srega earned 103.75% of his cash incentive target linked to individual performance goals, or 31.125% of his total cash incentive target. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>40</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=43,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=687568,FOLIO='40',FILE='DISK133:[18ZAG1.18ZAG15601]DM15601A.;16',USER='CHE109572',CD='10-APR-2018;11:45' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_do15601_1_41"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Bruker Nano Group Performance Goals  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><B><I>Dr.&nbsp;Munch</I></B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="do15601_financial_performance___do102172"> </A>
<A NAME="toc_do15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Financial Performance Goals<BR>  (70% of Target Bonus Potential)    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:57%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"140%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="140%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="173pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>2017 Bruker Nano Group<BR>
(NANO)<BR>
Performance Goals(1)

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighting </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Performance<BR>
Threshold </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 Performance(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>% of<BR>
Incentive<BR>
Goal<BR>
Achieved </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>% of<BR>
Incentive<BR>
Target<BR>
Earned </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#149;&nbsp;$23.8&nbsp;Million NANO Currency-Adjusted Revenue Growth</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>95%(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>$40.2&nbsp;million increase in Currency-Adjusted Revenue</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>168.9%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>25.3%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#149;&nbsp;$21.0&nbsp;Million NANO Non-GAAP Gross Profit Improvement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>100%(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>$38.3&nbsp;million increase in Non-GAAP Gross Profit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>182.7%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>27.4%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#149;&nbsp;$13.0&nbsp;Million NANO Non-GAAP Operating Profit Improvement</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>100%(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>$19.6&nbsp;million increase in Non-GAAP Operating Profit</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>150.0%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>22.5%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#149;&nbsp;$0.017 Reduction in NANO Working Capital Ratio</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>105%(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>$0.062 increase in Working Capital Ratio</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>0.0%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>0.0%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#149;&nbsp;$0.05 Increase in Non-GAAP Earnings Per Share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>95%(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>$0.19 increase in Non-GAAP Earnings Per Share</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>380.0%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>38.0%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:37pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Total</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> 70%</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> 162.0%</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> 113.2%</B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
performance goal reflected for each financial goal is equal to the difference between (x)&nbsp;the Company's 2017 business plan goal for the respective
financial measure and (y)&nbsp;the corresponding threshold performance level established by the Compensation Committee for the executive officer's 2017&nbsp;ICP.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
2017 results, after adjustments for restructuring costs, acquisition-related costs, purchased intangible amortization and the exclusion of acquisitions not
included in the Company's 2017 business plan goal, relative to the threshold performance level established by the Compensation Committee for the executive officer's 2017 ICP for the corresponding
financial goal. Currency-Adjusted Revenue Growth is determined by applying 2017 business plan exchange rates to local currency results.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
the performance threshold expressed as a percentage of the Company's 2017 business plan goal. Since working capital ratio improvement is a reduction
measure, threshold performance is expressed as a percentage higher than the targeted performance goal.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
the performance threshold expressed as a percentage of the Company's 2016 results. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
Executive Vice President, and President of the Bruker Nano Group, Dr.&nbsp;Munch's 2017 ICP included financial performance goals relating to his leadership of the Bruker Nano Group.
As summarized in the table above, Dr.&nbsp;Munch did not achieve the portion of his goals tied to Bruker Nano Group working capital reduction but exceeded his other 2017 financial performance goals.
Accordingly, the cash incentive award payout earned by Dr.&nbsp;Munch for the financial performance portion of his 2017 ICP opportunity was equal to approximately 162% of his cash incentive target
linked to financial performance goals, or approximately 113% of his total cash incentive target. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>41</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=44,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=221544,FOLIO='41',FILE='DISK133:[18ZAG1.18ZAG15601]DO15601A.;12',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_do15601_1_42"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="do15601_individual_performance__do102235"> </A>
<A NAME="toc_do15601_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Individual Performance Goals<BR>  (30% of Target Bonus Potential)    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The individual performance goals established by the Compensation Committee for Dr.&nbsp;Munch's 2017 ICP were designed to reward the
achievement of Bruker Nano Group objectives relating to divisional profitable growth, strategic acquisition targets and increasing sales in the division's highest growth area. Additionally, a portion
of Dr.&nbsp;Munch's individual performance goals was linked to maximizing specific market segments and product lines. After consideration of Dr.&nbsp;Munch's performance relative to his individual
performance goals, the Compensation Committee determined that Dr.&nbsp;Munch significantly exceeded his goals related to strategic acquisition targets and achieved or mostly achieved his goals
related to new product development and operational initiatives, other than his goal relating to certain high-growth product support initiatives, which he partially achieved. Dr.&nbsp;Munch also
achieved his goal related to corporate information technology infrastructure development. Accordingly, Dr.&nbsp;Munch earned a cash incentive award equal to 93.75% of the portion of his target cash
incentive bonus potential attributable to his individual performance goals, or 28.125% of his total cash incentive target. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Determining Incentive Award Payments.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Following review of the performance of our named executive officers in fiscal 2017, the
Compensation Committee
approved ICP awards to the named executive officers based on their respective percentage achievement of 2017 financial and individual performance goals as follows:
Dr.&nbsp;Laukien&#151;150.8%; Mr.&nbsp;Mattacchione&#151;153.8%; Mr.&nbsp;Srega&#151;159.6%; and Dr.&nbsp;Munch&#151;141.4%. The actual cash incentive award
payments to our named executive officers are reported in the "Non-Equity Incentive Plan Compensation" column of the Summary Compensation Table in this proxy statement. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Long-Term Incentive Awards  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee uses long-term incentive compensation in the form of equity awards to deliver competitive compensation that
recognizes employees for their contributions to the Company and aligns the interests of named executive officers with stockholders by focusing them on long-term growth and stock price performance. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
2017, upon consideration of a variety of factors, including the individual performance, experience and responsibilities of each of our named executive officers, our stock price,
competitive market practices and trends, including stockholder total potential dilution and annual equity burn rate market levels, outstanding equity awards held by our named executive officers and
overall Company performance, the Compensation Committee approved long-term incentive awards to certain of our executive officers, including the following awards to our named executive officers: </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="do15601_2017_long-term_equity_incentive_awards"> </A>
<A NAME="toc_do15601_3"> </A>
<BR></FONT><FONT SIZE=2><B>  2017 Long-Term Equity Incentive Awards    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Aggregate<BR>
Economic<BR>
Value<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock<BR>
Options </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Restricted<BR>
Stock<BR>
Units </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dr.&nbsp;Frank Laukien</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,750,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>84,337</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>76,192</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mr.&nbsp;Mattacchione</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>825,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25,301</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22,858</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mr.&nbsp;Srega</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>575,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17,635</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>15,931</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dr.&nbsp;Munch</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>870,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>26,682</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>24,105</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mr.&nbsp;Knell(2)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Economic
Value reflects the combined grant date fair value of option and RSU awards, computed in accordance with Financial Accounting Standards Board Accounting
Standards Codification Topic 718. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>42</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=45,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=183367,FOLIO='42',FILE='DISK133:[18ZAG1.18ZAG15601]DO15601A.;12',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_do15601_1_43"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Knell
resigned effective March&nbsp;31, 2017 and was not eligible for a 2017 long-term incentive award.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company uses a combination of stock options and RSU awards to balance the performance orientation of stock options to enhance our pay-for-performance culture and the retentive
qualities of restricted stock and RSUs. The Compensation Committee believes this mix to be reasonable considering market practices, the overall level of pay for our executives and the long-term
orientation of the equity award vehicles, given that they vest over a period of four years. In general, the Compensation Committee endeavors to deliver approximately 25% of the value in stock options
and 75% of the value in RSUs. In 2017, the value of awards to our named executive officers consisted of 25% stock options and 75% restricted stock units. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Benefits  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In 2017, our named executive officers were eligible for the same level and offering of benefits made available to other employees, including the
Company's 401(k) plan and welfare
benefit programs in the U.S., or those comparable local benefit programs for our overseas executives. We generally do not provide additional benefits or perquisites to our executive officers, except
as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Drs. Munch and Prause are each provided automobile allowances based on the nature of their responsibilities. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Mr.&nbsp;Srega, who is based in Germany and serves as a Managing Director of our subsidiary Bruker Daltonik&nbsp;GmbH, is provided a leased
vehicle and a personal pension scheme in accordance with local custom. The personal pension scheme established for Mr.&nbsp;Srega's benefit consists of three individual components funded during the
term of his employment by contributions made by Bruker Daltonik&nbsp;GmbH. Contributions made to Mr.&nbsp;Srega's personal pension scheme in 2017 are reported in the "All Other Compensation"
column of the Summary Compensation Table included in this proxy statement under the heading "</FONT><FONT SIZE=2><I>Summary of Executive Compensation.</I></FONT><FONT SIZE=2>" Additional information
regarding Mr.&nbsp;Srega's personal pension scheme is included in this proxy statement under the heading "</FONT><FONT SIZE=2><I>Pension Benefits</I></FONT><FONT SIZE=2>." </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Employment Contracts, Termination of Employment and Change in Control Arrangements  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On June&nbsp;25, 2012, the Company entered into a letter agreement with Mr.&nbsp;Srega which sets forth certain terms of Mr.&nbsp;Srega's
employment as President of the Bruker CALID Group. Under the terms of the letter agreement, Mr.&nbsp;Srega's target cash compensation includes the following elements: (i)&nbsp;an annual base
salary initially set at 280,000&nbsp;euros, or approximately $371,896, for 2013, subject to annual review and (ii)&nbsp;a cash incentive bonus plan with an initial target of 50% of base salary.
Mr.&nbsp;Srega was also entitled to an initial cash bonus payment of 100,000&nbsp;euros, or approximately $132,820, and an initial equity grant consisting of restricted stock valued at $400,000
and options to purchase 90,000 shares of common stock upon commencement of employment, as well as reimbursement of certain relocation expenses. The letter agreement also provides that, beginning in
2014, Mr.&nbsp;Srega is entitled to receive an annual equity award with a value of $550,000 pursuant to the Company's incentive compensation plans. During the term of his employment,
Mr.&nbsp;Srega will be eligible to participate in all customary employee benefit plans or programs of the Company generally available to the Company's employees and/or executive officers.
Additionally, the Company assumed a personal pension scheme for Mr.&nbsp;Srega's benefit carried forward in part from his former employer. The personal pension scheme is funded by contributions made
by Bruker Daltonik&nbsp;GmbH and voluntary contributions by Mr.&nbsp;Srega, if any, during the term of his employment. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;Srega
will be entitled to a lump sum severance payment equal to six months of his then current base salary, or approximately $184,619 as of December&nbsp;31, 2017, in the
event there is a change </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>43</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=46,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=1001461,FOLIO='43',FILE='DISK133:[18ZAG1.18ZAG15601]DO15601A.;12',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_do15601_1_44"> </A>

<P style="font-family:times;"><FONT SIZE=2>in
the voting control of the Company and his employment is terminated, voluntarily or involuntarily, within 6&nbsp;months after such change of control. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
March&nbsp;23, 2017, the Company entered into a letter agreement with Mr.&nbsp;Knell which set forth certain terms of Mr.&nbsp;Knell's separation from employment and provision
of transition services. Under the terms of the letter agreement, Mr.&nbsp;Knell was entitled to receive a cash incentive award payment for 2016 performance in the amount of $68,788. Additionally,
Mr.&nbsp;Knell was eligible to receive a payment of $116,573 in connection with his departure, as well as COBRA healthcare coverage for a period of up to six months and certain other separation
benefits, subject to satisfactory completion of various transition responsibilities. Mr.&nbsp;Knell also agreed to be bound by non-competition and non-solicitation obligations to the Company for a
period of one year from the date of his separation from employment. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the terms of the awards of options and restricted stock units granted under the 2016 Incentive Compensation Plan, and awards of options and restricted common stock granted under
the 2010 Incentive Compensation Plan, unvested amounts are forfeited if the grantee's employment or business relationship with our Company is terminated for any reason, other than in the event of
death or disability. The board of directors does, however, have the authority to accelerate vesting of any and all unvested amounts in the event of a change in control of Bruker Corporation. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Section&nbsp;162(m) Limitations  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;162(m) of the U.S. Internal Revenue Code limits the tax deductibility by a corporation of compensation in excess of $1,000,000
paid for any fiscal year to certain "covered employees." Prior to the U.S. tax reform legislation enacted in December 2017 ("2017 Tax Act"), covered employees generally consisted of our Chief
Executive Officer and each of the next three highest compensated officers serving at the end of the taxable year other than our Chief Financial Officer, and compensation that qualified as
"performance-based" under Section&nbsp;162(m) was exempt from this $1&nbsp;million deduction limitation if specific requirements were met. Under the 2017 Tax Act, this exemption for
performance-based compensation will not be available with respect to taxable years beginning after December&nbsp;31, 2017 unless the compensation is pursuant to a written binding contract which was
in effect on November&nbsp;2, 2017 and is not modified in any material respect on or after such date. Additionally, the 2017 Tax Act expanded the definition of covered employees to cover additional
executive officers, including the chief financial officer, so that the compensation of the chief executive officer and chief financial officer (at any time during the fiscal year), and the three other
most highly compensated executive officers (as of the end of any fiscal year) will be subject to Section&nbsp;162(m) of the Code. Any executive officer whose compensation is subject to
Section&nbsp;162(m) of the Code in taxable years beginning after December&nbsp;31, 2016 will have compensation subject to Section&nbsp;162(m) of the Code for all future years, including years
after the executive terminates employment or dies. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee and management consider the accounting and tax effects of various compensation elements when designing our annual incentive and equity compensation plans and
making other compensation decisions. Although we have considered the impact of Section&nbsp;162(m) when designing our executive compensation programs and incentive plans so that a number of awards
may be granted under these plans and programs in a manner that complies with the requirements imposed by Section&nbsp;162(m), tax deductibility is not the primary factor used by the Compensation
Committee in setting compensation and likely will become less of a factor following the changes to Section&nbsp;162(m) as provided in the 2017 Tax Act. Rather, these considerations are secondary to
meeting the overall objectives of the executive compensation program. The Compensation Committee will continue to monitor the compensation levels potentially payable under our compensation programs
but intends to retain the flexibility necessary to provide total compensation in line with competitive practice and our compensation philosophy, even if such compensation is not deductible under
Section&nbsp;162(m). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>44</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=47,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=36435,FOLIO='44',FILE='DISK133:[18ZAG1.18ZAG15601]DO15601A.;12',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_do15601_1_45"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Other Benefit Plans  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In October 2009, the board of directors of BEST adopted the Bruker Energy&nbsp;&amp; Supercon Technologies,&nbsp;Inc. 2009 Stock Option Plan, or
the BEST Plan. The BEST Plan provides for the issuance of up to 1,600,000 shares of BEST common stock in connection with awards under the plan. The BEST Plan allows a committee of the BEST board of
directors to grant incentive stock options and non-qualified stock options to key employees and directors of BEST. The BEST Plan is tied exclusively to increases in BEST's value regardless of the
Company's performance as a whole. As of December&nbsp;31, 2017, 465,000 incentive stock options and non-qualified stock options had been awarded and were outstanding. No awards have been granted
under the BEST Plan since July 2010. As director of BEST, Dr.&nbsp;Laukien participates in the BEST Plan. Dr.&nbsp;Laukien holds options to purchase 10,000 shares of BEST, which have an exercise
price of $3.50 per share and expire October&nbsp;1, 2019. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="do15601_compensation_committee_report"> </A>
<A NAME="toc_do15601_4"> </A>
<BR></FONT><FONT SIZE=2><B>  COMPENSATION COMMITTEE REPORT    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee has reviewed and discussed with management the Compensation Discussion and Analysis required by Item&nbsp;402(b) of
Regulation&nbsp;S-K, promulgated under the Securities Act of 1933, as amended. Based on such review and discussions, the Compensation Committee recommended to the board of directors that the
Compensation Discussion and Analysis be included in this Proxy Statement on Schedule&nbsp;14A. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Submitted
by the Compensation Committee of Bruker Corporation's Board of Directors. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 <!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="279" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Richard D. Kniss, Chairman<BR>
Richard A. Packer<BR>
Hermann Requardt</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="do15601_compensation_committee__do102484"> </A>
<A NAME="toc_do15601_5"> </A>
<BR></FONT><FONT SIZE=2><B>  COMPENSATION COMMITTEE INTERLOCKS<BR>  AND INSIDER PARTICIPATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr.&nbsp;Requardt and Messrs.&nbsp;Kniss and Packer currently serve as members of the Compensation Committee. Former director Stephen W.
Fesik served on the Compensation Committee until the expiration of his term of service in May 2017. Dr.&nbsp;Requardt and Messrs.&nbsp;Kniss and Packer were not officers or employees of the
Company or any of its subsidiaries during fiscal year 2017. None of our executive officers serves as a member of the board of directors or compensation committee of any entity that has one or more of
its executive officers serving as a member of our Compensation Committee. In addition, none of our executive officers serves as a member of the compensation committee of any entity that has one or
more of its executive officers serving as a member of our board of directors. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>45</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=48,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=779606,FOLIO='45',FILE='DISK133:[18ZAG1.18ZAG15601]DO15601A.;12',USER='CHE109863',CD='10-APR-2018;02:05' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dq15601_1_46"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dq15601_summary_of_executive_compensation"> </A>
<A NAME="toc_dq15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  SUMMARY OF EXECUTIVE COMPENSATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the compensation earned by our named executive officers for the years ended December&nbsp;31, 2017, 2016 and
2015. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dq15601_summary_compensation_table"> </A>
<A NAME="toc_dq15601_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Summary Compensation Table    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="25pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="37pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="37pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name and<BR>
Principal<BR>
Position

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Salary<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Bonus<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock<BR>
Awards(1)<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Awards(2)<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Non-Equity<BR>
Incentive<BR>
Plan<BR>
Awards<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Change in<BR>
Pension<BR>
Value and<BR>
Non-Qualified<BR>
Deferred<BR>
Compensation<BR>
Earnings<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Compensation<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Frank H. Laukien, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>704,269</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,062,517</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>605,540</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,491,583</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8,100</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4,872,009</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:16pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chairman, President</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>652,477</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,074,995</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>968,904</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>737,895</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,950</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,442,221</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:16pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 and Chief Executive</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>636,250</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,292,660</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>248,634</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,750,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,950</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,935,494</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Officer</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony L. Mattacchione</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
439,382</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
618,766</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
204,432</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
465,916</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
8,100</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,736,596</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:16pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Former Senior Vice</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>400,744</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>150,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>325,004</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>296,580</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>214,472</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,950</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,394,750</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:16pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>President and Chief</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>322,520</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>244,999</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>328,241</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,950</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>903,710</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Financial Officer(4)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Juergen Srega</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
369,238</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
431,252</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
142,491</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
321,866</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
90,444</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>(6)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,355,291</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 President, Bruker</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>351,121</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>275,001</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>275,092</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>84,262</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>88,587</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,074,063</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 CALID Group(5)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>310,632</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>275,003</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>274,999</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>251,383</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>87,681</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,199,698</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Mark R. Munch, Ph.D.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
523,141</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
652,522</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
215,591</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
444,182</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
16,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>(7)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,851,936</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:16pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Executive Vice</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>504,474</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>410,005</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>410,136</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>194,652</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>15,650</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,534,917</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:16pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>President and</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>471,846</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>45,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>385,004</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>384,997</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>167,983</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>17,050</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,471,880</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>President, Bruker Nano Group</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Michael G. Knell</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
76,221</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
121,055</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>(9)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
197,276</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Former Vice President</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>233,059</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>40,807</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>40,794</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>68,788</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,950</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>391,398</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:16pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 and Chief Accounting</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>231,697</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>72,789</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>171,962</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,950</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>484,398</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Officer(8)</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
amounts in this column reflect the grant date fair value of awards of restricted stock units, computed in accordance with Financial Accounting Standards Board
Accounting Standards Codification Topic 718. Assumptions used in the calculations of these amounts may be found in Note&nbsp;2 to our 2017 audited financial statements included in the Company's
Annual Report on Form&nbsp;10-K filed with the SEC on March&nbsp;16, 2018. The actual amount realized by the named executive officer will likely vary based on a number of factors, including our
performance, stock price fluctuations and applicable vesting.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
amounts in this column reflect the grant date fair value of stock option awards, computed in accordance with Financial Accounting Standards Board Accounting
Standards Codification Topic 718. Assumptions used in the calculations of these amounts may be found in Note&nbsp;2 to our 2017 audited financial statements included in the Company's Annual Report
on Form&nbsp;10-K filed with the SEC on March&nbsp;16, 2018. The actual amount realized by the named executive officer will likely vary based on several factors, including our performance, stock
price fluctuations and applicable vesting.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Amount
represents a matching contribution made by the Company to a 401(k) plan for the benefit of the named executive officer.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Mattacchione,
who served as Chief Financial Officer throughout 2017, resigned from the Company effective March&nbsp;16, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
amounts reflected for 2017 compensation, other than amounts reported under the headings "</FONT><FONT SIZE=1><I>Stock Awards,</I></FONT><FONT SIZE=1>"
"</FONT><FONT SIZE=1><I>Option Awards</I></FONT><FONT SIZE=1>" and "</FONT><FONT SIZE=1><I>Non-Equity Incentive Plan Awards,</I></FONT><FONT SIZE=1>" are based on actual payments in euros converted to
U.S. dollars at a conversion rate of &euro;1.0 =$1.1300, which represents the 2017 average midpoint rate as published on www.oanda.com. The amounts reflected under the heading
"</FONT><FONT SIZE=1><I>Non-Equity Incentive Plan Awards</I></FONT><FONT SIZE=1>" are converted from euros to U.S. dollars at a conversion rate equal to the midpoint rate as published on www.oanda.com
on the date of approval by the Compensation Committee.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(6)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Amounts
reported in 2017 include contributions in the amount of $75,145 made by Bruker Daltonik&nbsp;GmbH to the personal pension scheme established for
Mr.&nbsp;Srega and an automobile allowance of $15,299.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(7)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Amounts
reported include matching contributions made by the Company to a 401(k) plan for the benefit of Dr.&nbsp;Munch and an automobile allowance. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>46</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=49,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=1007919,FOLIO='46',FILE='DISK133:[18ZAG1.18ZAG15601]DQ15601A.;8',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_dq15601_1_47"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(8)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Knell
resigned from the Company effective March&nbsp;31, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(9)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Amounts
reported include matching contributions made by the Company to a 401(k) plan for the benefit of Mr.&nbsp;Knell and $116,573 which Mr.&nbsp;Knell received
in connection with the termination of his employment upon completion of certain transition responsibilities. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dq15601_2017_grants_of_plan-based_awards"> </A>
<A NAME="toc_dq15601_3"> </A>
<BR></FONT><FONT SIZE=2><B>  2017 Grants of Plan-Based Awards    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information with respect to individual grants of plan-based awards to our named executive officers during
the fiscal year ended December&nbsp;31, 2017. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="73pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Estimated Future Payouts<BR>
Under Non-Equity Incentive<BR>
Plan Awards </B></FONT></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Stock Awards:<BR>
Number of<BR>
Shares of<BR>
Stock or<BR>
Units<BR>
(#) </B></FONT></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Option Awards:<BR>
Number of<BR>
Securities<BR>
Underlying<BR>
Options<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant Date<BR>
Fair Value<BR>
of Stock<BR>
and Option<BR>
Awards<BR>
($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Exercise or<BR>
Base Price<BR>
of Option<BR>
Awards<BR>
($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant Date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Threshold<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Target<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Maximum<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Frank H. Laukien</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>8/10/2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,000,999</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,001,998</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>76,192</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>84,337</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>29.777</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,668,057</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony L. Mattacchione</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
8/10/2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
313,082</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
626,164</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
22,858</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
25,301</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
27.07</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
823,198</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Juergen Srega</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
8/10/2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
203,081</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
406,162</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
15,931</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
17,635</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
27.07</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
573,743</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mark R. Munch</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
8/10/2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
317,961</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
635,922</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
24,105</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
26,682</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
27.07</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
868,113</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Michael G. Knell(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
N/A</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
N/A</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
N/A</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
N/A</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
N/A</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
N/A</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
N/A</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Represents
estimated possible payouts on the grant date for annual cash incentive bonus awards granted for 2017 performance under the 2017 cash incentive bonus plans
of our named executive officers. The amounts reflected for Mr.&nbsp;Srega, which were based in local currency, are converted from euros to U.S. dollars at a conversion rate of &euro;1.0
=$1.1300, which represents the 2017 average midpoint rate.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Represents
the grant date fair value of RSU and stock option awards granted under the Company's 2016 Incentive Compensation Plan, computed in accordance with
Financial Accounting Standards Board Accounting Standards Codification Topic 718. Assumptions used in the calculations of these amounts may be found in Note&nbsp;2 to our 2017 audited financial
statements included in the Company's Annual Report on Form&nbsp;10-K filed with the SEC on March&nbsp;16, 2018. Unless otherwise noted: (i)&nbsp;option awards vest in equal annual installments
on the first, second, third and fourth anniversaries of the grant date, are exercisable upon vesting at a price equal to the closing price of our common stock on the date of the grant and expire on
the ten year anniversary of the grant date; and (ii)&nbsp;restricted stock and RSU awards vest in equal annual installments on the first, second, third and fourth anniversaries of the grant date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Options
granted to Dr.&nbsp;Laukien vest in equal annual installments on the first, second, third and fourth anniversaries of the grant date, are exercisable upon
vesting at a price equal to 110% of the closing price of our common stock on the date of the grant and expire on the five year anniversary of the grant date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Knell
resigned effective March&nbsp;31, 2017 and was not eligible for a grant of a plan-based award. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>47</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=50,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=809750,FOLIO='47',FILE='DISK133:[18ZAG1.18ZAG15601]DQ15601A.;8',USER='CHE109863',CD='10-APR-2018;02:05' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ds15601_1_48"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ds15601_outstanding_equity_awards_at_december_31,_2017"> </A>
<A NAME="toc_ds15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Outstanding Equity Awards at December&nbsp;31, 2017    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table provides information concerning outstanding equity-based plan awards, including unexercised options and stock that has not
vested, for each of our named executive officers as of the end of our most recently completed fiscal year. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="65pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="40pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="50pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Grant Date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options<BR>
Exercisable<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options<BR>
Unexercisable<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Exercise<BR>
Price<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Expiration<BR>
Date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock<BR>
Award<BR>
Grant Date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Shares of<BR>
Stock&nbsp;That<BR>
Have Not<BR>
Vested<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Market<BR>
Value of<BR>
Shares of Stock<BR>
That Have<BR>
Not Vested<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Frank H. Laukien(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/30/2013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>62,274</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>22.04</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/30/2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/08/2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>10,577(3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>363,003</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/08/2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>43,242</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>14,415(4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>22.748</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/08/2019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/07/2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>32,610(5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,119,175</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/07/2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>17,387</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>17,387(6</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>21.80</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/07/2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>10/04/2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>36,334(7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,246,983</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>10/04/2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>38,571</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>115,713(8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>24.409</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>10/04/2021</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/10/2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>76,192(9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,614,909</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/10/2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>84,337(10</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>29.777</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/10/2022</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Anthony L. Mattacchione</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2/25/2013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
40,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
17.41</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2/25/2023</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2/18/2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
9,829(11</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
337,331</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/30/2013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,473</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>20.04</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/30/2023</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/10/2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>22,858(9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>784,487</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/08/2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>12,972</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4,321(4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>20.68</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/08/2024</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/07/2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>15,786</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>15,786(6</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>19.82</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/07/2025</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2/18/2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8,621</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>25,865(8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>24.80</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2/18/2026</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/10/2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>25,301(10</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>27.07</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/10/2027</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Mark R. Munch</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
8/30/2013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
15,059</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
20.04</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
8/30/2023</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
5/07/2013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
4,000(3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
137,280</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/08/2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8,072</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8,072(4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>20.68</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/08/2024</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/08/2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4,229(3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>145,139</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/07/2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>12,403</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>24,807(6</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>19.82</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/07/2025</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/07/2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9,713(5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>333,350</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>10/04/2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>14,710</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>44,133(8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>22.19</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>10/04/2026</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>10/04/2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>13,858(7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>475,607</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/10/2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>26,682(10</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>27.07</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/10/2027</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/10/2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>24,105(9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>827,284</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Juergen Srega</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
4/03/2013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
72,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
18,000(4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
18.57</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
4/03/2023</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
4/03/2013</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
4,308(3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
147,851</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/08/2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>19,029</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6,340(4</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>20.68</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/08/2024</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/08/2014</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,323(3</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>114,045</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/07/2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>17,719</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>17,719(6</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>19.82</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/07/2025</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/07/2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6,938(5</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>238,112</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>10/04/2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9,867</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>29,601(8</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>22.19</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>10/04/2026</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>10/04/2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9,295(7</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>319,004</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/10/2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>17,635(10</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>27.07</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/10/2027</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8/10/2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>15,931(9</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>546,752</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Michael G. Knell(12)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
amounts in this column were calculated by multiplying $34.32, the closing price of our common stock on the NASDAQ Global Select Market as of December&nbsp;29,
2017, the last trading day of 2017, by the number of unvested shares.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>In
addition to the awards reported for equity securities of Bruker Corporation, Dr.&nbsp;Laukien held options to purchase 10,000 shares of BEST. The BEST options
have an exercise price of $3.50 per share, are fully vested and expire October&nbsp;1, 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
unvested shares of restricted stock vest on the anniversary of the grant date in 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
options become exercisable on the anniversary of the grant date in 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
unvested shares of restricted stock vest in equal annual installments on the anniversary of the grant date in 2018 and 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(6)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
options become exercisable in equal annual installments on the anniversary of the grant date in 2018 and 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(7)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
unvested restricted stock units vest in equal annual installments on the anniversary of the grant date in 2018, 2019 and 2020.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(8)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
options become exercisable in equal annual installments on the anniversary of the grant date in 2018, 2019 and 2020.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(9)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
unvested restricted stock units vest in equal annual installments on the anniversary of the grant date in 2018, 2019, 2020 and 2021.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(10)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
options become exercisable in equal annual installments on the anniversary of the grant date in 2018, 2019, 2020 and 2021.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(11)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
unvested shares of restricted stock vest in equal annual installments on the anniversary of the grant date in 2018, 2019 and 2020.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1>(12)</FONT></DT><DD style="font-family:times;"><FONT SIZE=1>As
a result of Mr.&nbsp;Knell's resignation, which was effective March&nbsp;31, 2017, no equity awards were outstanding as of December&nbsp;31, 2017. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>48</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=51,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=459067,FOLIO='48',FILE='DISK133:[18ZAG1.18ZAG15601]DS15601A.;11',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_ds15601_1_49"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ds15601_2017_option_exercises_and_stock_vested"> </A>
<A NAME="toc_ds15601_2"> </A>
<BR></FONT><FONT SIZE=2><B>  2017 Option Exercises and Stock Vested    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table provides information regarding the number of shares acquired by our named executive officers upon the exercise of options or
vesting of restricted stock awards and restricted stock units and the value realized at that time before payment of any applicable withholding taxes and brokerage commission. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:62%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"130%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="130%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="98pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="69pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="93pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="69pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of Shares<BR>
Acquired on Exercise<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Value Realized<BR>
on Exercise<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of Shares<BR>
Acquired on Vesting<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Value Realized<BR>
on Vesting<BR>
($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Frank H. Laukien</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>67,569</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,914,438</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony L. Mattacchione.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,276</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>80,720</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Juergen Srega</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>14,200</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>381,638</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mark R. Munch</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>73,724</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>571,867</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>17,707</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>493,191</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Michael G. Knell</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>46,094</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>480,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Represents
the difference between the exercise price of the options exercised and the closing price of Bruker Corporation common stock as of the date of exercise.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Represents
the aggregate value of shares vested in 2017 based on the closing price of Bruker Corporation common stock as of the date of vesting or, if the NASDAQ
Global Select Market was closed on such date, the next trading date thereafter. As of December&nbsp;31, 2017, our named executive officers continued to hold all of the shares reported as acquired
upon vesting of restricted stock awards and restricted stock units in 2017, except as follows: 1,237 of the shares reported as acquired by Mr.&nbsp;Mattacchione, with an aggregate value of $30,480,
were withheld to satisfy tax withholding obligations upon vesting; and 15,499 of the shares reported as acquired by Mr.&nbsp;Munch, of which 8,072 shares, with an aggregate value of $225,763, were
withheld to satisfy tax withholding obligations upon vesting.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ds15601_pension_benefits"> </A>
<A NAME="toc_ds15601_3"> </A>
<BR></FONT><FONT SIZE=2><B>  Pension Benefits    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retirement Plan for Mr.&nbsp;Srega.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;A personal pension scheme established for Mr.&nbsp;Srega's benefit, which was in part carried
forward from
his former employer, is funded by contributions made by Bruker Daltonik&nbsp;GmbH and voluntary contributions by Mr.&nbsp;Srega, if any, during the term of his employment. The personal pension
scheme has three components: a contribution-based plan of Bruker Daltonik&nbsp;GmbH (the "Bruker Daltonik Plan"); a pension fund guarantee (the "Guarantee Plan"); and a cash value life insurance
policy (the "Life Insurance Policy"). The Bruker Daltonik Plan provides for monthly Company contributions in the amount of &euro;5,541 (approximately $6,638 per month or $79,656 per year)
and a lifetime monthly retirement benefit based on the value of accumulated capital beginning at age 67 or a lump-sum payment. In the event of termination of employment or death prior to age 67, the
Bruker Daltonik Plan provides for a reduced benefit to be
determined based on the cash assets of the plan at such time. Mr.&nbsp;Srega may also elect to receive a reduced benefit beginning at age 62 in the event of early retirement. The Guarantee Plan
provides an inflation hedge and an additional monthly retirement benefit, commencing December&nbsp;1, 2019, with an annually increasing benefit based on Guarantee Plan earnings or, at
Mr.&nbsp;Srega's election, a lump-sum payment. The Guarantee Plan is funded by annual Company contributions during the term of employment in amounts which increase annually by the same percentage as
the upper earnings limit established under German law for pension insurance contributions. In the event of death prior to December&nbsp;1, 2019, the Guarantee Plan provides for a lump-sum payment in
an amount to be determined based on the plan assets at such time. In the event of death on or after December&nbsp;1, 2019, benefits will terminate effective November&nbsp;30, 2024. If
Mr.&nbsp;Srega's employment terminates prior to the eligible retirement age, Mr.&nbsp;Srega may elect to continue funding through personal contributions or the Guarantee Plan may be transferred to
a </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>49</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=52,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=1013485,FOLIO='49',FILE='DISK133:[18ZAG1.18ZAG15601]DS15601A.;11',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_ds15601_1_50"> </A>

<P style="font-family:times;"><FONT SIZE=2>subsequent
employer. Under the Life Insurance Policy, which matures on November&nbsp;1, 2019, Mr.&nbsp;Srega is entitled to receive at the earlier of death or maturity a payment in the amount
&euro;53,028 (approximately $63,528), adjusted for increases in the value of accumulated surplus and reserves, if any. In the event Mr.&nbsp;Srega's employment terminates prior to the
maturity date, other than by reason of death, the Life Insurance Policy and continued funding obligations are to be transferred to Mr.&nbsp;Srega. Amounts payable in euros are converted to U.S.
dollars at the midpoint conversion rate of &euro;1.0=$1.1980 as of December&nbsp;31, 2017. Mr.&nbsp;Srega may also make voluntary contributions to the personal pension scheme during the
term of his employment. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Information
about our contributions to the personal pension scheme of Mr.&nbsp;Srega is provided in the Summary Compensation Table above under the column entitled "All Other
Compensation" and the related footnotes. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ds15601_2017_non-qualified_deferred_compensation_table"> </A>
<A NAME="toc_ds15601_4"> </A>
<BR></FONT><FONT SIZE=2><B>  2017 Non-Qualified Deferred Compensation Table    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table provides information about 2017 activity relating to the personal pension scheme established for Mr.&nbsp;Srega. All
amounts reported are as of December&nbsp;31, 2017 and are converted from euros to U.S. dollars at the 2017 average midpoint conversion rate of &euro;1.0=$1.1300. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:67%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"120%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="120%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="69pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="82pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="82pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="74pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Executive<BR>
Contributions<BR>
in Last<BR>
Fiscal Year ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Registrant<BR>
Contributions<BR>
in Last<BR>
Fiscal Year ($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Aggregate<BR>
Earnings<BR>
in Last<BR>
Fiscal Year ($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Aggregate<BR>
Balance at<BR>
Last Fiscal<BR>
Year-End ($)(3) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Juergen Srega</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,729</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>75,145</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>22,958</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>427,763</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
reported amount is included in the "</FONT><FONT SIZE=2><I>All Other Compensation</I></FONT><FONT SIZE=2>" column in the Summary Compensation Table.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
reported amount includes earnings attributable to plan assets amounts contributed by Mr.&nbsp;Srega and Mr.&nbsp;Srega's former employer, which amounts were
carried forward into the personal pension scheme following commencement of Mr.&nbsp;Srega's employment in 2013. The reported amount also reflects the impact of changes in exchange rates and currency
translation from euros to U.S. dollars. Aggregate earnings in local currency were 12,808&nbsp;euros, or approximately $14,484 on a constant currency basis.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
reported amount includes $4,729 and $4,478 reported as 2017 and 2016 compensation, respectively, in the "</FONT><FONT SIZE=2><I>Salary</I></FONT><FONT SIZE=2>"
column in the Summary Compensation Table, which was contributed by Mr.&nbsp;Srega from his compensation in those years. Also included in the reported amount is the value of contributions to and
earnings on amounts contributed by Mr.&nbsp;Srega and Mr.&nbsp;Srega's former employer prior to his employment with the Company, which amounts were carried forward into the personal pension scheme
following commencement of Mr.&nbsp;Srega's employment in 2013.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
were no withdrawals or distributions from Mr.&nbsp;Srega's personal pension scheme during 2017. Further information on the personal pension scheme established for
Mr.&nbsp;Srega is included above under the heading </FONT><FONT SIZE=2><I>"Pension Benefits&#151;Retirement Plan."</I></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ds15601_potential_payments_upo__ds102292"> </A>
<A NAME="toc_ds15601_5"> </A>
<BR></FONT><FONT SIZE=2><B>  Potential Payments upon Termination or Change-in-Control    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following information describes and quantifies certain compensation and benefits that would have been payable under existing agreements,
plans, and arrangements if the named executive officer's employment had terminated on December&nbsp;31, 2017, given his compensation and service levels as of that date. These benefits are in
addition to the benefits to which the named executive officer was already entitled or in which he was vested as of such date, as well as certain benefits that are generally available to salaried
employees. Due to the number of factors that affect the nature and amount of the compensation and benefits potentially payable upon the events described below, any amounts actually </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>50</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=53,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=233411,FOLIO='50',FILE='DISK133:[18ZAG1.18ZAG15601]DS15601A.;11',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_ds15601_1_51"> </A>

<P style="font-family:times;"><FONT SIZE=2>paid
or distributed may be different than those shown in the table. Factors that could affect these amounts include the nature of or basis for such termination, the timing during the year of any such
event, whether and when a named executive officer decides to exercise stock options and our stock
price on that date and the exercise of discretion by the Board or Compensation Committee regarding the payment of compensation and benefits. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Severance Benefits.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The cash severance benefits contained in the employment agreement for Mr.&nbsp;Srega, and the amounts he would be
paid in
connection with a termination of employment within six months of a change in voting control of the Company are described in the Compensation and Discussion&nbsp;&amp; Analysis section of this proxy
statement under the heading "</FONT><FONT SIZE=2><I>Employment Agreements, Termination of Employment and Change in Control Arrangements</I></FONT><FONT SIZE=2>." The separation arrangement and
agreement provided for Mr.&nbsp;Knell are also described in that section of this proxy statement. Other than as contained in such agreements, we do not have arrangements with any of our other named
executive officers, including Dr.&nbsp;Laukien, Mr.&nbsp;Mattacchione and Dr.&nbsp;Munch, which provide cash severance benefits in the event of termination of employment or a change in control
of the Company. Upon completion of his transition responsibilities, Mr.&nbsp;Knell received a payment of $116,573 in connection with the termination of his employment. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity Awards.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The unvested equity awards held by each of the named executive officers as of December&nbsp;31, 2017 are described above
in the 2017
Outstanding Equity Awards table. Each of the stock option and restricted stock awards granted prior to May&nbsp;20, 2016 were granted pursuant to our 2010 Incentive Compensation Plan, or 2010 Plan.
Each of the equity-based awards granted on or after May&nbsp;20, 2016 were granted pursuant to our 2016 Plan. In accordance with the terms of the 2010 Plan and the 2016 Plan and our related award
agreements, except as noted below, no accelerated vesting of stock options or stock awards would have occurred as of December&nbsp;31, 2017 in the event of a voluntary termination by a named
executive officer or an involuntary termination by us, whether with or without cause. Generally, upon termination of employment, (a)&nbsp;any unvested restricted stock is forfeited and
(b)&nbsp;the participant has a period of 90&nbsp;days from termination to exercise any vested option awards (or, if earlier, until the option expiration date). However, in the event of termination
for cause, including as a result of dishonesty with respect to the Company or any of its affiliates, breach of fiduciary duty, insubordination, substantial malfeasance or non-feasance of duty,
unauthorized disclosure of confidential information, material failure or refusal to comply with Company's published policies generally applicable to all employees or conduct materially harmful to the
business of the Company or any of its affiliates, all vested and unexercised options are forfeited immediately upon termination. Additionally, in the event of death or disability of a plan
participant, including any named executive officer, (a)&nbsp;any unvested restricted stock will become vested and (b)&nbsp;all vested stock options will remain exercisable for a period of
90&nbsp;days following such event (or, if earlier, until the stock option expiration date). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee has discretion to revise or amend outstanding equity awards and may, at its discretion, accelerate vesting of any unvested option or stock awards, including in
connection with a "Change in Control" of the Company, as defined in our 2010 Plan or 2016 Plan, as applicable. Under these plans, a "Change in Control" occurs if: (a)&nbsp;within one year of any
merger, consolidation, sale of a substantial part of the Company's assets, or contested election, the persons who were directors of the Company immediately before such transaction cease to constitute
a majority of the board of directors of the Company or its successor to the Company; (b)&nbsp;if, as a result of any such transaction, the Company does not survive as an entity, or its shares are
changed into the shares of another corporation
unless the stockholders of the Company immediately prior to the transaction own a majority of the outstanding shares of such other corporation immediately following the transaction; (c)&nbsp;any
person or group who owned less than twenty percent of the outstanding common stock of the Company at the time of adoption of the 2010 Plan or 2016 Plan, as applicable, acquires ownership of fifty
percent or more of the Company's outstanding common stock; (d)&nbsp;the dissolution or liquidation of </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>51</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=54,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=549590,FOLIO='51',FILE='DISK133:[18ZAG1.18ZAG15601]DS15601A.;11',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_ds15601_1_52"> </A>

<P style="font-family:times;"><FONT SIZE=2>the
Company is approved by its stockholders; or (e)&nbsp;the members of the board of directors as of the date the 2010 Plan or 2016 Plan, as applicable, was adopted cease to represent at least two
thirds of the Board, subject to certain exceptions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
with respect to awards granted pursuant to the 2016 Plan, in the event of a Change in Control, if (a)&nbsp;an award is assumed or continued (including through conversion
or substitution for a substantially similar award of the successor) and, within twenty four (24)&nbsp;months following the Change in Control (or such shorter period as specified in the applicable
award agreement), the executive officer's employment is terminated without cause or is voluntarily terminated for good reason (a "double-trigger" provision), or (b)&nbsp;an award is not assumed or
continued, then any then outstanding awards of stock options will vest and become fully exercisable and any outstanding unvested awards of restricted stock units that are not performance-based will be
treated as vested. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
values of (i)&nbsp;unvested in-the-money stock options that would have been received by each of the named executive officers in the event of acceleration upon a Change in Control,
assuming the Change in Control was effective December&nbsp;31, 2017 and (ii)&nbsp;unvested restricted stock that would have been received by each of the named executive officers in the event
(a)&nbsp;of acceleration upon a Change in Control, assuming the Change in Control was effective December&nbsp;31, 2017 or (b)&nbsp;of the death or disability of the respective named executive
officer are set forth in the following table. All calculations are based on a price per share equal to the NASDAQ Global Select Market closing price of $34.32 per share on December&nbsp;29, 2017,
the last trading day of 2017. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="83pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="72pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name


<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Unvested<BR>
In-the-Money<BR>
Stock Options ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Unvested<BR>
Restricted<BR>
Stock ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Unvested<BR>
Restricted<BR>
Stock Units ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Frank H. Laukien</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,914,470</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,482,178</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,861,892</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Anthony L. Mattacchione.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>717,502</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>337,331</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>784,487</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Juergen Srega</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,113,817</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>500,008</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>865,756</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mark R. Munch</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,198,581</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>615,770</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,302,890</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Michael G. Knell</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retirement Plans.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The retirement plan provided for Mr.&nbsp;Srega is described under the heading "</FONT><FONT SIZE=2><I>Pension
Benefits</I></FONT><FONT SIZE=2>" above. In the event of termination of employment as of December&nbsp;31, 2017 by reason of death, Mr.&nbsp;Srega's beneficiary would be entitled to receive an
estimated lump-sum payment of $521,488, which amount is payable in euros and converted to U.S. dollars based on the midpoint conversion rate of &euro;1.0=$1.1980 as of December&nbsp;31,
2017. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ds15601_pay_ratio_disclosure"> </A>
<A NAME="toc_ds15601_6"> </A>
<BR></FONT><FONT SIZE=2><B>  PAY RATIO DISCLOSURE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As required by Section&nbsp;953(b) of the Dodd-Frank Wall Street Reform Act and Consumer Protection Act of 2010, and Item&nbsp;402(u) of
Regulation&nbsp;S-K, we are providing the following disclosure about the ratio of the annual total compensation of Dr.&nbsp;Frank Laukien, our President and Chief Executive Officer (CEO), to the
annual total compensation of our median employee. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
2017, our last completed fiscal year, the median of the annual total compensation of all employees of our Company (other than our CEO) was $72,517. The 2017 annual total compensation
of our CEO, as reported in the Summary Compensation Table included in this proxy statement, was $4,872,009. Based on this information, for 2017 the ratio of our CEO's annual total compensation to the
annual total compensation of our median employee was 67:1. This ratio is a reasonable estimate calculated in a manner consistent with Item&nbsp;402(u) of Regulation&nbsp;S-K. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of reporting annual total compensation and the ratio of annual total compensation of the CEO to the median employee, both the CEO and median employee's annual total
compensation </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>52</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=55,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=582108,FOLIO='52',FILE='DISK133:[18ZAG1.18ZAG15601]DS15601A.;11',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_ds15601_1_53"> </A>

<P style="font-family:times;"><FONT SIZE=2>were
calculated consistent with the disclosure requirements of executive compensation under the Summary Compensation Table. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
identify the median employee, we examined the 2017 target total cash compensation, including annualized base salaries plus target performance bonus, incentive pay and commissions, for
all individuals, excluding our CEO, who were employed by us as of October&nbsp;31, 2017, as reflected in our payroll records. In accordance with Item&nbsp;402(u) and instructions thereto, we
included all 6,125 full-time, part-time, temporary and seasonal employees. We selected target total cash compensation for all employees as a consistently applied compensation measure because we do not
widely distribute annual equity awards to employees and because we believe that this measure reasonably reflects the total annual compensation of our employees. For purposes of calculating the target
total cash compensation of our non-U.S. employees, we converted local currencies at the applicable 2017 average exchange rates as of October&nbsp;31, 2017. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Once
we identified our median employee based on that analysis, we then determined that employee's total compensation in the same manner that we determine the total compensation of our
named executive officers for purposes of the Summary Compensation Table, as discussed above. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ds15601_related_persons_transactions"> </A>
<A NAME="toc_ds15601_7"> </A>
<BR></FONT><FONT SIZE=2><B>  RELATED PERSONS TRANSACTIONS    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Review and Approval of Transactions with Related Persons  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have adopted a written Related Person Transactions Policy that prohibits transactions involving the Company and any related person, except in
accordance with the policy. For purposes of this policy, related persons include (a)&nbsp;our executive officers, directors, director nominees or greater than 5% shareholders, or any of their
immediate family members and (b)&nbsp;any firm, academic entity or other entity in which any of the foregoing persons is employed or is a partner or principal or in a similar position or in which
such person has more than a 10% beneficial ownership interest. The Related Person Transactions Policy applies to any transaction or series of transactions, other than product or service sales or
purchases entered into in the ordinary course of business involving aggregate amounts of less than $50,000 annually, in which the Company is a participant and in which any related person has a direct
or indirect interest. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Related Person Transactions Policy provides for standing pre-approval of certain categories of transactions with related persons,
including:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> transactions involving indebtedness for ordinary business travel and expense payments and similar indebtedness transactions arising in the
ordinary course of business; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> transactions in which a related person's interest arises solely from the ownership of a class of the Company's equity securities and in which
all holders receive proportional benefits; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> transactions involving compensation to executive officers approved by the Compensation Committee; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> transactions involving compensation to directors for services as a director of the Company. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
our Related Person Transactions Policy, any related person transaction not in one of the preceding categories must be submitted to our Chief Financial Officer for review and
approval. Related person transactions involving amounts of $500,000 or less, as well as all product or service sales and purchases in the ordinary course of business, are subject solely to review and
approval, ratification, amendment, termination or rescission by our Chief Financial Officer. Any transaction in excess of $500,000, other than a transaction involving product or service sales or
purchases in the ordinary course of business, must be forwarded to the Audit Committee for review and approval, ratification, amendment, termination or rescission, at the discretion of the Audit
Committee. In reviewing such transactions, our Chief Financial Officer or Audit Committee, as applicable, evaluates all material facts </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>53</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=56,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=478137,FOLIO='53',FILE='DISK133:[18ZAG1.18ZAG15601]DS15601A.;11',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_ds15601_1_54"> </A>

<P style="font-family:times;"><FONT SIZE=2>relating
to the transaction and takes into account, among other factors deemed appropriate, the related person's relationship to the Company and interest in the transaction, the terms of the
transaction, including its aggregate value, whether the transaction is in the best interests of the Company, the impact on a director's independence in the event the related person is a director, a
family member of a director, or an entity in which a director is a partner, shareholder or executive officer and, if applicable, the availability of other sources of comparable products or services
and whether the transaction is on terms comparable to the terms available to an unrelated third party. Neither the Chief Financial Officer nor any member of the Audit Committee may participate in the
review of any transaction involving such person or any of his or her immediate family members. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Chief Financial Officer must report to the Audit Committee any approval or other action taken with respect to a related party transaction at or prior to the next audit committee
meeting following such approval or other action. Additionally, Company management must provide to the Audit Committee an annual report of any amounts paid or payable to, or received or receivable
from, any related person. The Audit Committee is responsible for reviewing such reports and may make inquiries or take such actions as it deems appropriate upon consideration of all of the relevant
facts and circumstances. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Transactions with Related Persons  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under a lease agreement, Bruker BioSpin Corporation rents laboratory, manufacturing and office space from a trust controlled equally by
Dr.&nbsp;Frank Laukien and Dr.&nbsp;Dirk Laukien. During 2017, Dr.&nbsp;Frank Laukien and Dr.&nbsp;Dirk Laukien were each paid $263,195 as a beneficiary of the trust. Payments under the terms
of the lease were equal to the estimated fair market value of the rental. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr.&nbsp;Dirk
Laukien, a director and employee of the Company until July&nbsp;10, 2012 and half-brother of Dr.&nbsp;Frank Laukien, is also a party to a lease agreement under which
Bruker BioSpin AG rents certain office space. During 2017, Dr.&nbsp;Dirk Laukien was paid $124,303 under this lease agreement. Payments under the terms of the lease were equal to the estimated fair
market value of the rental. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
2017, in connection with our continued operational cost-saving and consolidation initiatives, two additional lease agreements between Bruker Corporation and Dr.&nbsp;Dirk
Laukien were terminated. Payments made to Dr.&nbsp;Dirk Laukien under the terminated leases during 2017 were $2,245,143, including rental payments in the amount of $306,143 and early termination
payments in the amount of $1,939,000. No further payments are anticipated under these leases. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Isolde
Laukien-Kleiner is the stepmother of Dr.&nbsp;Frank Laukien and Mr.&nbsp;Joerg Laukien and the mother of Dr.&nbsp;Dirk Laukien. Dr.&nbsp;Dirk Laukien and
Ms.&nbsp;Laukien-Kleiner are parties to a lease agreement with Bruker BioSpin AG under which Bruker BioSpin AG rents certain office and laboratory space. During 2017, Ms.&nbsp;Laukien-Kleiner was
paid $340,113 under that agreement. Ms.&nbsp;Laukien-Kleiner is party to an additional lease agreement with Bruker BioSpin AG under which Bruker BioSpin AG rents certain office space. During 2017,
Ms.&nbsp;Laukien-Kleiner was paid $232,935 under that agreement. Payments under the terms of each of the leases referenced above were equal to the estimated fair market value of the respective
rental. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Joerg
C. Laukien, a director of the Company, was Executive Chairman of Bruker BioSpin Corporation until his retirement from employment effective December&nbsp;31, 2017. During 2017,
Joerg Laukien earned aggregate cash compensation of 265,192&nbsp;euros in salary, or $299,667 based on a conversion rate of &euro;1.0=$1.1300, which represents the 2017 average midpoint
rate. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr.&nbsp;Gilles
Martin, a director of the Company, is the Chairman, Chief Executive Officer and controlling shareholder of the Eurofins Scientific Group, a provider of analytical
testing services, and a director of various of its affiliates. During 2017, the Company received approximately $2,623,765 from, and paid approximately $144,953 to, entities affiliated with the
Eurofins Scientific Group in connection </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>54</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=57,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=783186,FOLIO='54',FILE='DISK133:[18ZAG1.18ZAG15601]DS15601A.;11',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_ds15601_1_55"> </A>

<P style="font-family:times;"><FONT SIZE=2>with
purchases and sales of goods and services entered into in the normal course of business. We believe that the terms of such transactions are comparable to those that would have been reached by
unrelated parties in arm's-length transactions. We expect to engage in similar commercial transactions with affiliates of the Eurofins Scientific Group during fiscal 2018. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr.&nbsp;Meike
Hamester, the wife of Bruker CALID Group President Juergen Srega, is employed by our Bruker Daltonik&nbsp;GmbH subsidiary as the Director of Small Molecule
Pharma&nbsp;&amp; CRO. During 2017, Dr.&nbsp;Hamester received a base salary in the amount of $99,246 and earned an annual performance-based cash incentive bonus for 2017 performance of $29,520. She
also received a bonus payment in the amount of $20,566 which was earned in 2016 but paid in 2017. Dr.&nbsp;Hamester's base salary and bonus are payable in euros; amounts are converted to U.S.
dollars at a conversion rate of &euro;1.0=$1.1300, which represents the 2017 average midpoint rate as published on www.oanda.com). Her compensation is consistent with the total compensation
provided to other employees of the same level with similar responsibilities. Dr.&nbsp;Hamester continues to be an employee of Bruker Daltonik&nbsp;GmbH and she may receive compensation and other
benefits in 2018 in amounts similar to those she received during 2017. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="ds15601_section_16(a)_benefici__ds102035"> </A>
<A NAME="toc_ds15601_8"> </A>
<BR></FONT><FONT SIZE=2><B>  SECTION&nbsp;16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;16(a) of the Securities Exchange Act of 1934 and the rules promulgated thereunder require our officers and directors and persons
owning more than 10% of the outstanding common stock of the Company to file reports of ownership and changes in ownership with the Securities and Exchange Commission and to furnish us with copies of
all these filings. We believe, based solely upon a review of those reports and amendments thereto furnished to us during and with respect to our fiscal year ended December&nbsp;31, 2017, that all of
our directors and executive officers complied with the reporting requirements of Section&nbsp;16(a) of the Exchange Act during fiscal 2017, with the exception of one transaction reported in a late
Form&nbsp;4 filing by Mr.&nbsp;Joerg Laukien and one transaction reported in a late Form&nbsp;4 filing by Mr.&nbsp;Mattacchione, in each case due to an administrative error. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>55</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=58,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=532121,FOLIO='55',FILE='DISK133:[18ZAG1.18ZAG15601]DS15601A.;11',USER='CHE109863',CD='10-APR-2018;02:05' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_du15601_1_56"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="du15601_audit_committee_report"> </A>
<A NAME="toc_du15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  AUDIT COMMITTEE REPORT    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee, which operates pursuant to a written charter, assists the board of directors in fulfilling its oversight responsibilities
by reviewing Bruker Corporation's financial reporting process on behalf of the board. Management is responsible for Bruker Corporation's internal controls, the financial reporting process and
compliance with laws and regulations and ethical business standards. PricewaterhouseCoopers&nbsp;LLP ("PwC"), Bruker Corporation's independent registered public accounting firm, is responsible for
expressing opinions on the conformity of Bruker Corporation's consolidated financial statements with generally accepted accounting principles and on the effectiveness of Bruker Corporation's internal
control over financial reporting. The Audit Committee is responsible for overseeing and monitoring these practices. It is not the duty or responsibility of the Audit Committee to conduct auditing or
accounting reviews or procedures. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
this context, the Audit Committee reviewed and discussed with management and PwC, among other things, the scope of the audit to be performed, the results of the audit performed, PwC's
evaluation of Bruker Corporation's internal control over financial reporting and the independent registered public accounting firm's fees for the services performed. Management represented to the
Audit Committee that Bruker Corporation's consolidated financial statements were prepared in accordance with generally accepted accounting principles. Discussions about Bruker Corporation's audited
financial statements included the auditors' judgments about the quality, not just the acceptability, of the accounting principles, the reasonableness of significant judgments and the clarity of
disclosures in its financial statements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee also discussed with PwC other matters required by Auditing Standard 1301, </FONT><FONT SIZE=2><I>Communications with Audit Committees</I></FONT><FONT SIZE=2>, as
adopted by the Public Company Accounting Oversight (PCAOB), including the quality, not just the acceptability, of the accounting principles, the reasonableness of significant judgments, and the
clarity of the disclosures in the financial statements. PwC also provided to the Audit Committee written disclosures and the letter required by applicable requirements of the PCAOB regarding
communications with the Audit Committee concerning independence. The Audit Committee discussed with PwC the registered public accounting firm's independence from Bruker Corporation and considered the
compatibility of non-audit services with PwC's independence. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on the Audit Committee's discussion with management and PwC, and the Audit Committee's review of the representations of management and the report of PwC to the Audit Committee, the
Audit Committee recommended to the board that that the audited financial statements be included in the Company's Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2017 filed
with the Securities and Exchange Commission. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Submitted
by the Audit Committee of Bruker Corporation's Board of Directors. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 <!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="279" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2> John Ornell, Chair<BR>
Richard A. Packer<BR>
Adelene Q. Perkins<BR>
Robert Rosenthal<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>56</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=59,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=109140,FOLIO='56',FILE='DISK133:[18ZAG1.18ZAG15601]DU15601A.;4',USER='CHE109863',CD='10-APR-2018;02:05' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dw15601_1_57"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dw15601_proposal_no._2_advisor__dw102221"> </A>
<A NAME="toc_dw15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PROPOSAL NO. 2<BR>  ADVISORY VOTE ON EXECUTIVE COMPENSATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors recognizes the interest our stockholders have in the compensation of our executives. In recognition of that interest and
as required by the Dodd-Frank Wall Street Reform and Consumer Protection Act (the "Dodd-Frank Act") and SEC rules, we are providing our stockholders the opportunity to cast a non-binding advisory vote
on the compensation of our named executive officers, as disclosed pursuant to the compensation disclosure rules of the SEC. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
compensation of our named executive officers is disclosed in the Compensation Discussion and Analysis, or "CD&amp;A," the compensation tables, and the related disclosures contained in
this Proxy Statement. As described in our CD&amp;A, we have adopted an executive compensation philosophy designed to deliver competitive total compensation, upon the achievement of financial and/or
strategic performance objectives, which will attract, motivate and retain leaders who will drive the creation of shareholder value. In order to implement that philosophy, the Compensation Committee
has established a disciplined and rigorous process for the adoption of executive compensation programs and individual executive officer pay actions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe that our compensation policies and decisions are focused on pay-for-performance principles, are strongly aligned with the long-term interests of our stockholders, and provide
an appropriate balance between risk and incentives. Stockholders are urged to read the CD&amp;A section of this Proxy Statement, which discusses in greater detail how our compensation policies and
procedures implement our executive compensation philosophy. We are asking our stockholders to indicate their support for
our named executive officer compensation, as described in this Proxy Statement, by approval of the following resolution: </FONT></P>

<UL>

<P style="font-family:times;"><FONT SIZE=2>"RESOLVED,
that the compensation paid to the Company's named executive officers, as disclosed pursuant to Item&nbsp;402 of Regulation&nbsp;S-K, including the Compensation Discussion and Analysis,
compensation tables and narrative discussion, is hereby APPROVED." </FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
vote on this Proposal No.&nbsp;2 is advisory, and therefore not binding on the Company, the Compensation Committee, or the board of directors. The vote will not be construed to
create or imply any change to the fiduciary duties of the Company or the board, or to create or imply any additional fiduciary duties for the Company or the board. The approval or disapproval of this
proposal by stockholders will not require the Company's board of directors or the Compensation Committee to take any action regarding the Company's executive compensation practices. However, our board
and our Compensation Committee value input from stockholders and will consider the outcome of the vote when making future executive compensation decisions. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>The Board of Directors recommends a vote FOR the approval, on an advisory basis, of the 2017 compensation paid to the named executive officers, as disclosed in
the Compensation Discussion and Analysis, the compensation tables, and related narratives in this Proxy Statement.</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>57</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=60,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=227918,FOLIO='57',FILE='DISK133:[18ZAG1.18ZAG15601]DW15601A.;4',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_dw15601_1_58"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dw15601_proposal_no._3_ratification_of__pro02975"> </A>
<A NAME="toc_dw15601_2"> </A>
<BR></FONT><FONT SIZE=2><B>  PROPOSAL NO. 3<BR>  RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;PricewaterhouseCoopers&nbsp;LLP has been our independent registered public accounting firm since June&nbsp;1, 2016, and has been selected by
the Audit Committee of the board of directors as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2018. Although the Company is not required to seek
stockholder approval of this appointment, the board of directors believes it to be sound corporate governance to do so. In the event that the stockholders fail to ratify the appointment, the Audit
Committee will investigate the reasons for stockholder rejection and will reconsider the appointment. Even if the selection is ratified, the Audit Committee in its discretion may direct the
appointment of a different independent public accounting firm during the year if the Audit Committee believes that such a change would be in the best interests of the Company and its stockholders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
representative of PricewaterhouseCoopers&nbsp;LLP is expected to be present at the 2018 Annual Meeting and will have the opportunity to make a statement if he or she so desires to do
so and will be available to respond to appropriate stockholder questions. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>The Board of Directors recommends a vote FOR the ratification of the appointment of PricewaterhouseCoopers&nbsp;LLP as the Company's independent registered
public accounting firm for fiscal 2018.</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>58</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=61,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=595605,FOLIO='58',FILE='DISK133:[18ZAG1.18ZAG15601]DW15601A.;4',USER='CHE109863',CD='10-APR-2018;02:05' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dy15601_1_59"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dy15601_independent_registered_public_accounting_firm"> </A>
<A NAME="toc_dy15601_1"> </A>
<BR></FONT><FONT SIZE=2><B>  INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At a meeting held on June&nbsp;1, 2016, the Audit Committee of the Company's Board of Directors approved the dismissal of Ernst&nbsp;&amp;
Young&nbsp;LLP ("Ernst&nbsp;&amp; Young") as the Company's independent registered public accounting firm, effective June&nbsp;1, 2016, and the appointment of PricewaterhouseCoopers&nbsp;LLP
("PwC") as the Company's independent registered public accounting firm, effective June&nbsp;1, 2016, to perform independent audit services for the fiscal year ending December&nbsp;31, 2016. During
the fiscal years ended December&nbsp;31, 2014 and 2015 and through June&nbsp;1, 2016, neither the Company, nor anyone on its behalf, consulted PwC regarding either (i)&nbsp;the application of
accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered with respect to the consolidated financial statements of the
Company, and no written report or oral advice was provided to the Company by PwC that was an important factor considered by the Company in reaching a decision as to any accounting, auditing or
financial reporting issue; or (ii)&nbsp;any matter that was the subject of a disagreement within the meaning of Item&nbsp;304(a)(1)(iv) of Regulation&nbsp;S-K and related instructions or a
reportable event within the meaning of Item&nbsp;304(a)(1)(v) of Regulation&nbsp;S-K. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
reports of Ernst&nbsp;&amp; Young on the consolidated financial statements of the Company for each of the fiscal years ended December&nbsp;31, 2015 and 2014 did not contain an
adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with the audits of our financial statements for each of the fiscal years ended December&nbsp;31, 2015 and 2014, and in the subsequent interim period through
June&nbsp;1, 2016, there were no
"disagreements" (as that term is defined in Item&nbsp;304(a)(1)(iv) of Regulation&nbsp;S-K and the related instructions) with Ernst&nbsp;&amp; Young on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope and procedures, which, if not resolved to the satisfaction of Ernst&nbsp;&amp; Young, would have caused Ernst&nbsp;&amp; Young to make
reference to the matter in their reports for such years. There were no "reportable events" as that term is described in Item&nbsp;304(a)(1)(v) of Regulation&nbsp;S-K, except for a material
weakness in the Company's internal control over financial reporting as of December&nbsp;31, 2015 concerning the accounting for income taxes, which material weakness was identified subsequent to the
filing of our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2015. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a result of such material weakness, our management concluded in November 2016 that the Company's internal control over financial reporting was not effective at December&nbsp;31,
2015. On November&nbsp;15, 2016, the Company filed Amendment No.&nbsp;1 to its Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2015, as well as amendments to each
of its Quarterly Reports on Form&nbsp;10-Q for the periods ended March&nbsp;31, 2016, and June&nbsp;30, 2016, to reflect the conclusion by management that there was a material weakness in
internal control over financial reporting as of the end of the periods covered by those reports. The Company's Amendment No.&nbsp;1 to its Annual Report on Form&nbsp;10-K for the fiscal year ended
December&nbsp;31, 2015 also included revised auditor's reports from Ernst&nbsp;&amp; Young stating that the Company's internal control over financial reporting at December&nbsp;31, 2015 was not
effective. During the year ended December&nbsp;31, 2017, we remediated the material weakness in our internal controls over the accounting for income taxes. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>59</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=62,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=592933,FOLIO='59',FILE='DISK133:[18ZAG1.18ZAG15601]DY15601A.;5',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_dy15601_1_60"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Fees Billed to the Company  </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fees billed to the Company by its independent registered public accounting firms for fiscal years 2017 and 2016, all of which were approved by
the Audit Committee, consisted of the following: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2016($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>6,555,369</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,990,966</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit Related Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>30,720</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>5,887</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tax Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,078,281</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,059,953</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>All Other Fees and Expenses</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>42,286</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>278,737</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8,706,656</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7,335,543</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
fees paid to PwC for the fiscal year ended December&nbsp;31, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
fees paid to PwC for the fiscal year ended December&nbsp;31, 2016.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Audit Fees.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Audit fees for the years ended December&nbsp;31, 2017 and 2016 were for the audit of the Company's annual consolidated
financial
statements, including the integrated audit of internal control over financial reporting, its review of the consolidated financial statements included in our quarterly reports on Form&nbsp;10-Q,
audits of statutory filings, comfort letter procedures and review of other regulatory filings. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Audit-Related Fees.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Audit-related fees for the years ended December&nbsp;31, 2017 and 2016 include amounts related to accounting
consultations and
services provided due to other statutory requirements. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax Fees.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Tax fees for the years ended December&nbsp;31, 2017 and 2016 were for tax services provided to us, including tax compliance,
tax advice
and planning. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All Other Fees.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;All other fees for the years ended December&nbsp;31, 2017 and 2016 relate to license fees for a web-based accounting
research tool
as well as other advisory non-audit services. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Audit Committee Pre-Approval Policies and Procedures  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In order to ensure that audit and non-audit services proposed to be performed by the Company's independent registered public accounting firm do
not impair the auditor's independence from the Company, the Audit Committee has adopted, and the board of directors has ratified, the following pre-approval policies and procedures. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Policies  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Before engaging the independent registered public accounting firm to render the proposed service, the Audit Committee must either
(i)&nbsp;approve the specific engagement ("specific pre-approval") or (ii)&nbsp;enter into the engagement pursuant to pre-approval policies and procedures established by the Audit Committee
("general pre-approval"), provided the policies and procedures are detailed for the particular service, the Audit Committee is informed of each service, and such policies
and procedures do not include delegation of the Audit Committee's responsibilities to management. The Audit Committee annually reviews and pre-approves the services that may be provided by the
independent registered public accounting firm without obtaining specific pre-approval. The Audit Committee will add to or subtract from this list of general pre-approved services from time to time,
based on subsequent determinations. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
a type of service has received general pre-approval, it requires specific pre-approval by the Audit Committee if it is to be provided by the independent registered public
accounting firm. Any proposed services exceeding pre-approved cost levels or budgeted amounts also require specific pre-approval by the Audit Committee. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>60</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=63,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=818549,FOLIO='60',FILE='DISK133:[18ZAG1.18ZAG15601]DY15601A.;5',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_dy15601_1_61"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
both types of pre-approval, the Audit Committee considers whether such services are consistent with the SEC's and the PCAOB's rules on auditor independence. The Audit Committee also
considers whether the independent registered public accounting firm is best positioned to provide the most effective and efficient service, for reasons such as its familiarity with the Company's
business, people, culture, accounting systems, risk profile and other factors, and whether the service might enhance the Company's ability to manage or control risk or improve audit quality. All such
factors are considered as a whole, and no one factor will necessarily be determinative. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee also considers the relationship between fees for audit and non-audit services in deciding whether to pre-approve any such services and may determine, for each fiscal
year, the appropriate ratio between the total amount of fees for Audit, Audit-related and Tax services and the total amount of fees for certain permissible non-audit services classified as All Other
services. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee may delegate either type of pre-approval authority to one or more of its members. The member to whom such authority is delegated must report, for informational
purposes only, any pre-approval decisions to the Audit Committee at its next scheduled meeting. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Procedures  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pre-approval fee levels or budgeted amounts for all services to be provided by the independent registered public accounting firm are established
annually by the Audit Committee. Any
proposed services exceeding these levels or amounts require specific pre-approval by the Audit Committee, even if previously generally pre-approved. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
requests or applications for services to be provided by the independent registered public accounting firm that do not require specific approval by the Audit Committee are submitted
to the Chief Financial Officer and must include a detailed description of the services to be rendered. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Requests
or applications to provide services that require specific approval by the Audit Committee must be submitted to the Audit Committee by both the independent registered public
accounting firm and the Chief Financial Officer, and must include a joint statement as to whether, in their view, the request or application is consistent with the SEC's rules on auditor independence. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee monitors the performance of all services provided by the independent auditor and assesses whether such services are in compliance with this policy. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dy15601_stockholder_communications"> </A>
<A NAME="toc_dy15601_2"> </A>
<BR></FONT><FONT SIZE=2><B>  STOCKHOLDER COMMUNICATIONS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The board will give appropriate attention to written communications that are submitted by stockholders, and will respond if and as appropriate.
Absent unusual circumstances or as contemplated by committee charters and subject to any required assistance or advice from legal counsel, Mr.&nbsp;Stein, the Secretary of the Company, is primarily
responsible for monitoring communications from stockholders and for providing copies or summaries of such communications to the other directors as he considers appropriate. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Communications
are forwarded to all directors if they relate to important substantive matters and include suggestions or comments that Mr.&nbsp;Stein considers to be important for the
directors to know. In general, communications relating to corporate governance and long-term corporate strategy are more likely to be forwarded than communications relating to ordinary business
affairs, personal grievances and matters as to which we may receive repetitive or duplicative communications. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stockholders
who wish to send communications on any topic to the board should address such communications to Richard M. Stein, Secretary, at Nixon Peabody&nbsp;LLP, 100 Summer Street,
Boston,&nbsp;MA 02110. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>61</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=64,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=724547,FOLIO='61',FILE='DISK133:[18ZAG1.18ZAG15601]DY15601A.;5',USER='CHE109863',CD='10-APR-2018;02:05' -->
<A NAME="page_dy15601_1_62"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dy15601_time_for_submission_of_stockholder_proposals"> </A>
<A NAME="toc_dy15601_3"> </A>
<BR></FONT><FONT SIZE=2><B>  TIME FOR SUBMISSION OF STOCKHOLDER PROPOSALS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to Rule&nbsp;14a-8 under the Exchange Act, stockholders may present proper proposals for inclusion in a company's proxy statement and
for consideration at the next annual meeting of its stockholders by submitting their proposals to Bruker Corporation in a timely manner. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stockholders
interested in submitting a proposal for inclusion in the proxy materials for the annual meeting of stockholders in 2019 may do so by following the procedures set forth in
Rule&nbsp;14a-8 of the Securities Exchange Act of 1934, as amended. To be eligible for inclusion, stockholder proposals must be received by us no later than December&nbsp;18, 2018. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
under our bylaws, no business may be brought before an annual meeting unless it is specified in the notice of meeting by or at the direction of the board of directors or by
a stockholder entitled to vote who has delivered notice to Bruker Corporation (containing certain information specified in the bylaws) not less than 90 or more than 120&nbsp;days prior to the first
anniversary of the preceding year's annual meeting. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dy15601_other_matters"> </A>
<A NAME="toc_dy15601_4"> </A>
<BR></FONT><FONT SIZE=2><B>  OTHER MATTERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Management knows of no matters which may properly be and are likely to be brought before the meeting other than the matters discussed herein.
However, if any other matters properly come before the meeting, the persons named in the enclosed proxy will vote in accordance with their best judgment. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dy15601_annual_report"> </A>
<A NAME="toc_dy15601_5"> </A>
<BR></FONT><FONT SIZE=2><B>  ANNUAL REPORT    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A copy (without exhibits) of our Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2017 is included in the 2017
Annual Report provided to stockholders with this proxy statement. We will provide an additional copy of the 2017 Annual Report to any stockholder, without charge, upon written request of such
stockholder. Such requests should be addressed to the attention of Investor Relations at Bruker Corporation, 40 Manning Road, Billerica, Massachusetts 01821. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dy15601_voting_proxies"> </A>
<A NAME="toc_dy15601_6"> </A>
<BR></FONT><FONT SIZE=2><B>  VOTING PROXIES    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The board of directors recommends an affirmative vote on Proposal No.&nbsp;1, Proposal No.&nbsp;2 and Proposal No.&nbsp;3. Proxies will be
voted as specified. If signed proxies are returned without specifying an affirmative or negative vote or other preference on any proposal, the shares represented by such proxies will be voted in favor
of the board of directors' recommendations. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 <!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="279" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2> By order of the board of directors</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B>
<IMG SRC="g83886.jpg" ALT="GRAPHIC" WIDTH="337" HEIGHT="40">
 </B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B> Frank H. Laukien, Ph.D.</B></FONT><FONT SIZE=2><BR>
Chairman, President and Chief Executive Officer</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<P style="font-family:times;"><FONT SIZE=2>April&nbsp;17,
2018 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>62</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=65,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=390853,FOLIO='62',FILE='DISK133:[18ZAG1.18ZAG15601]DY15601A.;5',USER='CHE109863',CD='10-APR-2018;02:05' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">VOTE BY   INTERNET - www.proxyvote.com Use the Internet to transmit your voting   instructions and for electronic delivery of information up until 11:59 P.M.   Eastern Time the day before the cut-off date or meeting date. Have your proxy   card in hand when you access the web site and follow the instructions to   obtain your records and to create an electronic voting instruction form.   BRUKER CORPORATION C/O AMERICAN STOCK TRANSFER 6201 FIFTEENTH AVENUE   BROOKLYN, NY 11219 VOTE BY PHONE - 1-800-690-6903 Use any touch-tone   telephone to transmit your voting instructions up until 11:59 P.M. Eastern   Time the day before the cut-off date or meeting date. Have your proxy card in   hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign   and date your proxy card and return it in the postage-paid envelope we have   provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way,   Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS   FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION   ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. For Withhold For   All Except To withhold authority to vote for any individual nominee(s), mark   &#147;For All Except&#148; and write the number(s) of the AllAll The Board of Directors   recommends you vote FOR the following: nominee(s) on the line below. 0 0 0 1.   Election of three Class III directors to serve for three-year terms expiring   in 2021. Nominees 01 Joerg C. Laukien 02 William A. Linton, Ph.D 03 Adelene   Q. Perkins The Board of Directors recommends you vote FOR proposals 2 and 3.   2. To approve on an advisory basis the 2017 compensation of our named   executive officers, as discussed in the Proxy Statement. 3. Ratification of   PricewaterhouseCoopers LLP as our independent registered public accounting   firm. For 0 0 Against 0 0 Abstain 0 0 NOTE: In their discretion, the proxies   are authorized to vote on such other business as may properly come before the   meeting or any adjournment thereof. 0 For address change/comments, mark here.   (see reverse for instructions) Please indicate if you plan to attend this   meeting Yes 0 No 0 Please sign exactly as your name(s) appear(s) hereon. When   signing as attorney, executor, administrator, or other fiduciary, please give   full title as such. Joint owners should each sign personally. All holders   must sign. If a corporation or partnership, please sign in full corporate or   partnership name by authorized officer. Signature [PLEASE SIGN WITHIN BOX]   Date Signature (Joint Owners) Date 0000377054_1 R1.0.1.17 </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="1008" height="1303" src="g28562bci001.gif"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- ZEQ.=1,SEQ=66,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=55664,FOLIO='',FILE="DISK131:[18ZAG2.18ZAG15602]2856-2-BC_ZAG15602.CHC",USER="CMATTI",CD='Apr 16 23:11 2018' -->

<br clear="all" style="page-break-before:always;">
<div>
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">Important   Notice Regarding the Availability of Proxy Materials for the Annual Meeting:   The Annual Report and Notice and Proxy Statement are available at   www.proxyvote.com. BRUKER CORPORATION THIS PROXY IS SOLICITED ON BEHALF OF   THE BOARD OF DIRECTORS The undersigned hereby appoints Frank H. Laukien and   Gerald N. Herman, or either of them, with power of substitution, Proxies to   vote at the Bruker Corporation Annual Meeting of Stockholders on May 21,   2018, and any adjournments or postponements thereof, all shares of common   stock of Bruker Corporation that the undersigned is entitled to vote at such   meeting on matters which may come before the Annual Meeting in accordance   with and as more fully described in the notice of Annual Meeting of Stockholders   and the Proxy Statement. The undersigned acknowledges receipt of the notice   of the 2018 Annual Meeting of Stockholders and the accompanying Proxy   Statement and revokes any proxy heretofore given with respect to such   meeting. The votes entitled to be cast by the undersigned will be cast as   instructed. If this proxy is executed, but no instruction is given, the votes   entitled to be cast by the undersigned will be cast &quot;FOR&quot; each of   the nominees for director in Proposal 1, &quot;FOR&quot; Proposal 2, and   &quot;FOR&quot; Proposal 3, each of which is set forth on the reverse side   hereof. The votes entitled to be cast by the undersigned will be cast in the   discretion of the named Proxies on any other matter that may properly come   before the meeting and any adjournment or postponement thereof. Address   change/comments: (If you noted any Address Changes and/or Comments above,   please mark corresponding box on the reverse side.) Continued and to be   signed on reverse side 0000377054_2 R1.0.1.17 </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="1008" height="1303" src="g28562bci002.gif"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- ZEQ.=1,SEQ=67,EFW="2235152",CP="BRUKER CORPORATION",DN="1",CHK=961299,FOLIO='',FILE="DISK131:[18ZAG2.18ZAG15602]2856-2-BC_ZAG15602.CHC",USER="CMATTI",CD='Apr 16 23:11 2018' -->

<BR>
<P><br><A NAME="18ZAG15601_1">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_bc15601_1">BRUKER CORPORATION 40 Manning Road Billerica, MA 01821 (978) 663-3660</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_be15601_1">BRUKER CORPORATION NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_da15601_1">BRUKER CORPORATION PROXY STATEMENT</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_da15601_2">RECORD DATE AND VOTING SECURITIES</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_da15601_3">CORPORATE INFORMATION</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_da15601_4">PROPOSAL NO. 1 ELECTION OF DIRECTORS</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dc15601_1">BOARD LEADERSHIP STRUCTURE</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de15601_1">BOARD MEETINGS, COMMITTEES AND COMPENSATION</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de15601_2">DIRECTOR NOMINATIONS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de15601_3">ROLE OF THE BOARD IN RISK OVERSIGHT</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de15601_4">COMPENSATION OF DIRECTORS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de15601_5">2017 Director Compensation Table</A></FONT><BR>

<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dg15601_1">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_di15601_1">EXECUTIVE OFFICERS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_di15601_2">COMPENSATION DISCUSSION AND ANALYSIS</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk15601_1">Named Executive Officer Compensation Mix</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk15601_2">2017 Individual Goal Performance Measurement and Payout Levels</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk15601_3">2017 Cash Incentive Targets</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm15601_1">Financial Performance Goals (70% of Target Bonus Potential)</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm15601_2">Individual Performance Goals (30% of Target Bonus Potential)</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm15601_3">Financial Performance Goals (70% of Target Bonus Potential)</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm15601_4">Individual Performance Goals (30% of Target Bonus Potential)</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_do15601_1">Financial Performance Goals (70% of Target Bonus Potential)</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_do15601_2">Individual Performance Goals (30% of Target Bonus Potential)</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_do15601_3">2017 Long-Term Equity Incentive Awards</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_do15601_4">COMPENSATION COMMITTEE REPORT</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_do15601_5">COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dq15601_1">SUMMARY OF EXECUTIVE COMPENSATION</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dq15601_2">Summary Compensation Table</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dq15601_3">2017 Grants of Plan-Based Awards</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ds15601_1">Outstanding Equity Awards at December 31, 2017</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ds15601_2">2017 Option Exercises and Stock Vested</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ds15601_3">Pension Benefits</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ds15601_4">2017 Non-Qualified Deferred Compensation Table</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ds15601_5">Potential Payments upon Termination or Change-in-Control</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ds15601_6">PAY RATIO DISCLOSURE</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ds15601_7">RELATED PERSONS TRANSACTIONS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_ds15601_8">SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_du15601_1">AUDIT COMMITTEE REPORT</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dw15601_1">PROPOSAL NO. 2 ADVISORY VOTE ON EXECUTIVE COMPENSATION</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dw15601_2">PROPOSAL NO. 3 RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dy15601_1">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dy15601_2">STOCKHOLDER COMMUNICATIONS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dy15601_3">TIME FOR SUBMISSION OF STOCKHOLDER PROPOSALS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dy15601_4">OTHER MATTERS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dy15601_5">ANNUAL REPORT</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dy15601_6">VOTING PROXIES</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=CMATTI,SEQ=,EFW="2235152",CP="BRUKER CORPORATION",DN="1" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g28562bci001.gif
<DESCRIPTION>G28562BCI001.GIF
<TEXT>
begin 644 g28562bci001.gif
M1TE&.#=A\ ,7!7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M&\"/ ERX5#\(80!K3J%,>O#  P02A4EH@ *3< (U9=#_#Q,@HU0S^.>EBO
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M@!>HBH)(S $!?<@M#<"0 TD H 7HY:U $. )^O9#KBV8EQ,L\ E/"* .+$!
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M/Q-+JZZJ59X2 U>VC!SJ*1" GM1ZKP\K:#Q@H/6!0?MP ><VHIG7$#'_\PK
M @7,DCXT6J$#\:UD(IJC,@8B)1&#IS.F^9W]00%_@*,Z&@4@!@8-)0,@5@4
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M!:&].P@(E, $R+ !: L B# )'B (:EIUY;(&]]L/UI8$ N<!5Y<O-#"^.\
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MX 40D $OD 4T10- 4-2)/ ,R<-*)K'Y831!$H&H0H =LQP,%S!WDPP 3H*G
M$C2:N@5G(W!;@"Y!$X,"\:C&A /+X@(3@+,D\"N,,-@1L  HP _,.A 7P ;+
MXC-;(*D#<:$"Y]@!!U/[0M<3P :OX#,4#0#CA@,N,#D\Y0*O@)6@3062(SFC
M/3F2TX*+<@'\< $3X )_LB\3L 4!!]B_4BR<C0,^PT2),JLN.AX4L !.:P$R
M$ 1@0 49+#8-8PCQJ:< \*-CQ0/<=03C&W\$T0.2_X  3%!=GORG@% /">D!
ME/"/]NM:&5 #6V@U0$ $PTH0,]Q,$M9UMC?#5^4*^_4!$_ #KIP![Y0$4F
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M/&1B8[FS ?UP!+I24A)09^)"-Q0]9.-R!"ES!#RK "[0,/WP#W]69V:SUU!
M-1SP#]!=91!C0A061?D0 3Z6H6.C[!DJ /_PZTW$F^YAHVV& 'EP=:N#;"#
M U\ 2_AI!G=6TR/  _,@D/C 28@>"&4[3_)-Z6$0!8SP DKP BO NM7EW1H.
M""VP Q(@ 0+JR?%9WWK ;R< F0(! BA  $1@ XHN K#@"/*4 6(6!6!@ %@
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MSI O3:P8^$3EVQ,>U#+L2?!AQ\467@#\\ $ Q!\*R'8D^$3(@$4:DB@X(0#
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MK"0BF%*(0\902@@1R*#(*PLP^J0/?!-;8O%@M^>^>^_!7)2!+0I]<XPNJ%@
M!RVV^*>?AF U]1L86EUH"QPJT**""E2E/Z)) 5#30O*T  E81 +].T@"%@4!
M@T"$#1*00#L^]9 X[>,B"F@@1#AP!/\V;-!11]B@GJ@P$ R":B%0. (C!+$
M*K !(0O!% P*\#T:UM"&-\1A#G4X$G\AIWL4>,(7L, 7W.UP)-HS8A(O @$B
ME&!12H1B%*4H$E/=0U4060#T[D%".RF$@A<8" #$\#XOYLHB">@' @-%$2IL
MH% "8(,%EZ*  ZZI" 4\U0\6 B<2[.^-1X#! OY' 8HP0 )7C*$6J+$""$(0
M'XV40 6^D2A\=)$A6U"" A2P10F(@4T7(.0413E*4I;2E"A)PB165L,1]$$
M'EC=*64IQ19\99:WQ.7VGDB&+;#I!W-* #X89:=6 ?)_T-L"_6"EEB%T4@)C
M@*%"V%" 1?7_<DV2*AI%Z@B1(P@3 $I@0_L^=1 ._&DA%5C<$PUYQ4OA0 (%
M@&  GM#)228* - KR)HXT(4PTJF+]%OC$W,Y4((6U* '16A"OX=$A3;4H?TL
MP*H$,(8%L $&4& #.SE 0(O4B2$"B-3\.F@I<RID(A2Q)D2P61$)O/$@>"RA
M!D&Z*C/B;E$)L"1$@L"&(&B.@_V @1C(\D0)>&I-4*AH4G-ZD"-HP:%/A6I4
MI3I5JE;5JE?E%0,(62F)KJHA"3F"& HH*S:X[T]MDNA#'D(%4[4!@=B$'@#J
MJ$P\YE,A)3U"GAX"R K,4%?:-$A)NWH0+82/4BD=K$1A4($B8M6Q_Z6$P LR
M0H%]?"&N*"$D-21[PZ7L0P$%L)Q%\G&1?" 1!+!@2?2&$%J*@" 90QC""[2'
MCR\LCK8;^<807AM;7U'@&[M-QA=0Q5"0A#(!Q.U( AK;D22P%C251:Y'" G:
M,47W<M]X 02PJY%]3.DB GUL>*>X."M*] AI' ,($2B $5(D&4= H$M=M9 Q
ML*$-%5& "U;U0 ,B< QX/.2M'O)5B&BJ(@N,:6+O.H:3FBK "L:3%_^Q!3$L
M5[P73F(21+!<'?3!8E]" #L>((-XU; ')J  W5108HL(@1'>'4$$IE<1"O0!
M"D&P3!(.@=2"600!>(!!$':*M8HT@0.?^?\QP#*" "2TX\9!4$I'$-%CDB@"
M&5#P1!'>]H57>'<DEF!7<T:" ,2$1#L< 4$0>&!ACR2!';+3&9@HT8;H4B +
M,-B!O>+<+V28 "-1( 2&!0W%15%@#ZOJ!Q4$@1,<7( *T)RI (* 1P"DE'XP
MZ.*K\$0%"?03 %2@X$(N\,2!/)-5>!2?0OK4IS1>:B&O((.G\\'./<%W#//K
MX@8K$$J*W .QW-2G-%^@SD$7.X=H*AH9%KD4&I3@,A"0@*D4 ($50$"3]UA4
M >)J;6T#8 3-L3:E5E!%"D0;(^$^E0&L3>V,%& IR+Y'N><$ 600;4XKO@@%
M$/&#V@! " OP %C_*'"/)5VK(AW8CB*Z#)H,M"TQ8J9($R(P%J$LP :7]7'E
M\DW';2^2(ATP7=$*8"IK;_':;(Y!G.>MR7E+X$ 4&#E&4 >(RC3@'I>EQLTS
M H%X(P;:8S45FK37A!DL^W+F/E)OBH9T:RL >I_%>')XT( >: #:BXOYSLWM
M=$H!0 8V@)9%<@X],L\! H)!(@0*  $]^)D"C%P*$=9,E@*$'2.?E3:[C;UW
ME%Q6 :]8U18PDD]EFO'!,&3$-[X1 ?J!52 7N4#@)1O&?'PT(A(@Y#TR^"D8
MX*"%9UV(4,E"D51Y\5)BJ$ "$E"!(5S ]?\K- .HL7EI7D +"UCO!?3&_W?>
M?X^(+6#$)"(GA#Q) @0YZ(<4:/X#9'C $3Q !@=V0(,-V, "".@ IM:,!P$8
M A'\DE8*?8  )OS@"&#P(0!B4 :*M" ^*,B!]#%. 3SH!02+^4$R/3 '(H 4
M$&9Q!!8K&C' !R^! #&@!B:8GB0@@1$K@<11 "(Q$@K0 Q\Z.R2+F"+; 12X
M#!JH /N0C05HFJ6 @!/(*T9@ 0C(OB+8 2(XKS5(@D(0 /0CLRTH EB( #;8
M@#^8L8M0 9U1C =H@5<(@B*X@1;HAQ(P ";9 #"(#1IK@E?ZA@78 D\  R.I
M'@Z0$H/1 P%8@A\(@R@XA TH D*8!QSHF3K N/\FP($BW /*T(,-<((;&($\
ML8("B+[-L8TMB 0_$((^Z(<E*"(F\T(C@#\6G)PN\(0Q\ +P$HHQG+HFF P$
M6( 7R $!L(++DI9^0 $6B,)^T,%^Z)KHR3X>^ $3 )T-.((ZH !/$ !)4 !%
M'(.=P)+X4SXBH8T>[+U=! G9"X+]BK9I<[H$:*"O^B4 >((B,+U-TR8J:)57
MH8)LH@@<*"97V8 )$,8T 2M1@X";NB(*6H "H( O *$U>2##>C"P2C2*B"MI
MTY6XTKQ5T3VY<D:TXBC#XL5\W)5$6+,.R)XH  /9V8&RB(WZ4((<" <#D $G
M8($D"((UH$ 8S!< * 3_+OD# B "<4  \O :'D" (S@1&M@SKV$_S-"$'@"#
MZ^-(B_B!V. ++$ "GU"!A>F *:! /\"W/_,2O2$!7<P$,+B +E##%IB!)62"
M$Z&Q0A !*NB"0]" RVH"()@7", !#+ !+ZL("+C$NYH#:DB&I>@)Y7@ !$"G
M+)@!"A"$$^$+"2@$GZB'(O !"C@SC)",I1 0U:@" R "*& !!( ""] #M?PP
M&BL2!&"#@FD"+^"+Z7&$D11);X,!0! "O4B$"*B0?*$!HK&()J@"!=A(0,@"
MK$$ %&B )I*7L4@"AFP! Z'$Z?D$#=">%*@# H@!0UC""%" [S, "O2AHL":
M_R8H@9Z@C Q@@2BP 1]C R/I@=[0@[8Q@R?TEI? @#XP 1W0B\Y@ 1EX"150
M0MOHS4.(#2+@#R38#GTTSYT[L,C3)U6\@(IR(5>#DZ9BF<US%'Z@B (0!& 3
M ,&[' #X@/4Z@@O  9Y:KR? K\!2M2,PHPH@IG$2@#6BB "PDU #)->[@ H0
M _OJ@C;8']2;$PGXM2.(1K)XA3ZAGR>(NO-4493H$BSH **A  4T@D"( BEX
MMPRH@4/0B^LP $HD#8A\@@D8GW#@BP<@ DEXCJ6@A#R8!Q( "R)8@HN(@2BU
MC2EX38K( A8K"[T 2"S  R-1#@. CRV5&YFSC/M00/^+,(!WFY<?T\*\\+%"
M8 07> 4JB[@90(0=@!WC)"XR2T$#B"L=> 5!\ 0ZJ(HC0 '$G $$Z(,W^8<B
M>('J ( 4L(\LS8@?I(B*>8 .4)(1$(' 2(!)P)1^X("\*9H?8!<>!( C_00W
M<J.2O)P6<+N&@X /$ 3(80$0 )D,T$4 (#JR"$WN@Y,BX#]).+N@D$M-($JO
M<]7J\[+G(("J(PLP; $\Z8=^8#'RRYO$I(SFX--/J( ;&)%,18$5J$#;\#.+
MJ,FBZ;-RP8'H"P,9* $%J-8\Z8?RI(@NL<L? "=375$5Y:*T6A,X 3T.$+TA
MJ$9FI(@5L*9+,] Y,0!\@ +_#DB(4,.3-_J3!5 "EOI&.*(T%VB3O%*("S"5
M66,3-Z$@@C64@8C'-8D5TJ.U!XTY-OO7FN4(?E0 KB$+&:NZ_H@*2OP".-7.
MW72'Z3F!-="!!7",0@ "(@*0(J4,)^B/Z5$8+(E2@NR!56J"4:0(2=4!,/@)
M,-4-6>7-G#28%Z,Q)[6([OHX30"!!E@!!, !762[]"NR&?@8?I@"XTS1;C55
MN=""+VB!R: L?H "$]@,(@$$!5@DFSB1%*@"Z.F!R:!+.EB*=E$-H@&!.EB*
M#%""!?B":%L![2&2,'O2$KB.%: &!; [LC"#6=6,)1@"(6#(%(,%-;P(;O55
M33 1_\;5MB;:TD1I 4W0 Z(9 1Z(-J2KB!2XR,F=5D_<@9%S.1\C 2-!@);P
M"44004K%@A-8@%?XAN-\N!5 !N>$3L:Y$@HT@>5\+1*(USJ0EQU@7)V[CPPD
M$B5@@@>Q67W$'0IH@\%B-8;HAPWX!S80E,-;B&A\(H^ZE$B9E$51@ N -+2:
MJ?Z!@4EB@#DQ694Z*0@8@@40)PXFO7^Z*P*VV%:AH%<@BUE9$QS +[=RT ?]
MG_VE88_HDIR]$O*S +&@ #,H@2'H !$H@$-H&^T\%5X%@"Q8@^4< G[8@*;-
MBQ@PU@P@!%AH 2OHC,N THL8 3!(A@\(@OC ER>0 G]M ?\1 &)#P )4]3;=
MT /Y!4 !S->=I QW.94$( ,:0.,GL S>& (C"#0?:[B+*  EH "B,YG4X%,)
M:-WAO '8PBXB^(,A<(0CH(,H> 58^ [-V#"5&((G> 7']3;.!8#-N%0@7  A
MW Y/W<T%6 &7^&12)LPY4(0_N+?P^($]& )+F,B*L(8J^./(;($=@(4.* (C
ML88%T,S-M($AJ( %V.%)!N4&B %^Z0%@-@(G4&4 L E=YH<WM @0J$3GE4 9
MR)$G< ']C3@K*&8-$,\FYDN W*RB\1!8T ,-P()SA8^+^+<OG@03 ,YO,&9
M.%X?L 9I1D/0:($J]D>8]-<:[KW_\/FU:#HO$ST(4)QA3\(41WF3+K"($FJ3
MA(!0.N$IBFVUD V5(& KBVC9<?)H_"*!3S$G-AB(TM-//;F5/MF".5& 7]L
M%V8I$%990Z%9B*YA!!"!!\B"V*" J$$$T>P &""$%0@-(]&!0(. A?N *4"
M+H"!">B"$'#1*A""0$L"08 "0HC +1R!D:2 #X""/0B:'K""#H@ N\T6'A #
MSBV>Q+B6A?P"ND&$7O:QA=,;=[@,2G ',J@7-B!-LJ !*&NL%//7]BCE$['L
M1'B)'B"RK-06(=L6:J !**@#?MB83V #?#& $2"!KHQL'LBNH%F2$H">3R#L
MBB "+[C<_R[K ;6,LBX3[2"H@GG.'3"(CNF1@<FP&S:85XSH@2#8@W2.@D)X
MF"VX3B?HU;#8 V1@A,\P C;($:^;C*IA@SH(BA- RBC0EJG.-Q=8@J<NFBX
MBR=([;.YB)9A[FFS:RU@"[;KSDS5 R@P'<H& $NP6]0FA"X( TJX,D7C:F3
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M$"A\Q_=K)_B"-_B#1_A;^G5RE\;O(G?_0@JC%O\3&!C1@7=XE$*AA6 #+9"
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M@=H9"$$*\N"X=W_ 4%RBAB#X1 $]%,XC(R"!%O@!!@"+@1]'D*<'BM5L,9S
M [6A'I)^&^&$47@!2IBV& IA<F1,#@&,0&D=GB (>)3G$[@#<$GT(+@D\*T#
M(A"#M[' A-L>T2,Z8$,#0;" /7R"#9I(0@3V8(0@''I+$;B!(P1$C6.+@013
MZ$$5DM$!*XQK#T]PP11B(((A\.,/IM."&#(0+.$M8 HZV/*YUC"""&CA"3C
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M# [N+/^$"@@.$3Z B3#"'M23)6A)J\C6"3!",MB! 21,N$E$! * )7!.$H@
M0YP &]A! U"  @+ "V:AZS#!].@ ,O# C:3@#AC!3BE$U=5!!4A?]_T@ &"!
M$; !(;2/$""#42$1&8J #U" #AS"(6Y%%Y0 "!RA$6@)+!S@WBG$-V0$=A"$
M S)"AWS"'G0 "HB;G'T &_P!KU0B!0A""9"! 8(B6+R?"%Q.%(@A%*T!!=R?
M!O!#)CX?, :C<B@ &^0,#N %^.W'S\A1H^7,!21 !;0(%+"!>&0'RBC ! C
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MX0FL@0$>P0\Z3+2\C06T ",4+:1(P0\0@A < @Q(IQKZ;03XP;8@+9@U 0I
MP11\0@Z P18LP1(MR<!X!"+<+),,T6]V_RP%($(.P, KF"KU;, M;1T,2$%D
M]D46@(@(8$$&; $8- #IU@$!"%<0C(&A3(B.D*$'9$M,'2T,.%031,#-ME^)
M%,+?K@$"G%,K1NT.O K%, DF>0 ^,,$AV)T>C($@*D /""\,=- .A16(Y L
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M@+--P!&.E4PC,EPCFR#L  4PP0W<T )5004(@JID 0]HP0]XP7OYP0ECB B
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M0 I[:(_F#- #*Y0$#R09 0^HX82!X.,%(_C<";I'AX38!012: D-VD:4"!B
M!GH$ !'_K( 6 U  $^$X9 D 0(T?$&"+E;3D)3&924U^+0F,4$ '+$,!)E@
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MA$P6?0,B>,#_ ""  B!4H$YJ(&$/;!@* B8!B":4(8@RCN\>2+"G*+"A=",
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M=[EO,=>1S$'W# & %ARF!X8@0!;BV82[O+>%.X4(CYV>ZBCCP0L_@6,?9H
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M(3V LR B"39OEGK#S/"! VHI)[@ !2+@,C]BUH3+U_3N+G1 "DY@C>I!"D@
M$%H@\B9!!)*K'CR@T$:@-R$BY0C I8#H+2FD"29QC_J!)(R@#X+1#@P@"M[/
M18K !Y!@2%AH?;C 13A@,VB  TCBGHH@FI+ .4>DP"" "_)NU&# 62"@ X0$
M#/: C8K@(E+ $W!S2'(.0BB@'OH!-67 .0L, *(@!P2@#EHB"IQ3! I-(;1/
M  YC(C8 #,*S"3; "=QD,Y%! )R@-WI@$KIS*?^TCP.40B<\(42-\P3K3B\-
MJ0D@0>>L8 \7TPL0@=@$3SY^0!-B &1H+09*"AE\+OI^[8<B(@J@P (*X7LR
MX 9(X DVSG%H@*3>[C5;8M8\PAH\X!,,@7,.K A@CS]IX")'K0]$H LB 1 @
M0 ]HE-AZH$SWH!!@20<.@0/6* 9<9!)5P$7RKP>*@ J M$%3-$)&@ -""1GR
MK@<X@!$F0! V0!+48@*.P ,FH U.S0,N  =2BW.X0%)? 1G DP*X8-[JX0C
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M->.+#0JG"$3)C?[IU2*""[P@"C0Q(60 '@;"I4R  K*@#H0 "LQM#"0A!?Y
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MD7+@[7Y3KRD7!J# CTHB VB8!HY 9Q"T)/I@B@4N@B')X:"@'0@! C)@#7Y
M#!RW*O[>U<8 "H[@T<?."O#A-',JD>KIVVH9$)Q-".I #X! !]*- OI@A_ X
M]HG]\]$__5%.Y:A!SV0 "J952Z/S[UVBRCZBYC=S\_1.M,$>:PNAZ@&"0B$@
M  HB6*"DQ0))!6/8,  @"11  L,5O @@RI$(6XH  J"B#K(U /]&%(%8L(<D
M!&Q( ')DR$ 4)Q9ZV,"(,Z?.G3Q[^OP)-*C0H42+&CV*-*G2G13N82RP-&I/
M" JD#E5 YB=5JUR)-JT*H6O0L%097*WJDX)9H6&;HA1KM*H"!65U4LM:D )6
MG-0D^ 4K804%N(0+&SZ,>.@(#Q:(\+ P(L@-M(@,*>C $ "%#G1V<IF!4T<$
M%IIS:,))Q$96!*8!8(G(9@H LS+^$(@A #2 +$L*C@!C 0&3CSB;5*G +\CI
M;D5L5%41$VT'+Q2X%+% P_*))08P9\6;.+SX\>3+(Z:PH$%!"#]()QY!DB@1
M*SL1$4>:Y ;XBR=D^QS!PUM*?>(>3PC_[ %7!VM0L,=^B4%0P0-1\(!64"IH
ML!9/(_@'E $CV$-!>^;I="!(&B" @WHX0: 'ARS>5U F&_3#P1P ]' $##LX
M.&*//O[8%00G0/&'#PC@(4"22Y"!@!X1B( 2!(680.)P&&62Y"-8(!")!<71
M5Y(G20K@A0QB)@E$#_1%P<%'%&2@&PU_>!@) 3A% 0-I H$V @<D4=#"F!XH
MD0&5'028Q"']H, "!4@F^1"0DDY*::5+(9#! WG]H")B3<P@(% Q2)(A1@HJ
M)4,=.5%PPFD^R1!@5"^^VAMA$X:*6!1_: H7!)_BRM,)(5@Z$TH(N./E110D
MH0<,5 ( 0K//_ZYG1H$CS F )3!:RFVWE;YVD5D\8C1N0>!B!-%@ (35DUD5
M@H42KNP6%"^PX99Z458,J'N1 <"&18:]W@Y,<,&)O:DB>RPDD4$_4O@ @ Z'
M"& %KQ<QNT$1.RAP @Y]%'%#$G5H&D4=X(TP(Q#,<@ &11G(EH04!B2!# <C
M.X;,$82\%4/&FNB00S\B-! %"8((P(-Z0@1=PGX43$(Q-5ULX,1'EDQ!P0<?
MAT &@"WT4\(#(Z @2#]6D$&!$4<4L8<!/?QQ" <E&$ !#6O?@%,/ A3!@L3_
MU-$I *Q1W 4.,,SQ21 "M%STT4DCT$'&<U"@QP63@/$%'B!O=@,72/^?+$)6
MB)RHQ^*3TX#AFX!D,0$'K@J^@*8CB*# )V-P0 4UA0A@" 954/.#($>T''$.
M15Q0Q7ZC(T#"%L/[0$$6&8>@@P#]:"*((!YHX82F-%"'R-8R;. GI]1T(( 3
M-M* 0@X<: !M#@+\4:!FTPE.0@,=3#")!U_L-P+51"\$UF"$HD0@@=V5005T
M0%'@ /"$+^B!2A2(X 0%]P.*U,$?6E@! #Z1F0L)S& D+*$)3XC"%*IPA4&*
MW:8:D(424.,):SC(%R1@!$+@!!&3D8$4+-"",B@A-1R3#0TL<A%?T0$+'=B!
M!!#A'#Q0*0I@,$ &=H"/Z<0 ##[XQ@(*!('_%H0@"0N80P$ZH $,!"$$U- #
M$$"PA1=(X 0$P0@1=D4#)U[+ DWX&0J4@ \] $(&19B#!/2PAA'  !!)8(,/
M$/$')6" #2;H 1AJ  *:?$($*\# %NJ'@$)H @$_N($$: "FBR""!V1H@156
M0 U+*$$"'0@$!B8!A *X$58*  $A!&(%:C3!!H^DD(("J("W4 !90II"$S2P
M DC"$'ZJ:T(9)( 1!IR 2D8(P0BD(,<,)%(*1+,!-9 0" DT824_F ,^@H@1
M"EP( 7W800&:0 <J*@$$>SB?%[# !0U08S$0^1X(F%"#$3CA!4WP O#X*$-8
MT*0)/'B!$'[8 H=^_\!&&#$#WIC7@!8L00F( (/% ""#F #@!#,@@D<PD,'?
M/* ')\*!!W%"N6G-"@!5B<(D<+"%(J6*;IAAH5&/JA,9L($-*)B# 90*!1Q\
M! )&6( =/(@ (["!$%6A02!0B@+L[. B44"!>I*P!26,I"10\@DI/_*)'3C"
M"A"1@0A.>A$0O")9T'H%KQ#A JE>1 >OR$H%!<%5I"IVL8I%V'I^8 %$L($1
M>U! /8X !3:,0:5)_ 8_!%$$_8V5 B2P@ PVEH$'9F(&!U$1'GSP,FCQ@!I0
M4 \"5D $<6BF12 8PA>ZLP89U"H1?_@&"31U(41@5K-+PL@(ZJ  /(R!#?]!
M\$@7II"%,01!LW08014*,A\ 0:0#FOA402ZDIGU-L 7:A<(1=+.>"3X7(DF(
MP$E'T)N,%H0:'ZA 'ZP0!2EHBJ8P!0,5!-,B  BA!!1 P,A:$(XHV "O*@@!
M E"@ ,@6Q QSH %#WN2#9^9D!"6 @ M\P,""(*(.2=C5A(#W$0F7#"(ZJ)4J
M2R <]<C "J0$0QM> (!/O8DD2?! 07> B#(41 )8R,)87YN!,*RK!9KP\&[#
MT(,@H$ _.#&#%S3#! N8(3X9J-\(5)J%$,A R0#H0(0#="$(I"@G#+A@7NR<
M%R4T9 <(Z (,%H ,#8R0L83N5B9L,(0..&>80RC_!(6, XL?:. R=8!%#N@@
MD!WHX&$0P$,= 7!.36Q& TGP!%VM_)\-?+D%0%"H!9)  @XE40@_,#)/EZ92
M1$CA"TTP!!D@\(3_0F250SC$EPN-[&0/[$WN08" H<4/-BSA-T.H=@ $9 04
M[.$#3O!!!V0CG."\0@BJ*LX=#N)!"&0 MA]1*#6<H!X(X)8^JM-#$,BIH!H7
M9$()L(V)B#V$;P 9(SM60 ;V4.TA<*S#5JCV-QH@@^\"@ @E$&^;UT#'\]*!
MI@7) "!:$(B$WS2^@'BNG2B1!SL-5LFLCD@&)E !/4@" _X681(J@ QX>WSB
M\$L"#A1@!DW<"B<(>,4G_PB!!1%1P Q32/%;\9D3.0LA=#TX-L7Q$3L)4^.+
M);$!?K.R9IPPT-F:$D)O^(N,EC4!"&^R1T:< !%\(J)6!5! %F80H@:L6S,0
MSL*7U2UE$/ C!R6(IY,%YX2$D+E^]7C(9EI:*P45BZ;'XJNR6J!306)$WBHN
M@0(D(' CX$W9I.<6Y;ZLZQ7HH3,]X($0\@0 &O  $:,)<AT*0 (JN$1P$\%(
M$ZRPRJY!P3DM@"]/5!"!*H1H"@@X!!! KA-$+( -8)(^&S+SC8\XXA$&H $C
M@O#EZEBD"=PIO?G/;YX3E$ "!3""JGBX A!((<,WN <BAJ4L/=R &C0([:E(
MZ_\EG\ (QA<C.P !311-8$ &'4 (IZ0E+>!$-% "\U$0>N '&"$LE-!.YS-S
M4F G*B )4;  -_0)HW<1U[("$B@!^- &#] ?,L (+U  _/ "(Q )-S02W@41
M+; &D/0",*4)')=3,5 '2I $EE _;R)JI71*52 @ 60 Q5<2C+ "^) #5D!S
M'R@)_.07[:%Y,E!X"/ 'E[$&20 &#T0!EL (LM$$); "F\8"L!)-,! &#:43
M60 #)*%0+\ P(5  [3$AK5429< >AF0&;'81GW B/X125I (#:A+<]!0ZF8C
M"# 15N@%B8!0^)!!3L8>%G "G*0#-)$)X5=F1C '"H#_"$Z($3W 28YP':X4
M33QP4@BP4"#0!S.P8P71 3,0,Q8P=G.6$X62?\^"%2*H!-1P FL08'+D O6#
M?M%('@B !&"  PL "*RA";JC 480*4U0!R? 9K\W D=P!&#B0Y:G2%) &BH@
M C_P!3\P+4QQ H00 ?@0 5[2!# 0*SE!#0H@A0!0=YCP:=#R \-2 *0D&Q"
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M0"7F!89G2;V:@0?]0/^UEF$W8!#(BCH&&@,0 ! $T4"M P<P@ !D, $ 1!4
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M:C.C3)J"4UU68&'1<HYW;O^ZZ[;[;AQ!8$0/ :I08 0>^K B"3TV*&(."LP
M H L@#C!*P@R>'*?0@2PH8'F-N" 2D$$*6(*1";Q0!!)EJ/ "07TV,*3(FZH
M*%<<;BIIA!P$*&(&! I9_?.[$+O !M%@DTD+!BBP9 @V!+&\ 0H^Z4. L&2(
MH'*_*\I"DZH%T:Z/?E!H ($ W:H#4QF>ATLNVW?(%1 BZ#BU^4D$2"@)$I"1
MGWE$CO! #SJ6:\)VWPAB V"H"2*>%Y@11. 034H*!9!@.P48P1,<( 09K%6K
M[W7 <"&(PBM68@V-?&(-$2&" /H!B!;@0'_O&<$/[E<114CA 2U  ?>>4KXF
M*:'_!0+P@"-J2(@,%.8J"FB.Y:CQ0!OT@$J'82 "H&"_HD! @T4(P:#P=D4L
M9E&+6[1(/2*AF0[0801%L  6[".<"&#N!X!Q2XRB\!%:M< +N=+ $[X@'"<\
M !FE2P0)OK?'BB" "19H@14,( -?1003QR*"T#Y0$R)T!@\TBX$5J/$#/U"@
M"3:H2!),-(*,)&$'E)@$MW0%R@=0X 1 D$$1?! Y:@$@!1\!@0CPP8:VG$ 2
MU#B$:Y:R' 1$@@4(R, :/O$" ,A :!TP 1&HA+$*:*0)DHC") K3 2^ X <6
M0  7:$8KH#C1*[H:C@4HT ,ZI* (W+I:18;S $2F$ADS_W@+ MP102L @!),
M  0_AKF%]UBB@2W0! 4*$1L56,%9+S" $. (@"0LX %-X $!D&:!0F#O"2](
M@A0L@ @PF#.CPN%!ZF+3 @W,D@#H%*1":% '!!SA/1W8P0B EP0MC(J+.^5I
M3WVZIQ14824C$$$*#&$ 9R%)#]A3P9&JY@(6]&!=]",/&2CP@0L<@HPM6)P,
M\@F &!R+5DZ@1CN!I1--+FXQ"/A %]@ AA5DP%M7\<A*HI#(J#2 'Q7X@AV!
M!94>[" &'#A"$39@!2%@93>+JTA(5! "&< Q$7^0 %#$)QJ;WHP"U,#J(3RP
M@@Y,868K2@(_)C )2'14(P=#Q/\S:= _<'[O65^Q0OZ.<-LRI( '&E&B._]
M@";LB@A6N. "4N>MW7CA&W.HQQ[V$(78K*P%)MC,>^@* \(65E@0S4@3[E U
MH/0 !E+8PP,N^0 BU"$KQ80H(_!! B19Y;>?T, O]2D%:D1"(ZW-W1A>(:"?
M!EC  R8PET9@G61:P:9(W0)Y,L"M$T1@A%'9 U0#N8"V(. %)Q"!&,00"0OH
M87$Z@*.L7L<$)>CA/0B( *<ZL+@H/,L,=A #(FQ C0<+QP88<,R"*P("+;"#
M$E0@U\<,8  C! (159  /B2P ADL(2(O-LP><."#>DC9+2BXI&O2BUE#K*0
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M-5N!W1H P0*BJ@$(_ #;'5"H#%]#S5=\X>" 0$"BJ/UYT(=>] T"G%MC4V@
M4.,$0>"!#Q#P"I$(CP(M<)U%%-&!(MCA =_( 0S:X'A61XD-C+!$= 7B#FIT
M02$8,=WU!!(N1 0!#%1@Q HL_$:^(/_#"17X:D5TH)$GF)O.GZ"($ X!@YSH
M8%;\F'!%6K K;:)?+#G@@1C"\N-#0&$O0@@"%*C0X"P A!'XIJH1+RGH@A+
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M(C@"#D@-&>@'T#D"Y%)(G_Q)9U1)*DF"/I@C/+@<F3"2%S&HC:D:)("$ :$
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MS7[@ :4A2O+4IS[8 03P!#I0R1U0@>*\B!Q0,)TD@@V@S;J$42W=4DRD@ 2
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MDG U"Q""F?;&3R $%5"KC(B2"/!L$EB#$\">.P. D/CFV,:!L^.'*:CMJLD
M?,B "PR$#D !P80'8-J#)*B &QB!.0 !-A#1'&@_9O^*"B7]A!]@ WAX@(H%
M.P0@ >3.:8,N[P2N VIH@R>8@_8)FD&39&<J#BF !3]FB6;M O@JZR1VB(\F
M#@2P,('(@"\@,R!H&J2ZY"V "HZHB"YH"Z_"N/>6&2<F@3:@ BIX523^@)(0
MA S[ Z%&*AQH ))X'9@0B%>8LZQ0M62*D1& @NCJ@1NXYHHP ^RIF@X( 0E
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MH(,E(L*)>MC#$!*U2G^PXU5A:((5$@!*39(2!K&JR *2(01"+,J"*$C $WB
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MDAAHH%N'^@0'49 4&IRF)!YAE)Z3@AU@=6L/8JC EWP'&6Q9 -7N*H%NDZ*
M'M1!SF^!P#[X$4@%X.,#6_B"&<*@7 !88P<@( 0#*+#FZ+X3(B,8+JX@L 7[
M(& !,W&!!6A G5M5Y*\9 $0!3C"#P_9E> <<\0U.6Q$2**$^\YM!661MHH9@
MV#V2RZ<7[E>!%?PS_P8BB+,6:EBO'E"1 @H(]*B'D(0J&"!<@,B$),3P@1M
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M2GQ"&WSB'C0B%4C 1Q#.#M! .!A *3Y+ 13%/93$$R0BG6!'>.C 'F  ("#
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M,_/#%^R#-Y]B;$  +$"CGJ#D3L"AGE0 %9": CC+,5'#$X@8-8B!6(B! AB
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M9,#=$!;"&C3!:#G8-/5%$."3]4C!-LK&TW' %&3!$> * C#!(: 0!7!!7M*
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M0")DNDYGP)W#@ (@0V>U]IM00@[LMC7<MFT@ PY(@0>J2GPO@A3\!!<X%@5
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M/ 5 8+.3?4 2'ON-SE#C"9T%  C*!P!\%/<AM-WL"AB #S%0EFV;E<!:"Y
M)%+@&RO KAA>4*A]'(4"^YCN9ENKVM%"5[&;30 9<%N!\C;WN:7=K!(, ($$
M#,&Z2"Q U5)KV-?8U[\!%O" "5Q@ P^670!HJA5Z<(0%//@[2(#"@Q<0F3$L
MP"?_.NW" H+ @0@L8 Y-@&D3@G:"#O^!!1]<P!9@D$B4'.'#?6"0BG\ !A9X
M9,5!L $^?K  3WB #7^ 2A".  ;-@" \A[ Q%PSQ@)IX8:Z F<2''SP'&<
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M41IQX^(,  3FI4*F G<,Q0\,0 $< H@&\?*08L2"0P4N[UJF_\)9[(?8J.)
M%. K*)&4]@50,G$M,,;-)*&63HHY*& HJBUD(") 7L0'4C$74:3V$@$*]$,(
MP(#+&*0 6$<>:8 >\:*#2,* ,*!#&( !*, :=D2=)@>+HH K>N"?EJ,$<D(3
M** '/JH%EJ!0ZJ$BIY$F:](F;W(:V8X@BF HB,(##(4H!" <-D$00X,0,2\X
MXLXK0H(#_  !]. (((V6'''J#N'1^C ENJ(0]A#9'J()8L*;0C$(T$)#A ,)
MJBWY. )'?&*J/L$0:.0(QBX?'Z('DJGZ^D66%B,%GB,O]/$*CRT+P. ;/($H
MBL ':""9&E$&@B "UN^I) 8 ZF&6@O\@)/1). JA)XH@;W"2,SO3,S^SXK!C
M[Y!(L/:.(TPS- 0KRAYBK@2+&B0 -4_3,R1  CQC:QZBU0P@RB  'T;/ "J0
M(U;S?O:A_TA# ?(!00J@ '!3-+ #.QS"-%]3L"" .%F3)AXB^BC@-2$ -+O3
M.[\3/,-3/,>3/,O3/,\3/=-S-(8 PQ@)PTB E^(3P]KS-@%  N93/O,3/ZF
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M+^QW=^.7']8*>E/7]!ZT>X-W=I%W@'&7"APV\OZ7?]?J@$.75/>!"@YX>3]
M@/^W<OE!@1\X@[G3;N0W=D=O:<T7A-V7@\WW>TD8>\_W93'8?%?W'C)+?\.7
M5#\ A#,W4"DW?%7_=X+Q=R"&P(4O]V4G^'9YV'6IP'IEV(6UMW7C]X&U@",4
M@(AW>'5)%U15&'K[ER9N6'@Y8A^6> ^.EX*=6#W+V(S/&(W36(W7F(W;V(W?
M&([C6([GF([KV([O&(_SF(XAX -ZMY54EQ^HH'-4-W/M* FTH$'"JPLN(!DV
MX@-DBP*>8'0 Y0.\YI!;*1D4X EZ%PD1X -Z^"B2X')7=Y"?MP*^ !;L10<
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ME4: !^IO(FPH;P0;4&2%"'@ "6,H*+:/'/?R),JM!42"E&BZ3I# =*( ,@"
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M@B[JH)T[  RH8 (F80>L;E)Z8P;HQR?  &J\R&&XX,X9!S^T+P3\A5G(J3\
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MP  ']D ]1H8Q\& HR7"9; _$ 3$X,@'45<AUB( 1]/] Z<(0_NB !ERA (*
M'V R[M0B$R"3U@=07HX ]$&_?JRA^I+@"%2M)D(?DYXJ]#5]-)H*],>@" @!
M=YH@]->/,3I ]!VN!5R?):P@"0HA>YJ@$44#!/"  XX@TG(( KB KE']]J?J
M=$)?"GQI- PE]&$*$8CL"#S ^D'#V5:?)6 J)YJ1[!B<(Y*@#T+_/88/]&&
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MS  ;$H88:I,00-[0$YI6/"$(6GN!,(D-7WQPQ!(B"5"$#T\:AQ%P"U&20VX
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M++1P!P5$> )==$A(EE@DZ<E&@1!][/ N#7=)@ @8T=8:B*$(,!$"-3T4NAP
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MT'=181.TKAF7$?1C"QX Q/LL@!%Q8)4SA0"#'CQ P9645!(0:,,#5+#53VR
M$$- !/%\50)D#6$%-3QKR<Y75Y54]!5#8*H4BW!4C%0AH]?TP"&VQX5"^0JP
MR$)LO.[SU:86PA# <A($\,"#,6@  WU(SIS^$J;&,N19K-H7'VD0I(R #@^/
M(&K&-H:L #  9,G,P2P/>B$(2):Y8B$##0?Z7(5D%0#5Q1 %$%LA!4P7NN -
MKWC'2][=]: (C_2K -8+48+48UR&&L'_(=;K!&M&A0(9X  CMC &/+6 O1P@
M! /NFI#I\!$ /6@O0:K7CR9."'A6V<T1O)# ^0'X<\_J3088."$:F$DAB4#&
M!E0ESZ)2UE<*1<01-$%"7F4LN%*Q8'R\^+5(=7##1$T4B_L!BR[Q(X6CRFKR
M!*#0#B+!"B-90Q,,08;[L5< /*S'B-EK&U\-81*2:,(C+JB7*,S786;Q,'A*
M"IP1N  '.S# ^9ZP@37@P0I9G/)ZDY/!^_AJB]*:!!W^14 \+.%9/2[/"? $
M #-L=2\G^+!6'[ O&RB "TP>T1B)^KPGWZK08WVQ;<O+Z4Y[^M.@#K6H1\U<
M%OD.>)J2@8(E_ZH2"'QB#$[@<EC1P0$4;*$-K%I@^!!R$6K1$*65*D@?&ARU
MAAB/0BRR!T,HD 4S40,)YSH2!ZAPA,$1!$E^TNVF;TO99>/MT.GC0 ALI1M;
MO4!4#UHM/(C:1R*.EB"(R&%>($"_5IZX'V'@K7/8.@G@V$O;>>("#P0!!1NT
M ((NV8$"T.2:Y'F! 1  0$)\%88F0,$YVV8( IXP";J2M;*32(H0%K !"#8!
M'@W@ CQR4 4#6$/<$(\HC8$58;$DR@\W/==JK:"T*N1-BASX"_TR/MG< HD
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M=WX#9EU#<HD 70 (N([I74$-1L &_R*P!STA U9>!UFN$I^ #*6.%T+@YSC
M*BH@ LCPT<QGYW@. %V Z5N@Z^YP'8C UA$N(A*@K1;=:7G\!0E0U^&^S4HC
M J8N T%@!_P0"8 0!5# "(99(4VP!(8W!$5P)5Z  &S@!T+0/R]P?%0P: T0
M;SO0!46@ ":X!UW@ 2M !%*@ &8 #UK0!_)S7SF  E1P Q,N A4@$**"[YY)
M V50'(B!( # .1X2!57PBS_@)S3P."M1#R+P"5!P RZ0%?@'1GK0&PBP!2'4
M 6N0U#'1 A"1!<F1!%* *QU@,&90@H&N$K))!B/  V1@!$$1!;/4 T$N15U!
M!#TR DG!&O^;L3@0,%TJX"7P@M4@$!(R8$FWF10+51-)[9Q2@4E1@ )-UB/P
M!!X=T(\9$-@]@/-180V@I]2?T"-$<"X,X+3U_ (,T ,]@@Q!802VT00S,!==
MO>X>PN">IL<:+?K-_(J,( ASP#J(?0<I  ,53B&(P .PD ?ST <LP 13H(-A
MX#,N(@3U0PF1$ 8M0P")@!4MH/>38 *4+0$Y("DUO6D9$P$XL >(P$<ML 08
MT/R<\0,AX#-=T0.C+3<=,N71,TLC\ <OO6Q_T 5=<.4JI=0$,?3[=QU9D/0H
M<!TGH GXA1D \:,!  @M  &@D($%@!%U #R$&#&)"T;(X#WH,8/_H0T# #Z$
M@-A%$T,K &@$>DB##H 64R("4*$!8KTZ'1&VT&3&Y<N7*6HB;!+NH4Z>$9O,
M,+(#0*8[#X\^[&#B89)).'!L*6&S*  B(CHB<-)QQ!\#1$INC:AC"Z,?2P#H
M\0'@D](4/+[](8!6[UZ^??W^!1Q8\&#"A05+"!#@A6'&?/=]^5:@\63*E2U?
MQIQ9\V;.G"GED,H24D=DDJ) 60@X"IL);KGL@6(! 1L3%)",)/+( ((B+SYQ
M3,)!"1ZE%'+,L"9%0HZ1,6P\0$L!CT8 /0QU;%)%")/4#T=X&A/D",<>90!P
M =DX2A7HE)A8D&M%*\\68/RQ.4M!RL"'_WH.(EP OBS60  %^$YPJ0.-$,B#
MOZCZ<TD&M]#J0"D0GNM!IA$XJDZIATX8J9Z2S#* @A;6>,N/EU20Q*8HEB #
M(AG^X $ZO5ZTL8<2$,K@OZU 6&"!@50H"0(]5 1 D)TH$!* ))*9CR<2$>(.
M !EJFE(O"I@X"!&WX)++PPR0\:(S,\]$,\W+$ L@ 34!4R"!Q"1XLTX[[\0S
M3SWQ3 2TAWIPH@&J- &A'?@ 0X")=LIL8HPRR$ @AS!L X(K,':+!!#G#$BB
MMR9L(&"$(U@@XH\5"BFI/AN+DHZZ$3B8- <Z,(C-*$.&@(4?#P I[[Q*&ZLK
MK^I0F  %_K:B@?\'!7ZXX2$$!()(!49> 02"# XD$(<5   1@"A^F$"0]"@P
MX[\1%KC@!_FVHN"3!:@0!(P'1H@@W27$(@&'9KN(L"0$S!!!$*_>\O%/F9S]
M 0="ONJCS+T0R$!A2#-X19"%HXR( DS6I4"/BA=^")$%7OF" 2+076 GM*P1
M 2*1+T#A(+/XHJ #'"[8H@H MEAHKI ].'9/H8<FNJ]\OFFSZ)?D3$ RI9^&
M.FJIIQZ,DCY"0P 9&,:H@XPHI.CNKQ;Z09$( 20!8#:IFN!  R$>(2"13!'1
M+8HB6$CBD"-@*,%D91'9FPT;MF5WNH<H.&%O'BQ(@8ECGW48@3YVZ,'_E?-F
MP'@P!2+")X'-]8* # H4B/&A>U[*QW, 3D<H1M85L"E.)2*"':("$ECA<W93
M5V"%C@KX0H%5)5 ]](<^AV"?%THG_24(5@4@3L(I^.'0O2!(@,[HO_$A\Y>:
M/_Z;%[2B(/72\PF@ >\AHH#PAXB?7G<MOU%"@<TA8 "ASXG(BFK__^<,FQ8#
M-0:\X!M?<!H %;A !C8P,Q20@%84<,".4&" @:%& F*$/1OAXW!#D,WL+ @
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ML(<<;_#1$7F"(!;0K)U* ?_3SL.$'Y 1A@SXH+THH,(A*I4$U$($ <7=0EP
M8Z*NDFLDM(;)P?8R AC@(%ZIR8*$$=!T99?]?4@C=M'"646SM]WME9&!!PS0
M!(LB(!*!!0.2*6,B2=BF3'1[L9;5TX\(1*!9,B@"&S3RJ1BY]@7X($$8/O4
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M0( +N(!7T,D=*!%M9 @7L -.X?\'?2DY$:B ">"/>L"!G_P+&W.!5W#*R2@
MK="!&SBIR>!&PZ  =GB<3A0VV^E(S8" "J#)B%@YJY2!9 2,Z=L"H^1#W?D
M>UQ)<P)%2TH,MNO+P21,!GK!S&@!$8 %C[HG:W290/"9QI@]LC2"8^D J[P1
M$2B=/#.3L=,[O: &+"R*[$/+O;@2)1A%GN@6A "3PO1+*)*B-DE-UZ3-VE0:
M(Z#$R6B!B7L(G_2(Q2@ ?KB /8B1). '%[B!W:@ X4S.)+ $)V@#G@.!.0 D
MT#&"H8R+I;J -A@(:N"'-A"$L^")Z;1)"]"!C[L!?D"!9OD&?K@^@O@ -A"!
MF22(+AC_SM)DB"YP BHXB!&H DNH2H00@E=H [KDB0\0@PFX/@CX .A !$!(
M BJX #%XA1<8NS:X@.1T$OODN0\8@JSDC\@\N0FX !_AEX?AAU<@3AO3 RF@
M@HP\G _X 8B#C@S8 P7=' 2PA.%\RY%D@ZT!TC$(TB$5TB(ETB,UTB0ETB(0
M \:8)),4&G2$C'6TS2JUTCP!Q\O 1RIX42OA 400/07H@!#8ARZ8@XX) 0G0
M@QED S+- #^ @'-Y 40BB+U !$+ AQYPBR98@B\X ;2ID'W0@SU\B1$0@>2:
M@JB0 3#0@F]H%@@ @1^0+PHH@ R8@_L94WSH@K6D'43@@?JQ_Q(/^ )$N+2Q
MJ $A\+>+*X022  ]6(.$.) 9D $G, (/H $KH 8VV(%]*(0IH 97!8$>,9$J
M&((G6 C$V0D$H+<G6$H(0PF]J!!\.($=+  :J -0W8H"&%/M0081P(<.*),Q
M+5,)LTT8$(!S1==T5==U9==V===T_0 G#0!OBLUOF$W H(;'"S4)4( (^@L%
MP(<7$,;"X->_*  )Z$1JR =^U0J&]3 (\-<%D@!\V-<8H8:"+3,)<-@KG9H6
MT( GN+&4V!4G\3F"\!HFH#D]T "I&I*4FRH;A 4M$(3K\#*24#*N$$]6>@4C
MP $[< ?&^37VN3>(N,Q4HH+C[*FBX/^ITM$!MQ!""TB6Y20!JZ2 H>L0+'"'
MA3@*XQL!5\@S10@0F* #EJ."/="#E3"YC>J1C6+#/3B6AE@?ZAF(4\J++$&+
M$X"U_I"*N8" /G"Y#E"^*C77=R7<PC7<<ZT >:6DJ*FA?Q),P*"!#4#7*N@!
MB_(+/A, #H !3OT+". "WM021 B"W!NF3!" (^"!\4$(9, <PCC8+!H!#^C1
MS=@_ U U"N " >B'#0"XU(,!'FB 9]H B7Q&CAV:W<R8#A N *"$'\B+BR6N
M.7"I%P FZ,BR?IM=DT !+1""ZQ )AG (:)&!';FJ[5T G8';B" EB/"/AW /
MZ96HK> IFY#_ 1C$ 05H BLXH&0H308 OAX( 5@U@ X  AFH@I"SAA(H '^+
MB;$8@B$0@H%H@J'R.(A0!%CH@I*UDIKPGD2!CZ_I"!4@7[U8S8[IF1U(E#EX
M8!AU31@X@B/XAQ>6X1FFX1JVX1NVX71M4L/(,!86FA=HD\?M7 7H 1L@'16P
M7+] 8@4P@D9+,BZ@8+WPV,S)@B7 !SUXCJFXJ\O- ,X=HA& A^)-DRB(!+[<
M"FRSG\W!@Q+8!V2P@F=Z@1&8A-8UWJ<QD4"PH<4 4WP0DO8* 6T- 2.Y@0+0
M@Q"8C1# AT*0+VOA-ORDCQ# 7WC@%A09@9)H@AV0@!;(V9?H 0\8_PZT:0CH
MN5FG"# %,)$=T%;O0@ME_8+%J.0F6X$18(0X[KRMF*RYZ!@OP(?C,+YO*(,K
M:5Y,S@ 3@)A!+@2A2-NA4+,DH+>Q.)1/4&4*P61+^#^[118VWI:B"Y-3IH8F
MV*\Z?I-T35S#,$<[OJ3&< 3+D8L_> $QX ^#"IZBR 3Y<"T+N+T*4(*D H$7
MW9R+30(?<Q*28HZB>*[O2QM^>+=X*EVTB0(8"(,([=+HD0"<6HP) NCH$0(M
MB"HCN$@-I88/B.?R40!8B&=\J( A0$L%<"J/ K4*X ](9:KPT8+9 :0AD(!%
M&@%%NNE^?@*6.D\0T(+-40"@%@(/(  # /^!?<*8@5+#\8& C(XJM[2Q>N,H
MIX:J'1,#E%:H#M L?@)J&,7=M:)! (B!1[":A: F<%::3[B F]D#)H8/(3@C
M:K"$+7@P:DC"&V" I^N" /VCK!26OM@'07@UGH2%@4@"6*, GM6"O(TECGN"
MN*"&M80 A7X(O*86A*CK&W!D"D $'"#.Q"8(,5!#5ZM!CX".HW(20; #DDJ"
M&WCM?2"H#ZB +4 J)YF +<A;6*@W1# B(7 U'T&0\^.'+= "FP D4:*&$PC0
M)]@6U:: NL9+M7X3#D#7'298M),:(*:BQG ."(L$%/@!N:.$#& $-HCFB.@!
M1A6$$B #1( !%D3_$?C>@B! D?5FPSK AT-@!$'P!-!UWPR(@$.P* IP@3Y(
M,+Z<Y[1A@BF(@BTX B_XQ?C^ 4:P@!Z(@"W8#V+*<!BHEBZ  3!8F+Q9 -6K
M,238@A)?@RA@ BI8U4XD BA(<0M'A S'M9/+\""8 0J@ 39@04!0 2=@ [;0
M !H0<D9@@ATPDA74,P3; C: $42  AQ@ P]0*A*@@ASP@@J3@>= @$(8B2:(
M@ 6( !^@08V1\)>X56]AA,#Z@07( 3T;@0S@ !1 $1VP\37 F!98 C$@J<S:
M'!F  @F8A*/U<.K.H@+Y3#P1Q\YH=*E)1#-FWC1$='(Z G0=9X)-#"C=_Q,&
M2$<&),O*Z4V?(^,+!]Y97:5,2#PH* %JR &7Z(%+2X(7B+>5>$5!!#V HX8^
M,$((JY%2>S!LVXK#1  H>+ 0])9)D(H54+$UP ?638((.(@G6(P43HD:&327
MX *T(9W8I:0[*M1)<(E[L!9,?D%@!X#S3 (H (0G*P,DIH$EH($RR(0E. $K
M: )(2 $/B..IS03S6%0%R "EB %X(  :L($O<*AS<C/C(X H(+&:D02[&PA,
MH,01:+T>* D:J"WWZ,](@,<2D(!>&28N& ,VB  OJ(=JLY)((/0@* +'KO0F
MPB=IO%+5+HJ0G?EMTF%YU3!+HB0A!@P54.=/\/\KP*(!6$SQ4E*!)5" *,B!
M/:@2UQIJ',CRE= !N>O-VL)= "^YDD#SF\C-I2@)%=L),NF()+B[ATB$(%C!
M'_ ">B$LZ0CVE4@(C>""6T(<&& #0E@ENSL4X\CP'R@!2F!WU!LLKC $/:4!
M22@/C6\".J !2'A%1M@":5_S$0"#X:#DBT  06"#-BV*)O "(]"0BS@Y&SAS
M3 !)M34!G& )NV<. ZB'1J. 0LAP1@@TGB 3,F  "NB4A2""/)C'+RB$Z=[Y
M!DHDP^ 4L(:HS,A2  @ 1RX*!J@IG2*(F(-&#8J.9&#,Y'] ZT9<Q@">;X@B
M I*3JFH,%3 /F/@#,IC_1PM0@:X!GD='"!4(-!4+@5>OCBI0@.@"" HM)!F0
M\<@   "(\EA ,$E3PH@ 8O!X0*U0N(0MO$B4V,0*&412+"3D,@-A%"@D 2#X
M,06 D!5)V "B8.0&  A,7@)0486,(I< 3$9,\D4!(BAA.@(8P60E!4PS 'Q3
MTE(3%D0[HM"D0*.,3WY6OF8:*PF<I!$>#" XVD124S -]'!4 >_!OJ,]/!!@
M*F/! D  HCCQ >&M0\-<.';T*D+* P TE@"@Q$3PB$B1 6P$L.\%TZ% (B+H
M,T5!$T@.&WR*P"(T[-BR9].N;?LV[MRZ=_/NS32)%(2\J75Y'7H$(=^R+1E'
M_Y!AY6T*3[K8(%-4BG7>"!8TB WA@QZXRL>3+V_^//KTZGO_$^!>B_)\WX8D
M6$\^K[\"XV,82OB)!QE),-$  H>@\,,2PDFD0A$+L &&!3$XL04,:PAD S]!
MT%$07PD5R(@+1V34V ^,'%)13IV%EHD'/\ 00D3(>(%0"@-&1 ,8@L"P5!-@
M4"@89U+@X$-+C+!115]$)10%#%0(4H4"3"4227<)(<+&%D% Y @,6TRR!@ G
M1/"C"DOT (DC9=!@10=T3$9!(8S\P ,!/5"6@EQ$0('#%AX@Q085>EBA8$04
MX&&(<!V,"89@>#"" Q.,=92$)Y)8%T6)AR0(@")LH/]00D%0"-*'I!(M)A$-
M#3H!R&HM:6 ?K+'*.FMO%.PCP0=?) 3!-UJ IL@73R@AQ@H @)",KCDEL$\%
MH.4$BQ950B"&&%4"8,T.17V03)0)Z6%<;-1HP2VG+PBA1;&A02#$#WM\008#
M&0"2:T34;-LM;!1@!X"M0R0+P;+-[OI$M+%METS!SZ(;D0PEU"L&MQ#H"D(#
M$ 1 *\89:[PQQ[ =X9X %2@G00 !U-?Q;%@DD$  $HR' 4[&)L, !/Q89^^[
MH=7#3QLWI M"!=)^\,((<P!0P T*%O!) T]80 %3"#QQ0W8*.<O4"!?LH81$
M3_B0$#455$W!-WND"U/".7W_XC-+3^2LT%)%5? %H?5^0"BSX(*@!;B]%GOL
M-U\4730(?@CA![]38]'42PAH80#96E"3M&=SUQU1!Y)&GJXB6B@AQ-424<!T
M1 7DJB"S0R"$C\"A"?%UH=\$S>\'UNFPQ^4HZ[X[[Q$Q4$@5%?Q@X0E+/+'
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M0H. /U2-$D[HRW9>TP$3C& !-TACJ22"@"UT)PM>,&,RAF &QI0P(2H03P>
M8(8O_* .1@BE$W.IRUU*Y&/N$9EO2&:R)3(@ 3H\&R^3J4SS)&$"7V# ,J,I
M35XB$@"?\$(4@@, &=1!"#S @ VXB9)')$01*(C,)F4@A?\]5(!_(F&GP%H"
MKGUT80LBR XW8T.!3-PA(1U8@PRLP))SQD8/<R0E (Q@H28$KP*S@TT"%408
MA"BB#I$Q R#4"4\@_>8/?5$!'33J4"!9XU6284P39A #%&B@GB:8)DQCJC$;
MXC"8.CR9$!/PA6\ L3S4D(-N ,:UWR#+.K9*I1[#!529,K6I3GTJK+[5DQU
MX > 4, )=@ "+98AH)%)@O188M$QFD 1"W@!!$XPA2C\X07$X8D>@)0($2@
M!.)+2 F-*(,_*" )"_#!" 2* !QLL",M6(,"R$ !=Y D"SCI8E]?45C1[<M#
M8$0 03=IUA=@%4R27, <%- "36S_EAIJ3<@(8-B4/S0@"?**PA& T 0/5$D'
MD80J;G,K&PZ #)B]$28/9\BREHV'8J[D@1%#0X$.P !43*%!$#@ NTRT@P.3
MC<U>^Z+;[7*WNT^%0!>Z(P0+@6 +6R!$7460!"N (#D 2((76=*&R&1A*8A
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MU=1OW=0/&M,0_]XA(#:1#O2!#8&,%>@9>B "H-G0#B"B>8! #MA0/PA /_"
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M>ASHVL8(@ &->I;RNE(C_R$#3M! (W$>!#P!&\S!R>##)Q0O)61 _5KB^MV
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MV2T %0R/0JBZ[(Z1",P7:M4NOP@"1J=/%/P$!)!T1X# #[2!1R])=<2&$:!
M&S1 GC/ *Q=WK6.T15& K7>!%;S9*.' #[@7!LMU!X@ /QS"H. S%6R!8/0
M"G3!7X5&#V#H]254'Q1!@"^7UPIG1-@5%2 #@/11CUE#][J8N8][N:. <;2
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M@"PTH $[!/^86&,YTB0 <C( D$F1"D H*, ,-W_T@(4>EB #2'PZX.'&@@H
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MY##_"J1 7Y@R)3D"EUB""9BE $Y@;R0";XS C<8"ZWY@!BA !ZCN,WY$:"C
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M9H !0%3_Y/8@ ^8V71ND K2@ K[@9,B@JL3154"T-&8($:1@=Q&BY:R !MB
M9,!'P2CA' O"&@:1($JI+4?N TB@8;W@,84Q&", !WX@EAC" ,"A3A-!2RG
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MR,#X=D(!YHG_30VBQ@P"QBX(R&Z$&I)! :@AI0_"QEZ;(12@MVD#"\3"H1@
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MA* ($#\A>J *"EG_QPHA!! !'@J8Z96& O  !A: +X$" ?I %5FV_:2; IJ
M\$,U!SA 0GN@# *2!D+ $XU KALBX8=BBE#>)F+ %4CE#U9@" R*&@+O_2@@
M$_01A?\''Y+!813@6S.#&E:@ +"?_J@H!^;6(*A!>PKP"?" 6^30]V?":5F
M&J#>@21 ^P%B!0 %^X8H #!P'RR!$)[T>?6%# !JW[X<!"!!P;<7!PL\B8@P
M)$(%$A ,88CO)$((^)(I&5E0((@O"58D($A308"#"H2 !/$BY4&67V3 >P
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M.V2R::<[4-#! FP08@ -4FP1Q)XR0$'"%AX\H,,"K[ 1@J$((<+# Q 4,@4
M1OS(" MSL4 !)C"*1$&6 "1! @M)9)!G"0;HD$,_;%@'P@^F G)E2)M(,L00
M$N1VD R1X#/)#9] $:Q3(T0R@:(-3(L#"6P  @*U;,#8 2,H:F# "#_D&8*P
M6^  *0 Q  E#I-P5D1;_!4V@L,4"V_5&Q".[B02"CIX"@ S&0?35 Q2FVF!
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M8 *A1=*\Q:> "5E_X;.88(<=;!@&DKV\N+[;! ]L(1)3T!VRD+#K>5%>B3^
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M7\ /C@,!> @REC $3=$!D.")%T&(('&$5$@65/@$UL$=A  :"/_P 4G(&SJ
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MC# '3NH<23 !WA(!/+4 5*"./F.2/)6F/*5&SI&?M-4^C:D<S4(U%T$<++D
M1S"G2W694= KO'$G4?D<B' ^Q2$\$[>4'[ QW7.8OD$->C !@K G-GD!"R Q
M27 (R7,""S!2XQ=;GR!<%$ !3F"HS($ R- &F#A;(X!-.$,-6E"K/5!1SR$#
M"[ 'WX,(?T %$L.K;GI(%/ #QP8^2J,S#& &C"H2*J !SAH2/A$2>O^P;P Z
M D$P;G3Z QS0E\^1!(4P!G-*IVQ0!$O K<J1!'W@ 3SEKE\"CLVQH<[TEE_
MG\.A" L *'TP8<B1 9)JF8YZISH:I<6!"%I2' RP#_.Z)1M#'9W*,26@%HA&
M S"""!R+ 850!(R* %MPA8I$ 0G++&KV'"#P!PVK2"/@:S?#JRWSA]>Y'%EP
M54V@7R.AL\XD4DR& $%;,Q1@!D'&&P5@M&Y!*C_; ICJG^$V*\\T@3++''(3
M+]E*.S338AZ0LG[F 1I;'"\HH<X4J $K'- #-3\@M<3!LE%A!!E9JW_(#RC
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M!?  QHL0)Q "B" ),5 "-! (UL"Q ,#1"]1?I,U""\@R1! !G(X0&;'<7P4
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MJ)DYF,(U 7/A%94&>CXF$4&F9Q(VKR9<N&&VA0>4(-C@N(!C#I$29AD\K/(
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MD8-_O%P 15B"=Y4= &:CF@POD)&.SZPHFP )Q"# 6H2UX-MOI,NN!=C_;!*
M#9*W\:2J2> '&+0@QR1\8+_?: $/Q,"^LQL IXL5+@6^\7:;?",!8L = C[!
MACV,>N6#)WSA#7]XQ"=>0!  \3T4L */YTX!( 9QCD+>N1PY7@*3]YQ++]UJ
M"L1UTWMVC[I8( ,IF"\O%Z3"#P!!@1.L1 H*<!?7V..30Z! "SX"@2"<0(4Y
M6'D!K=? X HAA3W$!)146 #@TL*&"_!  8CX0QN4! $\B* ")/ !-?@! SO
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MO%* O9" I(TP$@"$C;V-'.D1LX" OT4LE'7;AYVN GB!=+'/0@""?V6 PP6
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M&;F]\1?_ 9$!#Y@ 9+"!*>$"SKB''8D4E/B9$1 (95KA+IB#%C $$("0J0:
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MB1W P@^<1B$P@A9, " TR0U\  H\ #7T  _$&^.P'XC4082$@+1H#/MIG$^
MP1?D@U!X0@D\002P #5DP!X\P0(X#")X0*N4P -$01  YOU\ @H,06F^29
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MC(S VJA$$_"(JYY&6BB P !-"8A7;I1$5NC* RS-"(#!"YSI\J3$)Y@/6U@
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M:B" .]AM4+1 =9@5*:=+\Z"$&4Q!"RS %=$6UD3H%NA.>_Y,)&4'2M0*QO;
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M<?)MI, /Y%P#:$0.[W 1F8$(M $!.#/*\B:=B, K4+$1Z][5&<L%_ #W(?]
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M)(('0OC#-\! "2DJH EKH$ D&D"!#-0$ 6!(E4)BT#J%.&() $B!FK*P RR
M((E$X$%+Y/8#0!A@3PB(0$MHIY F ,%_F=3D)CG924\"Y47? !:0--:E+XWH
M![\)$1D0D <"-,$#"V ##,(0$0@@ Q"XS, <\  &6?)  CF(0 38\(>0Z,%S
M"QD!#Q(2!1S:,0QF5(@99C@79'B.&C]8(1,(,!Q%=.%\5H#_P!T!4$, [.D3
M?$+*)[:P!2>P(!-W:!,.?A(#5G%.$QC)P MB9;L2,  $QIR+&82C @TDP09J
M3( -1E $-BP@"#M @!,(8$?/)0(,F.ICJUXU@BI@@0M.D*4'"$ $&/[K"!&
MZ!*B@$)$^-&<GY3I3&E:4YL.*A\:V<>CD":I]B#@#TFJ1^,HP$T:O*HP9=+E
M%S*8 1](Y 5N$AP$'D+"9"(0A91@'S3[&!)J F6#;7H3 AJHI Z$@ Q/M*,)
MX]F=!?S@JA QZ0JRR0)I(L =4TQ(!VQ( 6T6$@ Q$ < EOD4,ZA&!9*(0A4"
M!@(PI* *"2G "B:ZN0RVR08F LI+_Q?2@U>U%  $Q4BUGJ@3!)" 0PAH0$NK
MR"H \/6FL97M;&E;VP!9Y!M$"Q*D L##$67@!IU9)5DM(*H;? *'$;$C(/3
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M:0Z1CPNIE!>O^<YYWG.?!SRG >123W]>=*,?'>DVO7FP8.3;I#\=ZE&7^JX
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M319 $%ZE /0 NKW  $9@C&,"9@DA(3ZAN,WU$TA@ ?8M(FA@ :;:=JX(!$3
MUDA@"]I !,B !FQ(!JB(<!CA$&RH'K9@ <@6 &1@01;"&HK;M3_@!QBA>K-
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M$4BL)1 @!^I@"*A@!8@@D** $1Y@FQ/@!*XH"3)@!_*D +ZALSE'OD"(7O<
MJL/ K^; HA$H\U'.^1EAL[DLP%Q7!D!&+?*^$$J@$#3!WQ4 (%J J7#(B@$
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M:#6*=+  +0A"9+7FP&@1@H<RT+<C,HC$K\\U"2\\GMB8E^9"$V6?F\S4(E$
M_RL,ZE"F[B)$!750 MA84 "W".$/!!@!& !100@@XP9*0(16'K<6P8Q+-H"H
ME@$44 @DM>8@P@=  !Z0!!\H !'<8NYG?IL/'7"+(6C-EL;XF]\,!+\.&M,0
M\$>PKB2@0$\)H<&(4L!M":VF?7JT)@ PT9-K-X2WRB,"^"G0 =(4UBV(<"9$
M(6RFURUS( $]8 7X<A8S<"T#8P:6AA"QDA Z@"*4( 4-(GVH]P7X %)H]04+
MX ]2\ "'<("Z1PE.\ (2< )ID7T*42[(AR*C0@!30PGEY1M1L 'X51IX8! F
M@0A%,'E4@02!<'F9=X3-9&RS91X]H&X @%&1-%@+4/\#2I C/7!--  &<W(:
M". ".( ##_<K"T "-W 8"X S(D!QYY)6@*,')O )DD 5>K W_)8A!S$\_H$#
M=G,0&7(NA< (.+,$:B@A&)A^WL40W=4%=4$OBJ$)]; NE+!SB @DC& ^)A<X
M<X(,-#,; ) A9B8A8# 9?<B Z^8"6S !-H F/6!AUH9M?0"(6T!VW@< 6> %
M#X(01E!UE=,TY$454O JHX@ _T8"B^<5WX ""2 %6# )/K,%)9 "1<!(PS*#
M+^AX&^(PHX(%9E 7%' [P)$$BM<0NF:$&F%?0D@!DT 'Y(B$[ A,[T0>,F43
MFP)AUY=^P*4"---D#Y )&M+_'@\  D<'?9QQ'04P! Y!#6FE""CP %4!")&!
M*VQU&3XH?%@ +&C! #+ +2I =@A!+PU47$G !-IW;9_X-23@*QLI*DF#64:#
M?E3A*40R%#3"([.8!1HRB]*W$+PU&<<G&Z-U-5[  ",@@/JB$/9'%3)R)7-0
M%8DA)74% !#8$ \2(14H*FG5B=>D VZ1@-@G!0E0!=_P!PJ0 4^6#!=X$%,E
M(5<)&64P/+HG(:3"@IKQ(K6F@[C6@^N($=; 6KA&A.WXE]$46P*F)@FP$M!&
M5^^G$#V@50BP!53 <0^ ""A0 5OP<"!  GL@"" C PM0 <@0 B_5)3SB*\A@
M A0@_PAVT 4PT%;6L"14L05VL&T/4!05D '1@AU24 $G!#9[H' OY15Z4HL/
MP2=P12-4( B$0 :-L0<N  8N>18#\0,]\1F7" !Z$)L_$(<M "*C&%\98 =:
M,&T9\)AIB(AUX)FWJ0.,4 ')<!FYV9Z?,)D+<$(_4"FF=P(BP ],H(L20@)4
MH 7=9@.$V""CB @+T)N6%U].D  +D(R1>:!;,")-8 7_9AG(0 5[,!F/B! Z
M@(VD @*.>7C:UQO@N'@4@ >0D)<7(0-!&%_H> <J"I@R>DKO2$XOHUL600W/
MI1 @X"R*\ &GAA!/H 5*D Q#L0\5, 3]4P'L13S/%5A#\?\$YC-F\3 9U-"D
M>Q:>5#&D13H5W\"D/L$/@*!<SL6C5%4:)S"=$I)I2YH 1HJ(._ !SD(!.UH
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M4( "9SH";" D#-D!06 (3@,%"\ &@! %$<"R(M!46- $4, (M-$"7K!6)U0
MR%#,)V0SX_P"ZGP$4"" ?-HYIH)J_8?_:R=0S-X* 1UP.7-@L-R"%@:  1G
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M$S(4$  *V(<6OK"E [HD !BLR3[6,R<(/$$,&PP*-10H$P@DPX,46 %J9*(
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M.E5YKG2J_[2J0^2:VI= P BO$$.E>H"#C3PD=8C85@$L8=J7V'0,1BW(#1A
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MRA.GVP0/_& +6V #%'8%$D0IRB<0D$"+YP6 689$.:E)R$2LA:1;Z7$A5J!
M(6Z0@ _ )0M>:$]F^<WE_RHD"GVHPE::((D$/,%: 5? 54##[Q(P   &)_5J
M8O#''J#')@A800&H;(%,^"4)C)CQ&L+T[*EFX"/  @( 8O!96/*X"HQF345
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M0>(Q<,($7H$#$4&@$&602 L6]HHVS)AR)G\4?ANE4DJY!I&!+W,$9'JY=[N
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M2^'+'UB"K:@'*;@ F_F$+9@ G%J:L,RE IJ]"\"!"'A!07@%0; -[-".*&&
M"7202K&\,+(6A_B$!;B /ZB0O$"!-B ($GQ'TK2.B6"#"]@! P"7OHS%32&C
MVH2)3R!,SPP[#X( 01 !0;"+J?J!5W@9GYDJ)U  #.#,#  V(HP)(_0<O*,
M2[#"2("V+B#,2/@0U-P"+V".'C@7 +C-"]@",""#$%PA&7""6T$,% *90R!,
MW?C,"8%/'("+RR1-)[" $5B "?B!H&L;Q@2VEY !1K@ 9&.--GF6P*0 (^!,
MYKP]0C03"[6![/]Q+.2R  K RAFET1KU$VG\!N3KD[BR&56JBM'SB208 B78
M!PPJ@"&8QF@< MVAAD@$B6^8GB(%@ +XG2-=LK]D-0# A^)Y"07X!J1# *>
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M (%=RXG%4!K8D10/D(HL8 ,/ %*=J <8^#U2_\L &+@<:SB$(A#$I=/:W>@
M-H '")+*/$D"12S:RK7<:]JF/E':+*B8*! [<?J&OE4<5#38'N6WVG*(N&C)
MK4V>G6#'YM "L@4![M.;*!!1G.B4H3'6'02*]>M:VZRVQ-&0!(D"1FC(F:"!
M(BB>SRB>.ZJ1KV$F$) 1.XK<.Q$5W;W<[-7>:])*'<63)D"!5_B!NI6!L)E6
M@/T):OB$"#"],!J"%P*M$^ !+=@@X*#%)SC3W5 )^_%4,4 I!7B"<@VC+V"
M5+T++Q7@\T!2LLTCOV D,1@]$$@&G76( ,"'%T).B-V#5_6\:42 :?P&!:"&
M!-@')7B"SL('_(U&:O_8AV2PH&M[@O\-8 NB!##X E@8/9G[ BR84J<(4Y-S
MQ0EI843@7;Q0B=&[-OB=JF^ 8$NQ@6]PX9C0X6A\@C<%"0G&!Z?8!PDX80JB
M '\XX@F!8@MJ)2\=J2F.QF08J21X 7[%H ON5P#=0F:;B"2M13,S@PN HYUA
MM<5(7(? !"_HXF#U7\^!A]2 @'CX J$)HS&>JGR[V2D]X0+Z!OW9AQ?P5,82
M4R;V)B2S,0'>WE 6927*7#XI '(%Y<FE6:C]@I7-B23H@B"P@UBL #]R"!U
M!B>@ C0!EI/DD0G8 N%ZB?UD@VW93T($F2Y(S99 #)1@#/0AS(V(@2*X@!__
ML%.:8$<C0 'XM A$F  V1  D$ %^L!:; H,V,-V02 )D>(4MV(&LP((<F %$
MV %LV0-D\ L=6( V )6E68!W.Y<>.$%DMB,SF  <J,8H.(+4K ,%&"K^%"[+
M X&(#"-&SCO<_($B#HG]-)\F$($)6 !=_(,+0*5Z6&A!8)!#0@8[R !( 0%^
M8(*Z102,?A(]8(0*V()TMK8<H((*>"L*R((ZF #,0)\M0 %0>>@?\(LH0 ;^
M](H>8%\]$#0U_('+00 22)";*Z;6:(PLV-"#6H OP&J0*$4[PH3 ?0ELZ4N<
M7( N"!$%D1&$68(N. (3*-$XQ(R.0(&COL@? .:O_VXZ+EB"0X#,!F@!JWO&
MI1EI1F@ !."'(! !S!KER:;L][DDF$TF-ET!" )=3N0)\0B)KVM'Y4$YV2"#
M(IF:N&H !G@1'_&">V"@%)T/&TH$%G/!$:@"CC"=QU _.;&)O@#M7WR(U8@/
M$:F7E/.@/A2X%]"#&D "*Z"!-5 3AU2 #K@!,I@. Q!0@K"@#MB#%8AMO& "
M0#A2!D" 1Z(('QB.A[B0O"2U*KB+($::=');O, Q_ 2 "M N%[@!Y[ @_+5=
MQ9""X%T_-$S2TJC;*''O%H"4\=L-K ;J$$@Q)4 ?J[.2,"*#V3-P *!' %"$
ML%6!W+8E ] !:!."%EG*+?\,6X=X. JIB5E2@ PX21?)TNI]%N10 2NH%1'1
M"+HR!+I" 0O" Q/0$ I7M29(%PKXCB_1G]U !C\HA#GXR8#+QA8(!-@NIM)
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MFF#400G_WUAW'H89:K@AAQUZ^"&((8HX(HDEFG@BBBFJN"*++;KXHH<2?!/
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M":7SER 4@0W_$NJ*$=@ A:J<YXH1& \$.@!&E42A#AV @1440 ,4;$%\ "@
M,MB  N]\H@V'@ %I$+& (/#@ 5'X 0? P!L*9 "0.CH!&R) DQ%(80LD )Q'
MDK %-OS!.SJ8@!Z*@,J.Z $'6Z@#E:X8A,U1H M4R $8TL*&?D1  P:002E)
M<#D(@#("E)J (/H02%6RP86%8 0)&.&=.#K!.Q1 ABU+0,2NC. '6UB __AS
M/Y<(@@V,V$@4,L &,'#EDFRH@W.2(,\Z#/ JGXA %C_2SKFXI O5C(XDSSDZ
MG8R #9'@EAY>L8 %,/$J'>A#$9S9PIATP'^(F$A'>A#$ 76 #5+H_Y,B$OF'
MC1A*#S"8B!ELN4AA89$09- 3%=@ @RGT"HM5&4$.,CJ1TX4RG1YQ#1L,*0,[
M='*627PJ5*,J59E=\'DW^POZ,/(-<C'@!3PK(8E> @AJ\ T 9%@/1V(@ @4(
MP0D/( (8+! ^JVWHA%:C@ HQE(0+6( :/[# _BK2@"2\P@(T* $9A& 1!$QB
M#=3XA@%H$!HB!+(#(6! #T+3 P\TH  O0$ 7?% 7"4FF(Q!0P0&)L#D0=$<&
M'G@ "/[PP#Q>M@>GT4$D ($ <GF$ BU03 \<Y((&,.0N(5%  M($PR,APA /
MJ,@#$,$O$$ D"6Q8@P+\ 8 >N.437"G$#O\4T(&D0" )8N$($V;3'P[IH)(O
MH5-ZMFM3'?#&"&O  FK1XP4L9$LF0%! #P*!&I@DX5'7*0-> CF"UW[B#RL8
M@0TP5!+_(2,0##C!.G7"@$PPD"$<]8]P/!)<#!V6##IPBV7)D!<#1*$(4Z#&
M\^PG7THL0+1ZH$DF;*  ?!#W%2OP:TRX8QVJP/8/U9M.JO+RW"*,-0!3?3*4
MHRQE$97-JC=[ @@QM ^>57%$#XJ '<AG&HXT@300D.U2R) $V:+1K1VAK(3W
M\8$N0.$N.J$L72B@A[MLE ),2%0/2--")60@)@BHI!#Z\IPG4 $)G*'  K**
M9P!DX@X<T<,41H#_8/GU\RPQ240E*[(_C[B I0C>QQ/:X$;TY! !-CB2-?H2
MA2H\H E2N, $8$!<%]Y&D3>X*?QVZ*E68F0+5)(NA^H!4DQS)!/K+ 0/<%V$
M!["5'UOHBQ#8H+N;]B%HR""H3DX 9O)I.B=0PPB:K6" )* 00V;P'[-%BB%A
M?R32,O$?$7ZXW9%ZI 7F84!&@BS;),!C5#,$0!\5FY,0&V&D2?@ /X)PES4?
M*0M@P#4;[$R>/;MD"PT807RF+/*1DUS*5<U9#;MB@ 0,(0%L*Q':NN"$R>07
M/8)V!P$^RH HL)EJ3J KLL&TA3WX@PU9Y4B( 2 !!;2 S]U! !,N%&B7_RQ
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MR5U5%LR![^Q!EJGB"X@06)$((K#!*77$F&%$%D0 ([A5'3+ FEW$8MS.;6Q
M/WC 9! !OW4$-0B"YG!<PKB3ED! $T0 "A@:$] 5#3""YN23'I# YI3&#WT9
M"@B";5RCO:D'2.D)*_7)"/1%$LP/J03D$DB'J$F8'C#"#P!%242 "-R8:/C'
M5=# /3V #& AK7V9;*C)[3V''K!2 Y0C^#6)*IDA'IC2OZ39>>@ %""#%)P+
M#EG4'I4&"2S !?0%!AS"/7D' L0D/OF%-6!CAD6D?)@D"H!!=$T$)20AKYR
M_SUP1--M5X;IA IDV%3^ 3*\T4>)6%GVEKCUH$M8))6 FHY0 ":@ !N( $8>
MI=X8089!0!GA #(\6@^PD@4X)#J=!P+H41W$! A403).)F56)MDX3\XXD0(8
MP0*(P N,RH]\0S6ZR#<D21((2-WT0 X%CAX<W=;\%:^P X:,@-8QC0XDR:$5
M8^%T@,99IF_^)G!"T,Y\@P3&#%:1AQ!DP$+]R!>,9HOHTT09E=Q0@&H2SF*D
M#M=DQ ,E031ZA Q<GM,DP0\L  EDS?'01F\&IWJN)WO233YL%>-DD&O2BN0
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M(&R.*DW4[5  'H#1YE#%376 >5H4O+H%A*D)(P0B&Q3!%G!%$SC!%D !5XQ
M!BP L3T,%PT'(AS"S+GD%N2 !SA'#\"K33W( C "#!0K[\"C,P& $!Q"$2S
M>!1M_Q$P@J4@P@\H!$?HP'C.E,%&44%DP07HE(EV*]S&K=SZYC)2Z D$&5 @
MG-:)$-*TCKVU@": @!;M(P4@P>440$ZH3UI!AJC]5KE,Q A41WXN!FE\P%B0
M@ D$'$?4@_?)7T%DGD?$ ...(B+0!%4HP"$  A+4  FPP)12!&J:%A,D26U
MVF"]G4[,CIJ(!2)"AW>D9$<TP6DL'Q;,(@#DE0P<;=Q0@L>11Q=H"0)$0$&P
M;/BL6P0<'070 .VPA'2PQ*A4!.\T[PV6QAIHKA%<3HX9@ )@ZMRVK_N^[Y2]
M)X_FC!'<!03<@ $80#T$D5<)8(D@@ A8A; )01?@0'4  /_H'B_SY9L!8("1
MY0 CK%*HA=QU!,$"[ $#(( V 8 \0EA.G&9.3.&;G49L$0 $/ &_\@ U;($/
M_( 2_, 7% (8;,$/P,,0<E),P%D6A("\.<L%; $8-,#9 4 02@?P<D3X384X
M+*G\'5.Y>L22$J%-4<36;D$0S("PZ=GMF(&$:"Z[?:]7>B'US:SJ<, ")&UH
M-![\KC$;M[%4U:W-*,+_"<&YT&F)G*95X) 0H, +@ #A)C 1Y.WQB@-%&-E6
M[%B-Q&Q']"I*$,8"I$DA0$E[Y40?&4!)O%'H$G)%$  -B( 2J)8": 0,+X 2
MW%BO\I;J')]$3,4?;($Y9N 7L);_!2"BD"G%"OU%4BP%+'I'$PM![$+J=40E
M1?# "DA <OG01^A!["P&:4D!+^<!78E:Q)P7<^33%YR0$D@ CU$:E;JQ-W\S
M."/.$IV-XR271]0G]OPO&X0 :[& "EB!$GS"M'%2P63@"Z2)#['8'V!!#XB
M!!A!JB@R1IS #B 281!;!WO?[LW!-_!:Z!XASQF _>!#%Z@P"S/!"[- /TM
M+0(H'A#"/@ ?!12"#41BV%D!/GS S,'0"QA!7 WS/0, "]KR7Q""!#2!5.C
M*$(QL2' (=R HP+<#\S!/KAR$I# "PC!U"9,'<1S ".<%-!5<=!5%#/&/CRO
MGNV!!/@>_[U-!TF&,UB'M5B3#<_TJ).>@/384MZ )L^\W(B(YP4P FYVP!90
MP2MXAQED%018 M=.!>U@P"L0@""QJ7. @+XE@1YL0:H0H'1T0+&"@%L@'!C@
M .Q@X'C\H@&  -!4@(^Y0"DKP7!!@+6)P! 6U __&IDYG^J\3@6X0$QPIEVK
M$5I/3 ^8+NWTSEI3Q,0Z$$U%<#Y2Q!;\SJ7\@!W@0&EWSQ9T* AW!&:KCIR&
M2=Y8Q=WD#96HP&I.W5AGMW9OM\R\)P;=3 ^@$@3P2$>XC?^&U4!ZS7+CC"JM
M*'>_-WS']YC",<TLQM%%:4<DP(PX)XC(#X$*T2_33!3 0#?+M_^!'SB" ^<X
MXPPB-*D"](\JBE Z)SB%5[B%7[C<T+>3<N89_P CH#:ZMC6&CSB)E[B)HZG9
M* VC2L"R>D3_&NF)Q[B,SSB-GX?B@.O-@  _N, /3, >,)$=U[B0#SF18[AW
MF_7,C  *:$$"*,$W=$GJ[ ./PGB15[F57WDX:[C,/ C57@<#04!HLB^6CSF9
MESFW+KC-,$ 6Q Z2YO?;\+>9Q[F<SWF#:KG,L!;Y!< 3=,$7AGB1TCF@![J@
MTVV:X@P"/('PM,$-) H#2'D"P/F@1[JD3WI4V?G,H$TRF#, !H"84[JG?SJH
M)T_^I?C-,-,63(#P*+;1O'FHM[JKOWK_X5CZRU"G%^@+!-! CQP-E<,ZK_>Z
MK^=,E>5,7C,42)&!HT,ZB&B!"TQ FRY[LS,[JD.[LT?[LU<[M5_[M&>[M&^[
MM6M[MW,[MH.[MX?[MY<[N9_[N*>[N*^[N:M[NXM[T,2[M,?[!># O-=[O3.[
M(#0[O=L[O^.[OZ-ZO]^[O/][P0L\P,_[$(3S!>2[P3L\PA^\\"3\PP?\Q$O\
MP%<\P4/\Q7-\QD>\QU,\R%O\QW<\R8N\R6_\R6,\RI>\R[<\S+.\Q$\ NVJ\
MS8^\RN?\S0O/KLOM<!9GS @B%$.XG_?\ATS KX,(%E !V$C !X0S#B3]APS!
M-X!-!63KW,HO_X[;3-,>)1@ME(]\58I<@-1_2!> #3YH <.7?8>( 9([#3\8
M/=Q&Z#>\_<PDP =003)4U-&X=8E$/=MOB (P_=<D@-J#LPL$_H8D0]5_307X
M_?ONJ-W##&C5=1=,@&(GBGG+?8>0O>)KR-E_S0N(P=I_/H84"]C$O1L'^U7U
MP&69UOE&N-BC2.*;_GDH0!N S3Y4 -3;_GF(@9-]S1X@>]Q^J[#?-_.E*XIX
MON\?%>%[3=J7?O-W1#(L_-?P _'#K:R_C""J*D84@.^AZPAE?X<@_?0?:NA[
MC>%+__G#0O![S1Y0@QO+[^3#C-B&$A@9E5=-N(DP__E# $!0 3"08/]!@P<1
M)E2X<*"2#PPA1I0XD6)%BQ<Q$L21D6-'CQ]!AA0YDJ*8;R1#\I. DF5+EQXE
M! B0X*5$!0@3R+SW<6--GS^!!A6J$$*7H1,3B#FZE"G("TVA1I4Z%4"R+U0/
M5MB)E6M4"=\"O.@ZD$'.;RL]/AV[EFU;B0P$KLU7P6U=H"[LYM4[UB1;E7L!
M?XPYDVW.  4^X@V\F#%0!4;7)FT\^:):RI<Q=Q1S=>T>Q)E!%\P'EN;:?5\2
MH.UH.71KUPCALE5"][7K";5QUTYV<BV_S[DG#R[=E8SAK1U? 5>>^7%A+<LQ
M)X<^?;&8 &P]4P_\-6SA &<_WM8^WBZ$N&/_)3PD'UC\>O==DPWQJ_H]6^'>
M QSGR+I^_Z8*VG#./[OX&]! H)X8KJL*;CJ0*^[$DNL+\#SJR<$+:V* '[;P
M>0[#KA3[4$22XIMO1*\"&&*?M2 P[+?]3HP1)  %E#&J]FS,L2+KL'M1QY]&
M(RRRF>C+",<?D5Q(@0W7<BC)HPI\4LJ!GI"O-Q^G1.F^R+XX["/IL@R3QL@\
M#+,F,,V4<K<>TV0)0K9>D*E(C(YL\T<RF!Q+,CM;JI-/&S<S\<^0MNRJ19T^
MBG+0$R$(<*T7U%M4)$4E_9#'M;2J%";2X/P.RXM"U/1$"BB-JD-10;(051'7
M[&W.524JE"L(]O'G_XM/+2H5UO[(<%3/,G>M+%A+.1LKNV$GRD>F"/5,@,*.
M5$5V0#QEBU3:B?R\UKV^KM06(EFQ,B"!+G&M2%=OIVNT1G0A0I/=]4KLC)IW
M$^).0:YR2BT\>M^#X%RF]N0WH6P%5H[;L?XJF*"8OF&6*P9>^.;6+Q4>3X'S
MNDH V(H'^I=CT.(=*U..1_MBQ2&]](C@CU^###W:6 8@U)AQ>^(Z5S\N8,)[
MJ2I+IG(I\ICFR<;\=6BAAV8L&7_8Y/@KU#K5UZ.9DVYM2;;RV9CCE:NFK$J_
M@$;77OST,[+KVHK.6"F:W3T[LZ6;KOCID[NBX+1G873;-9>[FFMHKO4.#/\6
M*Q%^E5YP>W:1)PGV2>"%QA]W'/+)):\\\LLIQ]SRS#G?W'/-0>\\],]%+YWT
MTT=/W73545_=]=8KSR<!'!A/0/;;;<\=]]UU[YWWWWWW'1\QUHZ9]GWP<3SY
M%Y9O7OGGF8?>^>BIG]YZZ;&O/OOKM>^>^^^W#]][\<$?W_SRT2=??>9?X$<,
MX.$//O[Y@Y? =L8O:+#BDGFF*DZI.^(" 0R0@ 4TX $1F$ %+I"!#73@ R$8
M00E.D((5M. %,9A! 2Q@:$'0X =!&$(1CI"$)33A"0_(MX(A;BH^2QFT4!A#
M&<Z0AC6T(0J/,#08W)"'/?3A#X%X0A1\[$U# B#_1X9P 24ND8E-=.(3H1A%
M*4Z1BE6TXA6QF$4M;I&+7?3B%\%X 8Q]C IA-.,9T9A&-:Z1C6UTHQ.+IS 6
M3B4G$PO<'?&81SV>*$C]FTJ<7KA'00Z2D(6LS1RC<JC\A"0)_&B#%O0'@F08
M@"/4((-(DE"!"E@  9JL "0!4  Q7'(@%/C$'CSY  !0X F ($@C'ZD "GS
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MD!&PX0)=@,%=4:("YM8' 3FH@B""((*) B +V06N11 )E1:-*VP3&8$'"
M2N#@ 0IHW H(4H!O-*  "H" $JC1L !+["8(^,8D;I"/FTA@G0JP, *^D(^!
M0  ?0P P;WE R2@<U9AXF,$(P,!,I8)W(#U@1 1<.0)XJ'*_$NB#/:G+!E=2
MH MW=<1C 4"#,E!R!"+X:1'"0($?L%C&MT1 !G;+!3H49 102&XFK-!85PR$
M"!Y0)02XT ]- * %,^ L&\*PRDGX8+&4; )C91"!%^C_8;P4, -M78(,YE)
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M__ \L/\ $< @^X53H .<[SM!6E#N]R!@ 6,&P)L_</M#V  ?I@<#"HH)$=@
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MA1(BP;BL 1Z$H%L%C V^ ,)DHMHX*P<(00G8BKD&S0.>"4R_@!J,P ,2  P
M@?W$T2!:P"47,1J_ 0^6@)Q@TLJ8-,L _Z '7,$ "H &/" 9R*#E=I8#QBX@
MV2 $OD (^@ ($$$*7J  TDZU-JL2^S$#$#$2(<$?/H \N< +1&T2F(L(>(#
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M>!$ "1;X",#@."%5?-G "@Q,#\9@#)S@08T@ F(3$"B!$78+!.C0('J@ "'
M#&:@LR28L8@,@0="!70/$?RL"1H8!DR@;L>,$D3UE=B @2-@LXJ"#=A ! Q
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@BBJNR&*++KX(8XPRSDACC3;>B&...N[(8X\^QA@0 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g28562bci002.gif
<DESCRIPTION>G28562BCI002.GIF
<TEXT>
begin 644 g28562bci002.gif
M1TE&.#=A\ ,7!7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M=^_]]^"'+_[XY)=O_OGHIZ_^^NRW[_[[\,<O__STUV___?CGK__^_/?O__\
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M!9@@A\96(@!3J$@.^'N#X-H@"050P"9$H(Z$="(%92T()P+P P 8P0457D0
MP%  #N0 P1=!@0OXRP."8*&__;4#?#]RX@"8H<, >,&,[YN0&9@7(A^.0T)B
M@&*']!C"$XF!"")L8!A/1 $R"$ *(FR2%P3@!J&5<0 0@=D@IV+,AXB( G"0
MA*N>N/_"J1(R&)0+$@%+ K\/T4  SEN0)?"WP0!XPX7I+-8YF*',"KAM111P
M@E2$00<DX$(J4L!8DG  &XB@K ( :Y$8! #02T@!.2R<"A=8.2(<\(, #*
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MM@GN:)D# 0.3I@]"8& !,(X?V5CIQ8HI$ *0974GD 1^N7T $ %:4(JFR)H
MX):SJ5<R@ C^)VYFD&;:]XR7R%A8N(/TEPI%<)8*X (@P']I=F,-602$Q7C
M.8:+P(9!J0*YEEF%>(A V6#GR(J-*)(<__!@7!8I\' ! N=CA)5>22  6$9F
M'*"-9R!WG2<$\>ELK]EY=R!@ 3"5C761C84 ^*!7<Q  HY9>(=!BVKA96) "
M?$80G><..+!E.W<*#?!Z9K!9];5E37AHC<4%0,B;F_4&%* ( J %9)99)X"4
M \%H.,9?14!9$[9L"F "OV8!+@"= .!I9N !T/6?9I %\?EI5V4!%T98P)=I
M528 G+B-!J8/*F!@*1H,^_6' N%I6@D #U9SO+F?>!>=)S"+ Z%O&48$*0H
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ML;F;<_"N\:K ;>NN#&P&Y<D!&)!>8>EE@T"<6S@$>> /<I #3K !3'!O[I:
M!%"^8""E6$L T:@.([":5\5D,CFH16K#^OEYN7@I;YJ>17!5VE=IG6C G*I;
M\*"T*J:/F;6FKX>__UFI!.@/DJ #K7B\LR80,TJ  6"[\ =A'-"@^'!A!2!C
M^*=M33:A]*4%0'BTE3BF^X5C4"P0;X!U>L6>IM6D7LL#P/O$'C!6)T #6AND
M\9G 5+F-_XD(&["DHO^*D0VLD>O66.5KI3LZO,MZQ;R: G& HY2:8.?HM?M;
M7P%+FXM  ?5  A1@:@T@IV4:>RS !$Y  4&0IY&:OY(@ *:0 G\:?-H)!A%
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ME[QLVA<"H!!:Z<5E6^B(=1P =B#E ;>>2PT' OW%*1 &M) &%Y $-3!A(;
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MC88 <@"@\!<@B8$W6NJE'*(" *<4+C%V2L&#0XX3 :1 L '& )^'!F8P217
MZ)V,&(<&:('Q#8ZB!3< B$#$S,&J&&,4[:' AJ0&$F6(.&ADD]0+-]IF-!)
M:55.%15H2;$% (<YB X!(*F3 V"=%C:Y0&1'[!0.G*(Z09IDQ8N*$3.BX&C
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M!DIXP,"'B6Y$:DX'=70=(SLW0'I5$$&; Z !Q4##?6W>7CI00I%U5T$3TMN
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M@VZ"JH. OL$0 "S(/C#RM=;+B",Z+//SB N@&C(R &&Z",O; @LX@1RR/)W
M AMJEQT "P6H-M!*@O?0@$&8P7@@'PZPD=T*A@2PF4I@I6#RC1#D  $P!;A0
M 'O( @X8LULA*K%2"N#*E46PARF8B(0S 002IO_JH4(!X(2600PQ*H"@NZ]C
M8*\Y;#!*(*%2D(43 S$/: !*V"]9H()#N"]*:*.BT[K]PB_[B@0-.[K].@8
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M!7!!ACR$ABN;(ZH>>$B%CZ0!$&@0TS#&-XB''/((4,,(EG F(V"C-["'<0(
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MQH$19F:H>=/FP@@&"";T:='HP3PK?3*UV33#2X(8>CJM2O4J$H(1KC[MFA-
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M8RW<P0!O($(/!&(!)IS!,8LX01(:P $KNV,@,=#RI!$QA?*> ,\<8,$%W P
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MA,&J?1I5;IEX$H 7_($Z2 0'S, ^X,,"3-A0F)B0#84%X$!9X@/312A*FJ5
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M:-V^6:K)'A^_K +X0[9YG#>CZP%?[R+PVA42'0(^6CI#'M9=XJ,E >SF@!E
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MMG.+W);1H0'XP<PEF?$Q-ZFQJ;E.(@E4+(DA.$$L !MJVEILQK!1.P<@@R0
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M-X DH0H#9N#" 2.#L8_#&4P@8*P9PG(#E.L<" -(+FZ(0![A*%#!LA'Z@8
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M BE>,]GEEV&.6>:9::[9YIMQCFWB>QVVF-^<@0Y:Z*&)+MKHHY$>&66>&XZ
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MQ"$X( ]>;MKZ(@7L"B%,H1ZD8 -P@ Q(@ 88#O@> @;J@"^62S?D80CRH$T
MP CJ+<$B0 /Z;@3V3N 6D??VZ@U@# !*0@'S(BSPP29, 01,0!'D@0%.+@*"
MP3@4P>GVX1 ]H$OTX>86X00,8B0(I0 7<=_4+]!^*-FZ)Z,V!K"$C@AN( ,T
MP X,X 7L( ,60 ?_( PA=""P(H#H+*#?,D +9DX'0" #<L 3#  %N@ 2KC&[
M9  ?X  %-&P&2J !4F[L;@ .-" !ML (1  4%D ".4 ;,X 3Q T=(0'\]@H
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M2V(S!Q2Q*6+@(%# #@BE!&9B"JK1'11@$^83UIYS&[_SNH SZ>1A+&P,!7Z
MMU23-<,R!!Z!QE"N"D!A!B30!X(@/1Q""U)2'O^4D^@2(@16( ;J,0,D\ UH
M0!P)H ;&$Q(2;0MB8-H6 0P@0Q44 !L+X,P6812_4@XJ$A)BH A:["&PH ,.
M\QKO($#=T@?:8/V^,S%+  -,,M$\P!]5<@K>P 144QA:;$>%H $T@#IGP!["
ME 1XHMF@U#N3D#XC  N*L3WM4A[P$@P$H$:#S@^P40 &$@XXP0ZN#SE)($D<
MHA.D@ 9HP 'J30&"X S@X$9+@@4@:PGN0 /PJS&V,0U <#@7H$]>S;VT8!OE
MH3?YH @6P$_!8 %HL]M2,SH=M0/@P D5 0-R  ;I<P-B0!5:\@SV$291] YF
M( @F\&'*:C7.ZEW.;+3_B& L%L'2IH($2.!1)T,'5&3%&L "JB!'%Z$P1T *
M5H#?I'43T,%1H\0>"C7=SH"W>$(!N$ %(J,C8B$.GC,,2, #^P &8B*O$"XH
MV(WHHG5:ST#(JL((G$!:N6"Y= PA=(P#P-0"R.PA(B /%H +#($#EF!?SRRT
M$"(RM$SHWM4("@L;G'4(DG$H66 XCDS(['$!X, M#)(O,N /_$$(W-59>R F
MI2 (5 TA7D 2H(-5"X\R.J$%#F9B%T ++A8&#@$C=$ =]I('I>(.GE-:V^ T
M%Y8#M.!(_TXPO>P&R,(_AQ( J,O/$@)L$U,&]"$%U"%@'Y5@1XMBM:!-SDS2
M_TI"S7!K*$.+18,.MX@3.OY T0P68;%NUDK%)',1([2 (B(@ VAA$V:.Q<BV
MZIK"!VZK([8V7MTP8,D56U^ S/HL*3K 4=N !,* ":9 <P'#Z[HU)J>/;+>U
MT!;Q!OJB"Z35'N[  BY7!Y)$4@_K!R*@'^3! XQ@(75@"ASU*^J2; </(2P@
M"9PW!/+@<K56!8(A#A0  1"@ 3@!:D6 < W 4A]":_\BM(2L3V:B/:H"6TNT
M ) 0(?A #MX@"*)T4# KO:X/;&^T8^7@NI!B8]$6LS8@!Q2# [C@2!T""Q!!
M'TY@[C!"<DV!=9=K.PC@+(9N@&E@7,MU$_Q#LZXKOO\D=^Q*:[3(;MMTE74%
MU0ASSEY) '<E=@0> 08,<@9"8'RU0-;( 2,.F'/%RR%@X 9F@"3#X"N"P%DO
MMZX$D@;<@"=FD0*ZP ,]H">;(E1[!1EU> N2M"-@("2PRQ1XI5MKX%U':P06
M  :P#@O. @DMH B$+G,_;%F[R1??!Q@U1BP?>"P$& 8Z@!9H@0$,E6&ED1I-
M5'3WC(EA3(_YF!9DE$0'D%M$@$;7-0AXHB7G$1VVL@4600H2V0MJP(YMS"%T
MX%^W )'Y&!*6,RG @ 'X& -SP-DT0#%D#@O\RE%)@ !P &SM6 /N@&,Q37>%
M3@<. 0DYH TH0LL,8,_\+AC_(, ?P*!/+A@B<#0Q[8$"$( (9HX$G!49BS10
M#V;)^&*X*B,'5&$RYA=3;AD ]'4LYS$).*$WQXX<M*P?^!B]%K8Q[+)('"0)
M/.!]T7D*4&!LM4RU%&"Y'D(+U $&2B"1'V'H\)@+2L"6D?',^  =2N+S-M.*
MV]($FI:R+G<L/8 /[$"5:2&QQ%(!=& L1%8FL+D:A0$"3,!F%S<A*,#07H!Z
M<2"87Y<#*N$&^)@,%KG;>C-T8V 0G#21=?7#'"*"^6*(^7E!8-*;(T/(0""1
M^T!2\RHF;M33Z",#0, "6F ?>,(9.: 0V\!9J\MY,:]$:[HD\E$%.  $8@ -
M3.$1_Q G!NQ@DPW@IIM""_XB5-5+8EF  E)!1\'9VUP7(4*K5.2!"PQ" 6 R
MT:YO*+NU))"8KP$@E'?UFSV@$O9U:XLP(#T: +"@AQ5 "BA;,&3"! :X!.19
MD0V ^7  $?PJU>S,)DP$X1)B$!@1 #C!Z]Y@B+% -XE@JODXZ$RZ"SX  BSK
MGZL#F 52V_AK"?:8%OIAPQAVKW1, 4B@F#53F/48!\ZB&D5Z%9L:(8S9(8)!
M$5"@RF3BI(D-&IU-QR#1O.U@!$C MG$@#/3.(-\[@C\6(6Z:L! B%G#;88Y5
M-9+57=*Y(V2 (RR@"V*R!P8B [PEKUHBM[+5G45VZ-P:1?\;0+):+AA20K7S
M A3X*G6%%,=00"R0V$2:E%@Q(E22[ TV ;>W^($W0$[S2\2?V0+X"P#285-V
MVBW:8'V[ )P=@@_ %BPP;PG.8 585 6,@"%.S%'E! 6&($\+2W)?[&0-8 S6
M-X0[0I(A AGYE5!JUH Y8K*G3B$?HK) #\F;XI/A=\EQ /-@H"4T= /^.1\/
M(KN#H&G]@!9Z-+"TN\64"R@X01).M(?/;,5B @LL"TG%CCQ.$] 2,R4,.BDD
M RSHE@<L8.+RRA#RMB1H_)$KHZ;C?+I.,R^\("S+#ISC]XHK81 MP 1^X'P%
MS6Q!+PBNO#;YH(<3>"@+0,0]=RC_$STIAA*\98)'VA&W:M-$H%+8"07"RS8I
MFOPL(D !NQ4: VNR/8OR#D%,.X*SDU<!BIQY%<L"V H ,-7*":(VDT)0@Z$-
M5*0:*<('2+IGW5T@P((B8UKHAH$G_MD/3" F.,%DL?,K^@JQ2H+5NA1_7T"R
M1> KM(!7EZ!ISRRN*$).\RJP&-J]3*'>'L+."!YQY;0 ?* +,@#"+QC$12(+
MI$NTA1W!#J$ES^(-_++DN0!-X]T#MJ.&.:'>F+WA^D1;5R!.&9VYW1"[,#:'
MT;T//#[3 W$0%1<-,*N8G># E@#CX=DD'14I_  4#GM\<^ ,&N+6D=?75; (
M&B"X_6[(_UF4S^V@(=0S].;LS4PD"0J V R 4N$='#]:O*XZ8T),-48,7N X
MY+/^$5,!$=#R(>!A$Q !']0+F9,"LE!@$RZ  +PQKTX $4*@!IX9+%P $3J
M'?67"U) "A(@0]#VE1/B(YR )/)* TDM$/]5'4 _!2*OMA&"!9YF"%(B!TI@
M+7R//@]FQ?Y!"C:AAA'Z!)S@((S #H+@ CJ@)%Y@$U+ #S-?:_$8ZP(4#/*
M" +@ DC>(?ZZ(J)Y\@/@%((@"9V,;.W@1/5W \T;ZT9+Z[26UA!"#  B18"!
M9Q1P^>>$"Q@#%I@@(M!E2XP;!A8-V9"#!P 41%Q($F(@QQT $?]TJ " DD..
M5!=(2-D0XPQ*D0"";;H (8D E#Q-!0EP(4P6 "I/(*JR@8.)+0 4: F0T(Z
M''4 L+ AZ0,8G@ LV#& THB^DS#D<'VQ%:6"+AX <&(28,A)'%.:ZF#*!YT!
M!7<;!J 1Y$P!+6T7A6CPQDE;GB@V_74'P$@'KD1S& WC86T#!9O !!L"-L8@
M V]PU$,$HH"1&Y0!Q#A1+T3;&&9Y<L A8D21!JY9O]&"Z(+@10L!Z*A+W$ ,
M.[QY1NC'6\,&E,<!+)&$H0W313IYPBL"/,3.QBZ*0%(+@B2"YL/\I1@RE"YE
M#C""GP$;9#I/%@G*GX_ACP@0'!9#"$3_(")' 2JEDD(82>D@@@ F>/ &$ST
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MY#4_PGM]U7-3((%C'5,F%A08!$K>0  'G"0"?\AQ 2P-+5&'BZ@ ^',$/D
M4]$*JV!9!'0Y 263 & &8=!!GC $F;6\MU\+8( ^.: N'S\+K5EH[7RR#(J=
M$#G+TR%RW/R09IXH@!9:_ABF\S"A-U!US:+V=@&"D1DXY,$+EAY!CJV5@1K\
M 1(1P+%^C,P ^BY@ S/P= RDH-)Q*P*J),FS?A:0#E#@S=(UH 4<P"+I;%.4
M%H^(@$K@$^01] -)/NB'J-,A[X!#*P\!!TL>^H!I ?0U"^8.^)>(?.3I6, >
M61VW%\"( @<H8@3QV  M_]S1K;YJW-(^H+29?[Y6DW_)%(?*8 0R('4 T%@!
M8:CCU?L!AR]I 1+2#A>YM\R!1XS "^X[LEV-3 L5>(_=UHJ!".S9KS]X>G#]
M>,1.+!W4(07#T]O6<P1<C5-7DP82/E"TV=Z09_?%0!(J#;2B46* ONJ8 T'(
M I]OZIP%*(*-;\B!&^*Z$4/P) =Q2/O::Y !WL!:P@"(N+5"_24+P&$!X6Y8
M<Q8QB&\M8.0DR4 Z=KJ BLO:WDENRJ63K(!FZ_@-1.B !WPP'<O3-P](\/'T
M4'"!.UB@"QOX@SXIV@^H'U@1:7L@/FI A#XL0.-XEG@@"PO'PP(R!U.(\I<6
MT?\2;4 #([$$-$ "FQ "*Q #CZ42+: 271 &0= !RJ$*B,,%H$  7\()CV /
M*\ 7;= %7: "'* !;4 ";2 $*9(EP5 %!H #-, %#I" !D$#8< %KD42&D #
M7; )6L(%PK$L? $"_ 863J$/6F("(.@&3*&#7$ #4\ ="O ! '5PPM &1; %
M)+B#0: ('* #&E%A78 #JX4"-=@&'2!B]M %/\ "(+@)<M S#P2"-P* 7< %
M4D!$E?$#PL ;,> %7+ B7!""#G ',X("$S@KAD$4-; 6*Y!:-%0= % )/)!Y
M!< )-685^#!\W"1NOQ6#,5* ,3@H!M$&%$ #M0$M&@#_@4%P \0E!5Q0*AYP
M7AB2AXNP@W<X!1S "3M( KNQ&FZQ@VW &K1W&RKP!O9  ATP B<0@E)P!Q'0
M9"1@#R"@ U?H/J8'BR,Q!V[0!:QH # @'.D@B%Q07CSQ!K#(!4/0!RD2!A3P
M68M@#US@A",Q \%X&&78!6U0$$3@!'%@!%)  F%  R>QBV$@C*Z1 "<H!5GX
M 2#8!B.1 UU  C10 A]PA^NH@P8Y$AH D+$8 ZG@(/+8!E501Z9P 2%P!#9
M 200!#'R0"3 !8>A $S !6<P EK@!ERPA!Q@"F9X WS1)2WE6VW0!@X0(Y5
M#N151YP @@/( 42PDC0P@;8(_Y-2,!1$$ 8E@!$0V ;ZM(MM$ 20X1R[F(\@
M( !+@ @.DR;Q190W( #!X !$>1B+X 0$P 6G@  DX !FP0=20  (* ]WZ [$
M%8SWP0)2D(\+R16V:(?B41\_((5$&00C$73Y* <<@ TJP )( 5DPT ;SZ .;
M( (6%0-%D $+P +N& %$0 (E< 2A0AP%D ,M,'X$>8L@$0,&"&>P!2U-@0-M
M()!3H&)=0 $UP 0D,)%P6(_Y.)=J^ ,C8(=A\&8H< )NT =#I  5%H,C 0,
MN0E?,32<4 \WD <.0 %=P 0:D9L'*!6<D IHN!\GX"";<)Y!\ .D 8(QZ6%I
MU&)O-/]/@*0 ]O!H]H <DC =,0$ 9=$4Y#>+&B K0X)1IB(97,$!7* "'[ B
M"' $\; "Q 8)&, )/SD$7@ ',S $#3!#7?$5"KH6ZK :,9,#V842BQ 1@T,#
M6V 8L]-7@D@!TX$"ID:,G% 0]@!#,Z (BY 5/^"(1@ &"@(#/& 1A7$1&4%>
M;6$$2; ".  "&) !=*$ $3(I(= '7T09,# 2)"@'2#H;,D$G0F *=2$/&\ %
M:! !$!JC6C<2G !GXB9LX6)BM>(''P!#\D&"3Y8DQ^8#,6B4&<0!0Q(!IK 0
M2Q C"F J6" 8C(*# % #&O,""XD%V:4%*L 76<B9SC$D"@#_ Y!Y$1M! QY@
M06L!0RJV!<"&$C@@JJI6:^[5&[=18T9P&"FR!1;@!J  !RSP%9)::T,@  I@
M!P7 69!0 QO0,Y8*%JWUE!JQF(H9#-"% Y#!*'? !ST !]$:&7J! JLZ$;#:
M%$MA!%*!(2U@$:"  2P 73EP'_&E7C1FBQ]JK +PJ3$3JGRA#O#X"-%J-PI
M EEH TRQ&BIQ!G"0 1_0 @I@ VVQ(QF  1KPDUT0JR8@JF' <$3!1I;H.%M7
M!1"EI4>PJ0"@!346I75J,#B0@BVBHJ"0!_VJI1O@!U<$8DSQ!AZK -#%%7Q
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M3#&_7HBU)S"^9PN(2DQ>@,8)">  )8 R]$&)7=&"*\85;_ 5"RH 1??!OI4
M00 "!F $]_&+M68'8XP22X &,: HG2 +*) *4F"\15  &C 2;P#_&EK7 BA0
M#W7L ;1:QBH0 5V@7GO<QSRK [ [91MQLD0PO@D@! $*%CD0P<;; 3Y DD(T
M!6]PS!UC"M*[$/K:=5P1#":0 &YP!QL\.&V0&5N<)="H7D:0"M-+O@+@ T&0
M #0@EBAA 460$L=A$?<[NN+&!4(,;.\,O::L'&:17J[1 >M;JUAKP'"F$GS<
M 0(@8 A*%/EA D2D #)0@\L6 R#LO)DZ$3TL!#W2%@91&"LJ!6V ''0LP>I
M&V;#FP"  998&VL!N4S!>;P!C5L0!(MA"C]@R-G#"0%I X/RI!C" PC=TB&2
M(N\%8B+F!KQQ6A'@ SH0!IN ""N27Q1J_ZM*L1W*B@/B:[SW\4?]Z4;_Z4<O
M?6KS')N1P1I#9!=;\*(-^ 8T,*;! %X1W2\6J@#XT ^B&@\-,!';4FMNX%
M8%G.NJ(H(LM&8&H 8&T!7 4930,;,$-U%+J#@QGG17N]H0 .P!05Q1V5.Q(5
M_:XC]B88 :7N^@(Z80)\2Q*UUJ0Q,S7!8 ]AA0.:DJ9-*M:440D.* PLP ,5
MBK5"(@ A.A/]< .S,P,4H%=^\-2T$MPJA!)84&,1  .D/2G'=L=N3#"M@<!(
M,&A;(6R: ;\DB(,& :T6\!*NK -#H;:>RQ4:< :;F@-RH  QW14T( "G5;5-
M$:KP:Q X6EZ4RO_&-W ;?/NC8&&KEM4<7V*K2LRLW])O+;LL6* *^PVL,O(2
M7?' 6D P*G'1>Y$'00#0&W'(JS'?T C0,2,&=6!9>_:N33$$CJC<7D'&UT+%
MKWP;3"$OZ8 #3ERU'*"KG^&"C^)4JS4IM6$Q:Y%]V/L&[C@K%C $-5 #R\%H
M7.=U'% #I@ :1$ P/^L!EJKDZ\VR<)R 0N-Q@[8;XF8/LA>P)SJTHV$56<!?
M$H;/ / !(^%K!C"U"ZI>,6'*T^$4V<NF6XLN') '+9L<OOI_R@H#LA(!""
M%&X*@\(5*)# @BRWF8H"%Q*_$>#>ZHH6(2$$P9!?%A$[UT*T9D.VS_+_!FT0
MXGQM!S5P%PE]$B#F 5I 54I;7KZJLYPP"(F+(>3@J[U6!"O >BAA O25$C%-
MH[SAX5QP!S*GX;%K&[:ZFMN17Y$--(#TNVX4O'+D%><M!,G+ LM+,,JV"*G0
M5F]6(25  #8@!7*;Q4UAH0DZE4ZP%T6\#UQ@%J8' 3CP%>"M",;,ONR>&4%
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ME<!L@#%%*$PF7A':U:)NJ0(9/RS8:4#2#@<<;B!L2J'2!+X50$&7.!+$\F;
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MJO'"G53_[$Q? AB].FM3?I?"@1GWP2 1F $(J*SC&:3GQ?<AKG'%-E4X6:@
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M !#0 ?';/KKCNRF8% #2 /88B0+H+A*@ 7?P/.>C@3O@@$H OR H@0_H@I0
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MV L#LL.!+A &+J"LI7"6B)!%>!P)([@ JL0+6_._-JB\RS,AT)(@T?(@R *
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M.XB(H ( 3GROP+,+'6A"R0M;U0BUPNJ,EYS9L_]C@D6E*L2:67UP@-\-@0C
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M,C(8@1D9@32H$8!0X,4   #!Y(%J &#,EH(H0.0ITB!/'P <QBCD, ,$)((
M%B'8P,)#P8(<!@+((T^1@)(E%=#JMP% !"\%  @D.$.1GT<&./2#XR-+00L0
M?!94T"_+C(HNE59\@T#139=)0;G<Z)2#J4, _-!"0-*J A8A%U0,1O5IV#X$
M@8(: 8J@4B\--)*,D/ IRC$S_<S%&7.FQ8V0"D88EB5/%@X+;M8D^*8?*!Q3
MK*9$T/'CHX(4K>:!8Q%E: !2O=3_\+("P(PX&N_0_(- -( %8\&&Q R@!N0:
M!7T@#=9' :B;,$'<%%Z0EL*2)PGZ$'TR^=$1 PT8N:$[I3P5)F439HBSN$'O
M!F9HQOS&71Z9)7T@"/P&*TX6[@'8-7G0G6ZUUJ%W!L (:2@2@57*O>1%.@$J
M9QM-*$D%1S#>+=(/2XH8@&!)&53DQV$GM600 NYX],9*!J94X$ ^>+<080^A
M  8'+KUQV!A.Y>>2!2"@EM]D.8Z D$<S0.!4:44A4 ,MR6F6CA?/F8:24HHT
M9^):F/FA4)8%W2A@/S4LH%!.5OF 4&H&A#D:7?VP=YA+$82UP0PSC= /""&^
M1)]RQ$EF_R%D@='$ @A.T4B?5)"4-M!Z!2UB1W-DRL0<31L1A=,P@R*6 0A(
MF!:@!8=Y(4 _CU0%TWT<T*+("$B5M$AG#G) JE63(2$IGX&"0-AVN_+:JZ^Z
M$1!   G\6JRQQ0H@A;#R'-NLL\]"JYX)^#" PP_18INMMMMRVZVWG+C!@#Q#
MC.6MN;K->.ZQ<+;1HKKOPANOO"XM0@,"#' AQ+S[\MNOOR8M@ -L_Q)<<+0D
M"$NLP;P:$ $3PH*PL,28+0(!"7=X-+'&&W,<P0PDX.,;QR/_JL ' 9*<LLJ^
MIO-!&*RN'+/,V7("0L8SX^QML,/&G.RR.0,=M-!#$UVTT4<CG?^TTDLS[2O"
M/*O<\,,!1-RTU5=CG;766W/=M==?,[VSPBK[' "S8*.=MMIKL]VVVV_#/?'3
M8Y,L-<1QXYVWWGOSW;???Y,L=L_*F@VXX8<CGKCBBS/N]=PKVTUUXY-37KGE
MEV.>^;."KUSVV9J#'KKHHY->^M:/1^WPW::SWKKKK\,>^[N<DTWXY[+CGKON
MN_,..NHI1UYUTED"I2NT*)#@;D&<\.=M#)<AQDD'C[) 0+F\<L";4H]"Z\,'
M/V3L/06*B%P#BM@K]E)NNRIPITLL5!JO OA415,-!DS&/?ORD- _^=WZ@04@
M<TH$1(89\YV+-[U;( -#1[N4>4YI$<#_@7<>@ZTW2*$?UU, $T)0@)MABP,Y
MX(%SM'"!%BE "TZXWJX:90 %P.Q9',!!!]P$ "/8 P3]^$ 1+**%AO0J C"0
MQ4O: ,3MO*$*Y9KAP.*UB"2LIBAV ( %W*"_[2@@"" (RP=" $)H*8 +)2"#
M!FAPF1C(03<I5(>Y(J %-C8PCG)LW._JICK)R:PF=6))4OK!@)E88!,=$$"H
M<$48L(# @"4)AF8:I@%]7*D@?!""#BZ#OT<PLE*TV, P^+BJ@B@'3O$A2 Y:
MX!P=4""-5"0 #=AH*L)P #[NN(DIG*"B#*E@(X11RB/R8$, X&\J+9D!$_"A
MJQQ #P L:$ P_YAPAIGXX"@H>D.J"B!$V 0#%'YH R2J69#)\/$-%)B)B?H
M U-RX" J*  ',H !F41 4'"X&0?R@(!$ L 'D& D 7=B@20TAP.<<,(=+%"%
M(XS*(^E(PQWJAQ,N!)0+6T@')%C 'Q]8R$#I" P+-K" $*'@B!8(P7L@H8 E
M%"$+^.M'=P" @@2<H25EFJ6 'H'1#2A@& W]C3S<8: W8'(V!K%!3.=HU*/^
M[8$DBZ#,%$ $-U @"&<P@ ^80 (*#*$/*#A!&#9@@BTH  ==P.H6+- &"A#
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M,2)CT>0<Q^S<RO2<0HQ4 2P"=V45*0[!!KR1 L! %9! Z%F >PD#?9E$D1&
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M5+/T;;IH"]2:3L+NR\(:S$LE "(0W#5NPA%U"Q.:KJ]8@%YERQT:2XS@2;2
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M8D Q32BA[9IQ$2.&#=>7 -!L$!<0&I\QNBVQ&9^/#E^Q2[G@S7@Q02B?KG"
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M"S>G:(HJ((=!PPA0%'E#RQ<&>8,)/E-)80H-,C4%':\64J (#I8X,Y5_T%$
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M'_OP@ 80D!:O\*22<BS SDQ"-\4506E"V$$<5Q:!/-!"D>J:WMHV4(,1U,
M2P!3'D9@CSY8L@!-4=JE2/-$=:62 YUHP1LD%Q'1J= @FK3 $)H91PX<Y&*/
MFLFB*L$#LD306!X"0!XP$ 1("("8(!053%003X-(+PM&66405*!"2^Y /BPH
M <K"1!TRC;)5/].(73 JD2JT4P,*>E>)=)"%>)%J$)@,4Q#R4H4%/"('<BC
M,@_:H3<0P @\F)I)'OH&&B#!DGHT2UE&.C9UD XC-R@ QBJAL+49  9JPPC-
MW'(Z<3D$3,3)FYW@L,X)//\2 'P0BT+O&28M4$T./E@B,'_CAS@* %T84T &
MY&&/2]FE"XI8  M8)#K9;.$Q!D'G049PND4HABE@2-0UXX@QMW"!#(^801+
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M 1)TE1A"A@")&9Q& 6& S0O$DH,;9" -%U"'!:9XS(8L\Z:0@(/3!F> ''0
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M(.^'*=U 'NZ/,3B#!8+@!@M@00:F";>%02P3!>M0'!5@#'& (Q&"-4$@!UD
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M#7A1)X+LBM;E3$_,=+.H;YF$<[?$!Y11212@#=94/BJ!=A1@$Q)@[=P"95!
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M^(B+] %':=)"[^6#="Y$]C?DY6O"[TL"(.P8 ,"I!0  .%2@&.*!@Q9W1FX
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MT;W0V-!.\/6"?T8D -)2 EAP@6,A9?W2:(M<4,=!2]@]W.G"$4";;:BW'IL
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M44AFT-H%],\(0P %"^RA61. 8 &H'1+OQH(6!SZW+C@XPQAH08 &H$ *H%@
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MK*=\"K /M$ $'8 J_[9GAK8H$A%@"@Y0A!WA &Y !L*P!0JP>VPX/2X4 9Q
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M.541>JIXVI6KA,6%-D!&_YT) Z?!AP;0JZX!J;DA7[;Z$_[0JJE /'VY"%*
MELJ8 T+A&BA@#X>@K=HEJJ+J'13U 7QBD8)T :UZ 1T0'5B0!"-@ F6ZFDNZ
MFDTJG"/P2K<!4<*A !_ ?-;9F4B@G6.*!%V*.BSD+J.36-HXJXIW07)@$>F
M/1D#4#8'&UB &4ES;[?Q-+KY6 \)AW/P9+&!6VTQ TTC>1P@6 ?;&AR  82U
M%,_Z& J !%81)4JC$BN[3&W)KUQQ E.@ >65 RE  S2P"1V 'YN0"C3@ "=0
M50U2M&W@M$ 6 TY0 T10G BKL;@!%"])2O<6&G>JEP7P!C!)6*6A?LKJ&AR
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M&0&:%S=1@0.*D 9=T'FE<@%",(*/8 2IX,!^L DRTGW_488J0^&]&E 9EQH
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MK\$Y!Q;4"15#"RY0'V)%"P14 ,%@ ^K75B6@"!H!9.Z"%DM!"UI053& %!O
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M X.C%1$P!T[0PBNQR"B0R$"##1*!UV?P!GNW$OU0-$#+(Y(@ *: &8&!&*G
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MZL/!*0!.(DB^J*?"@HT6?P%4*K*BDP@/7V\4B(OB1 #:(;C.Z5CR+@ +%WB
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MJL1,*"6$D85)<*X3T^Q HA451$ F#>@-TP0"&KP@AB1)B@!NR*<J394&!39
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M 'SHATT  9+XV39PXH70@@[@A!NS &$!@#& *S\ @3<850V0H5L5F2[X RX
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M *  ]NKFK' X10@ZZUD7[;AUHW>+;T]5ZRD /W *Y7 # N""' DJUG4!.R"
M30 CJ)"X#GH#>_=>\#4!A5B$(B@/-_@ M+_/&&@!#O@ %0B&,) +#'54HG$+
MM+<N)C#P7GJ#(.!X DB J E0+*@*+2@@'("A+JC4!H"!LW][+?\(%)C@DB(!
M" I0%'<Q'V#01;"#$1A7I>_K6HN'''J#3!F!/" 0^** '"8,4&7Q42T).>"
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MP-WV#L(%,   !:+BSD6PX(0#UB12%3P!A3IA.L78X!]W,$*(%-()S!"*03G
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M )IGXX$!6!""&(Q% 3"XR1BT=S(==(A',<$&1VSBO0C@(*4RP(T%@H(%?P'
M![:D'%Z3 A6IY+6O"\G*5@+0%;\25B=V=,D;@N>A!)S #BFIA @H(+V54H )
M^G##3V+@@%0DX ;;U (BW&""(C3_ #'X"DP +J /*6R 0'K#02JDP 4I>,"*
M $A+A+B B# 0839,*2529L"%5/Q#"DISS0%S@ B#U29\2"&?2C2;"@>P!QX!
M*($#+M ]N6QBM37DP@DN0(./:$!Z)-#'J'3D$A380WJZU Y&%F$"SH;, INX
M0!B8X"]X##<!/R@ !LDH/B-LX@1.^ &H]".Q!X;3!=.\T(%4!!<%X$!Z=A#
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M*$ -^KZ4""!!*0J NSWE5'@$8H V$@,[4@+O/3]L(/'"F4+@7>('#$ 9@4A
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M,5$%*\+B5W@B+F+$+?I5+^XB, :C, XC,3*%)CI%V.F &ZR>5?QB4SBC4\1
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M2_C !]B#I_J/$]R!/IFITJ3#K>&#0J0! K2!P;  "&A $4!", 3!F!J #^B
M U1!.&E!/>"#%J2"W)CJE4*9!C  /M4,8[1 KCH GS!K986!"D!&=]#*(I0
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M3:! &"S  AR52VA!%8!"&A#=(G0!_WY "[P!$?Q #6A "!CS+Z& %#  $J!
M%;"SOF$9#J I#-C! G#"$&Q B+(QW7I,#OPP1$>P"?#-!X# (\B2 :" &SR"
M O\#1@-S@ EL@!%( @,L !/PS2\O **<)P5 @@0[,!&4 "P_BT@O "T8ATM\
M !D\=!+(!0YO@K5X&B< IS6#PB,$E0$,PSK30CV@P2(@:0QP+ L, 38- :@$
MC4P(L^JL,RJK2!'(,PV0P1]P 0]HS@UD ">TJ05ILP-,P0AD,^#&P$BC<1\(
M- / @=8P00=D ( 4P >4P"-P0A%X0+G1< >HF)1:P 78+Q<P54Q[\AM[P;Z&
M<R O@#.K2!]#]%"S]1V/@3P(T&@H0KNJ@ 4,6AL&U0:8 @X';%/=<\=\%2@$
MCD>G 8H%PRF 0IC>P1MH 0BHY_LB18NFXXO"HP\40<W_!(7=7 P)*$+5H4 4
M64 ?2)-*W!H!D  18!+1H;10>(>OJ,Y]>+7.:=DB7%BTN$1<U804*(0T*< )
ME  ),.H:^0#159!G^ $*BP"F/ L'< %-E#?:4  )-#"# H!(128B(((($,L;
MT$"!>X9'I40.",,\L=46H \%J,UF, $%@$)I. OS<4 0;( RJ<1.?%H-M/%L
M[)S(#%P=>TUHO$ 4-94Z7,U]+D3%M#8)?#AMP8"&N00GR,C0*(3=0"&,-T!2
M[2<#.4%W1ZE0R.<5"E."00C@Y4$.7(@I>!-#+!"#L\=Z*\3A_<$2E?*Y*E5\
MV0.H7+4 )'29LS@::$#(Q(<0_P@T!0@#%T@"*"5,&VW!M?34W+V19^3!!J#*
MH*K"&[0!1]@G0G@ #!3!AYL %N[-PJ$!%DC!1' !:^A:I/OX %=!7"Q!VA!
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MKBEC<$Q@PCCD*/\,FW ""$;"@DU\<652HLPOEX"GE&A @"4P@!\^D I]=*
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MKXJ][.10KT#1'4ZSC%^=Z;7DNL,C40"->YMM;6N;?;C=-H3B-[]OCYO<#N)
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M ](*0A^301G$0<N- S0@ ))@XJIB$Y(@W;;$EF[NV[H%$7ZIW-Y !OZCYSC
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M4H!\%E8*"& 34J!O_LELU#4RE5/\<E/N["0NHK:,%, &]-0(*-9O"#<R0!9
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MH84P&R+44"!  $@  J0LE)<T9X$%;4!-S0HVK-BQ9,N:/8LVK=JU;-M"_U0
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M_P595D]^^;="WC>C3/.KMOGNOU\HU0WKS),"2#3@D )C/!(:^(X)8S?X"7"
M9!(;\[+RAC:0H 0;2$,;.G"E-]G(>P2LH 65]+;()84#&I@" %!  T5,QG^-
M"=7U+HC"%&8(40=,B@;4 8!%#.)ZT9N5"F^(0PMECS)RVTD."(" #T@! 1
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MD&H&Q1,^__=SP: #0H E,[<:D1&#0;@:$#!W&,=I,K%E$0%J/3AFG($@M/"
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MZ@??F99N,A&F_W #<,D)9Z ;'4H1//J@#Z$ 0> !'=J6%ZH% %.@*TH2R5,
M.5 '/NJ@,VJ7RK28++HI&&&@-/JC23JE6RJE%O&BYY$'#9H\'^H0BS $*^"A
MX.&863H11A "M*( 4C"DZCF793J79GJ@;DH1C,D!8T!!.-!>(&H1.<">9 *9
MS1D+T'F33#5L=<(!.A!U6' #I,D%%S L9=H/IVD!//@&P*((<\("'L0!PP P
MI0H)'T !5.<#\,8<^J5>!-!>(Z"J[553)  *\>":1S4#PD "_,4"H" /N$JB
M/ @ "M /N\H!.. .-- F%J #'9 #E1H!:2 ,#! $6Z  M% #JGI12/]% @0@
M:<% F;*I7R2 G!'Q G:@&SM@ )5P!O)  >WU!A^ KL\3K,/*/P! JQ0 "?RE
M8A1  -LR MO(7V4:#)8# @7  ?VP *JJ12A  ?B0 W(P%2A@K!]$ /X:&C/0
M!Z9  ?SE85H E6\) )_ZJRJF"#H "?OUA6D@,03P/'#QJVK) JFZJ@"0!SB0
M"A.+,;=*  UZ5&-@.2+$ 5J@"(Q(*Q)+ "R6!J?I [%VJY&%$<C* C6K&Y40
M;"<;%W<P%-4:KK*9L#IP!Z&!5!/;H!;0#Q!P!YR06@#0JS7+ ;2 !&GPJP!0
M"4)@  J  (S*M;\Z)^"*#U<2#) P R0060K_X 7]^JU7BP_C2HG\@U0+(+#C
M*K"2Z[ ":QX<H(/X  .<P@*A$[&*8+<BVW+4T@_F>;)2\ > >U0L,+$SBP#X
M@P)E&Q&WFJ[!H BF@+40D09<( ($($*+X 1_$&^2QK1(>JS<ZJVO&[MP:ZX.
M%@&P.[C'Z@48H*HJP+F4:*Z.NZNO*PPEH!<<D 8$4 *2!J[]H 69<ZZA6A$O
MT $$*B/Q61/>!FX:8)_?1R9O, 3)8PJ&((<S4 0>0$%8T&'D=0<B>@<"P D3
M6@GQ @.#>E1:8 <;$ Q#L &&J (*  /?%@$5^VDQU 53\,%"0%X_(  Q@ B[
M"J<>H !:< <:( 4,_V8"4\ !]G E%F"AM]N_.: T(] %&SP'$UJQ L "%Y!6
M6N &?1"U!D"I @#$'@ Q&_#">J$!)HP"$PH1?' #DZ$!DM '%E##&6K#%?JN
M1<!@FW (0:H".P #16  <+H!(X #VFL"?1 !'R#!-UD%30$#0A !1! "&X "
M2; "*-#';\ $Z* ;G( & >,&&U #, P IB %BE #F_H6,A!U0>H.$="?G  &
M1B )"T #&< $=T $9_"Y"L %'L<)%KL$16#!-+ %'# "\; %[6$*<A !6:RZ
M'Q0&3X$#+< !1'"C*% $*T".6_ &)(L%G(+  ( #0B  <%JDBV #)IP#.O_J
M$$ZZ)J],7IQ2L1'@ [:L9$V! QYDHP+@ WT,$3&0!#-@#XI@ F@@QR^<.3(,
M"GXPG!J@"B,@##MWNUSPR9S0 1QTHR6Z!2AP 8K@![20Q';0!^D@0@CMSET@
MQ5V@K5R@%T.,4T,@ "@0R7ZP!,8L R50 X5L4F'@S$S *1'@!S@0;);L#F_
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MU0,QS8.Z /PV%)B^N(B+%+B#Y$N+-Y !$2"3_V$@ *RJF004 3,SC!CX!T\
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MP <90H$$Z(&$B!<<2("NT (I4 %J2@!WJ,,2@*6>D$8&J(&&& $-L,,,T((
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M=NO=L>?6'I[[>._EP?\6GY[\>O/MT7L&_O_<=WSU]=G?=Y\?/@#YU^GW9U^
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%N $! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g83886.jpg
<DESCRIPTION>G83886.JPG
<TEXT>
begin 644 g83886.jpg
M_]C_X  02D9)1@ ! 0$!A &$  #__@ [35),3%]'4D%02$E#4SI;0E)52T52
M7T))3U-#245.0T53749204Y+7TA?3$%52TE%3E]324<N15!3_]L 0P ! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$!_\  "P@ )P%1 0$1 /_$ !X  0  !P$! 0
M       ! @4&!P@)! H#_\0 .A    8" @$# @0#!@4%     0(#! 4&!P@
M"1$2$Q0A,0H505$6@9$B87&2L=$C)%.3H3)2<K+2_]H " $!   _ /OXXXY(
M*A  1$WT#SY, "8I?3]_48 $"^/U]0AX_7G/_._:MUV:US9*IE[;["D+>#OD
M8X,<5JTADW*8/'!DBHHFQ=BMM=L@I^L%TE!.K6TTR(F,N<Q42*'+A4>X+%%I
M<()X&U'[)-E&+M,QF5BQIHSF*D4UTL*15&Z*=WV/9X)JWI=@8!1?#)?ER:8I
MN'+M%NX:JK^YSOSN=/*G1QSTY[GNO;*W!1UEC,NBV)&*:JBJA'!?<2V9OKU=
M-%-,QR*LV#KW3&2*HFW25(N/F-N7V8?'5.GTZ7T7)1$$6ZN\^G::2HB8_H$[
MA.Q+"D0"%(*X^RH=,Z@$13<E*90/W2WEWT@7"3V_].NR9:N(J(N7.)]F=)<J
M6QNY4+X8F"G/LTX]!S'K+?\ ">O6\^96.*)5SLUT .<E%2[@Z16W#Q/.FB_9
M_KFPC7";1]9+WI->LF5!-V=103I(VG6"6SY%ND$&:1Y!22;F/%';@9%N]7D$
MU&0;0ZY=D&BFVD@2!U]VFP]D&X&%R"F.$K4WK.660,_JZ&3Q%=4ZUDZ*!N'@
MRHR-2; 0AB'$?0H0QMV ,4WT ?J  (@/D#  _;R4?!@\_IY .3<<<<<<<<<<
M<<<<<<<<<<<<<<<<<<<<<<LC)&2:!AZAVS*&4[C6\?8[HL&_LMQNMOEV4#6J
MU QB(KOI69EY!5%FQ9MTP_M*K* )U#)H(E47522/R>1V9W\WQ8M7NBF/*QJ;
MK5/J O![I;<TZ>G,EY(JB[5XW3M6OFEAS5&P,H=^\%G*U*_;'W&@MIJ&!&78
MXJG(:39NEKG8=/F&<@.4K!NKG7:C?JUF;K?(:["9GG*YAAH[?IBG+#7M9<#%
MQ)@6,CWR9C-_AR]+LSH&96[=S)/!9M54N@F&=:M=]<X8]=U_P3A[!\"J4I58
M;$>-*9CB.6 JJZX"NVJ$+$$<'^0Z<KB=Q[IQ7<+J^KUK*";-7H((>D0]0?L<
M1/\ _<3<B!2E_P#24H?X  ?Z!R;D! #!X, "'[" "']!Y+[9/'@"@7_X>2#^
M_P!R>!^_U^_W^O-5]FM&]0MRH(M?VAUSQ)FQLW9KL8F4O--BI"VUE)R(BNO3
M;V@BTO%*D#")C)RE3L4-(HG,8Z+DAS&$=!9O0_=G4DK&;ZT=MY:STN*,DW=:
M8=@UMN^=,)K02)FX$88HV&,G-[-X9E(]B@[:P[.=LN6:*=>01!U7H]E'MR$V
M1U&[$Z1L-=IK7;+6/[AJGNS1(#^(,B:IY;]D\^>"0>JQ;K(&%<@QZ"=&V'P\
MK((^&F1L9/GZ<>W=QA+E"U*2?H1Y^B?D/I^OG[" "(?U#Z!_=Y'Z_IR/'(>H
MOGQZB^?V\AY_;_7Z<>HO_N+^GZA^OV_K^G(@(#]A ?\ #Z\<<<<<<<<"(  B
M(^ #ZB(_8 _<>4>=L,%5X:4L=DF8NOUZ#8.969GIN0:1,+$QC)(Z[R1DY:06
M;1T>Q:()G6<NW;E%NW2(9150A $><P[[W1=>M:G75)QGF:0VSR:V$Y Q=I#C
MV^;A785TE#)JMWZ>!8&Y5NMJE%-UZ#6RRP"*QF$@BW56<LG"*=-/N=V&Y:(Q
M6UOZN+73("216.C=M]-BL9:W%2*)D4VJZ&*L-,]H<LF$YS.%7,=;H:@/T6J"
M9BD57<@@C0XS&W>5;UTWMSVGZW<*)JG^(O XPU.S]FQ-BS J@C*MK1D?8C&*
MTA+G,<HE8KUUA%(%3(!C.#%5%>N2>O/:;6VLM9"]I>!G*,3$2#X&%ZZ]:JPI
MB!FS-1=1[8Y6O;+P<\SB60$4<+NFTLU!JW3*JY,Y(DL5>X.M#=3*^VC?8RM9
M3C,1W$^OF5(['E:VFUC5MKO5/9F/DH ):0D\1/+F[F)%"SXTEDG-*R[78FWY
M"JE<MA6[.!R!/BJ]:QG4;CCCCCCCCCG"7N*D6=$S%UR9OV%IU@OG77A;-^1;
M5MBPAX.4M=<QSDIS38EGJIL+F&JQ$>_<S.%<,7,+D]M"SWQ!5JQ6"IVR4CII
MS"Q;$_9'%>7\3YNID5D3#&2:'EF@SJ)7,/=<:VZ!O=6EDC^H/=8V"L/Y2-=^
M#$.0_H<B<BB:B:A2*)G*7(_J#]C?Y3?[<@!RCY^A_I^Z:@?T\E#S_+FON4-M
M]5L(IF6S/LK@#$:)/E@9;)V9<;T-,!CQ4!\'FT6:+'RR%)4'90*)FXIJ J!!
M(8 T&O'?ET]T!VSCY/??"%F?R!7@L6&*7%LS:]<J,A."C=-MAVK7E0'2WMF^
M"U.!'$D'I-'IN2&*8;+BN^;4&XLXN1Q1AOL&S3&S"RB#&1Q9UZ;46%@N<GH$
MH(.WM B$'8JE52.0C [M0I%$Q6(D)@ ?6';%GV[O'D-@_IK[0;;,-7@IIO,P
M47!>L%/?L .( _96;+N:VRXF62 5D&#F#;N2@9-%Z+)P8Z2?FE=R.Y^9? TI
M735C^L1JR"*Z$]E_LBPPT7;G ?=69R-<QACJ\G3<J(B#9,S*=>MD'GK,HLLU
M(4ZE"+DK\1%:X]8T#J_U68JD'/NN68Y)V6V.OA8QN5THF2-D&6/,6-D9&3.@
M*2I'K.6;1OI(H91-)50K)*FU=G^);D'Z;:X6#I/JL7Y446F8*J;M7A_Z1(4B
M;9"NKVFDH&.50#+&=*V%,IB']KXWE(#K:\;5]:G;9NM2V=5V-VFZXX%[3ESV
M#%6<,7ZIY_KF=\ VP'\6\<7W"^2T-A*[+X]L:#6,(+E^WDU8J70;)QE@C'C!
M8RS;YT5NP[L,I?:&?6W<'N$PIAZ6T^H67JK3-KZ[JU2-@JC=86\Q>*EXJ*9T
M+'"[%U>K[DZ+;1#^S1M@;.YW&D[3K"@B:4>_)<..O5>VO["K1,-(VF=O>V&0
MG"Q@422K?X83.3J-=H"O[*:RL@Z=0)48]R0[5TD_.Y9H?#?L55'+9995NAD-
MAEGL7C8YA,Y?[A-Q</Q";EJ#=U;OPY=GJ:+^0".?/G4;.OFD3DQA^5I,VZZS
MKXZD#[+E!N"4\J0PH+;+ZR5?8+<B/?6G5O\ $B9$S*%;.@E=H6 U+T;-/5(L
MV"ZX,+;C6:Q-"W3'\NY=) K _P 90#9Q'MVCB-3:.T3.$R[1J=?G9:OY,OWD
M[)@H<6:BOP]/=%&:!EF)RJHF11)B0YFZ*JI0%ZV*J9)^B8S9Y[S<PI\WFU/P
M?L9A.(N;#8;<V];BOIZ6C7]6F;UA[".)'=&8MVSPDG#L6^%:M5V<ZVEGCE!W
M\B?1=.HU-DW9L%"('7%6E]B6:+QKEH?N)GS&L?$2E[PSK7F3)M593XS(0JTQ
M2Z+,SS;\S_AV:KD]\-+X9UUOR6?AI3PE_P A),G7M+DU7V%W^DM;M ]0LX8P
MI2.3\B;/VC2'">#Z9<K9;7*5FMFS2],;MCV*YR"<M<9%W$TIQ:+(O,S9EYB:
MDHE)6;=&<O7:I^N)1$0\B'C^T8/Y%,( /\P !_GR;CCE+FYN&K<3(S]AE8V#
M@X=DXD9:9F'S6,BHN.:)F6=OY*1?*H,F+%JB4RSEV[71;H)%,HJH0@"/.0MH
M[F,.7NUS&+] <.9H[)LFP[Y"'DY#66(B6^N-2F'"?R2-\A;<WV0K^#(%!-J'
MJ7"MSMVDTW*B;((P7!7)6V,<EVGM8L].G<B[2;3:(=0.OADXLZTI47;?8[-]
M73>B@=:(F]@M@U,4:SUF==+$<1J3F(P_?$@;&<*0ZJLDLR?QW/&K1W3WEN_I
MS8P'8=WS9?@)MXS/?;=1LX;5X=K[E^J5X2$CUIJ)PGU]UJLKN13DX<6#$*\T
M249/4I4&Z3-PEUGHV;.P-1A'4O6[J8QQKICA"/.:LO-E-K<18>CX%CX1%FS7
MP[J?C[8YW'O/2945H1.:8-F@I$(,KZU!]&2HW&G;7<FKLUVVITCPHFM*G4:1
M&'=1\K95EXZ&!JD4C4U\RWLI5H>1DSNE'2BD@IB5FU*5)H)&!RF<H&KZ6HFV
M4G'IM;1VD[.@HHE,$=N,>80TCIGE23;)-V@L!D-;KP]8I0@_*6C@6?OW)UU4
M#OGCL6A16U3VQZO\&YCKD?$;G]DNY5AH3.SP=K1IN4,VZP43%DI+P4B=U7T[
M/CXFO58H5ZC&4L^(JE!W>$L<,^<_ 0?,'A&C%%+ ELVUT2Q'%5S&^/\ O#V(
MOETK4H6%K>-]7U=4-LLDRCQ-P!F%);XAP7IEDDQXQ@WCU*^PB6M?A8Z':F(P
M,X:NQ9G+N]UWYTW-R]D?-Z67L=9E)JRQBJK(8$S%LYA&HZN;!6*WN96?;WRF
MS.$Z[/N).7HD1"%JLM6,F6C&N#9I[)NIZ!/2IYHW9V0>L?''''''''/Q<-T'
M:"S9RBDX;N$E$%T%DR*HK(K$,FJBJDH4R:J2J9C$434*9-0AC$.4Q1$!Y=9+
MZ5NL;*-KE;S(ZI5.@W&><_,G[/K_ &[)VL4U8'1S**.EY]YKI=\7_G2T@JJ=
M>35DDW"LDY$'3XZ[DA%2VQ(]-N!Y.9)(N-GNS;\K10*@WJ@=FFY*E>;E*N57
MRA\G*3B=2]2*:3(4RSOL%:I)^A$CDA7/*$RZ$>L0SQE*W##.3,M3#(5E"2.:
M-KMLLK HNX6%9RNK$W'-DA7Q4=#Z"/ 2B$DGA$4?E)+')ZQS[C+J/ZP,/KQ+
M_'N@.HL',P2OOP]E7P+CNP6V/<"W4:F7;VVT0<Y92KG055346-*&44!0XG,8
MYA,.[56QECJCE1)3*'3*D1N@=JW)6*K7Z^5!LHJ"YVZ(0\<R]I ZP J9)/TI
MF5#W#%$_UY8&=,C95QG"-)G%NO5PV*>*I2)7E7HU_P 74FQM':!H\\<8A\OW
M"BU9U&O6YY8CAPE8_P P9/VL6W)$.VDF[D8C0]?L6V6JCQ1/)?3YV#Q#$JB9
M$I7&LIIKF]'T.5W!&JJS"B;1!,E(9%%,[PK5@\/'+K%3=D(U]#Y7\#]K4\D\
M^ ;JU[:OD?&,[\IZNX]59^R01 2_F:.?%(SY/T'TL?F?-.'@4VY@,41_%SVK
M7I)14K?J9[:'J9&[E1)9+ N"VY7"Z0I@V:$3>[-MU4E'P'4,DLX(DU; B<KY
M5N91$%+95[/=MK,5TUQ7TJ=B4Q,"V]V*;Y8L&H>#H5TN1T1%9&3L$_L/8$(A
M,$0<+(J$;22[@Z:!"M"MW/RT>1_95%=Q'8':]6DG'33>4,%8(R98;WF+6K*.
M^^L2F)MJ(.7A64+$05Y:XQR1"S#2>HKD'TS2SRLC9*4#F2D36>KSS,#Q4AQF
MGMPMLM".ZBCW[#W1A$:OY$L^FMCP'1]+,1J-;*C?*A_'LS;I//[*3UGQ5,M;
M9*PBE84;6MQ4*K./W5=J;P'$X=8R+@G:AQW#]KY&GQ+15M/L-6Z2<2)X6GV_
MKH[WKI.!$QRK(5I Y(C6N%CY5%NB^1(^6079F0+X>"U 5V[(\)GLGVJF6ZS_
M "CVIQ^NHO8]LR>1> /P^G8K/)0DLLIZ3&B+5LE69D5#>@I3(.)BMOB+G74
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M/J&5=9VB4.VE4"RL<LVB%WC!=<224P+%$D:MDRCZ<-X9P\E:K^$]QQ:5#LD
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M'W'QY$>2_ES ! 09M $! 0$&R " @/D! 03\@(" " A]0$/(<]()$*  7U%
M   *4YRE  _0"E,!0#^X  .1%,AA\F(4P_N8 ,/]1\CR8  /H   ?L  '^G(
B\<<<<<<@!0*'@H  ?L'T /\  /L ?W!X#SY'[B(\CQS_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g257822.jpg
<DESCRIPTION>G257822.JPG
<TEXT>
begin 644 g257822.jpg
M_]C_X  02D9)1@ ! 0$!G &<  #__@ \1$E32S$S,SI;,3A:04<Q+C$X6D%'
M,34V,#$N3U544%5473(X-39?,5]#14]?4$%97TM?4$E%+D504__; $,  0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_   L( -@ _P$!$0#_Q  >  $  @$% 0$
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MFQ5-';9XATB*IE34GN/6Q$-@I76MT7=C#DP+QEINMZV;U&UM;#;V=]N--O\
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M(= Z#Z0Z9N]/IS:4I2]>Z4I>OI[H '7^O0 S04TQ])"_Q ;^$/XBCWBF]'I
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M]]!00Z^1<)^Z14] ^ &]R< #J*9CE]_*Y+H+-EE6[A,4ET%#)+)F])%"#T,
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MQC*[<K/47<?GZU^*8;,QQI]0.H/H!7/N),G'&,8QC&,8S&R4/&RZ7D9!JFN
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MB)>\<>^JB0@=.H>'>ZCU\ 'QRG''7ES=-^QO,1=MIAE%S/%7?NU./,57H?9
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=OVBRI^[9H@YNZFDL<YNZ0IC&Z%'H4!,/@ B'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g866941.jpg
<DESCRIPTION>G866941.JPG
<TEXT>
begin 644 g866941.jpg
M_]C_X  02D9)1@ ! 0$!G &<  #__@ \1$E32S$S,SI;,3A:04<Q+C$X6D%'
M,34V,#$N3U544%5473(X-39?,5].14]?4$%97TM?4$E%+D504__; $,  0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_   L( -@ _P$!$0#_Q  >  $  @(" P$
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M'0Q2B'7KT$ $.OP]!]_. (0! 0(4! .@"!0Z@'P /3P#]WHP!" ("!"@(!T
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..%,8W0H]"@)A\ $0__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
